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Directed evolution is a powerful tool that mimics the natural selection process to engineer 
biomolecules with improved and altered functionalities for a wide variety of applications. The 
advance of biological engineering based on directed evolution techniques depends upon selection 
assays that can practically search large, diverse libraries for the most improved variants. In 
Chapter 1, we begin by discussing the potential of growth selections to serve as accessible and 
robust assays for directed evolution. We then delve into the existing approaches to expand the 
scope of targets for growth selections beyond those that are intrinsically linked to growth and the 
strategies implemented to improve their throughput and sensitivity. 
The yeast three-hybrid (Y3H) assay is a versatile system that can expand the field of 
directed evolution if implemented as a growth selection for the search of large variant libraries.  
Although the Y3H assay has been successfully applied as a positive selection to evolve proteins 
with improved functions, its expansion into applications requiring a high-throughput, versatile 
selection against transcriptional activation has been hindered by its limited dynamic range as a 
counter selection.  To address the limited dynamic range of the Y3H assay, we undertook a multi-
pronged approach to reengineer our Y3H counter selection to have a high dynamic range. In 
Chapter 2, we discuss strategies to improve the dynamic range of the Y3H counter selection by 
maximizing the growth between cells with activated and basal reporter gene expression levels. 
Specifically, we elaborate on the development and characterization of two Y3H counter selections 
that were based on either reporter gene degradation or an alternative phototoxic reporter gene. In 
Chapter 3, we present our most successful strategy to improve the dynamic range of the Y3H 
counter selection that uses the dual tetracycline (Tet) system to increase transcriptional regulation 
of the reporter gene. We employed a guided strategy based on both rational design and library 
approaches to find the best Tet Y3H reporter gene construct with the highest dynamic range. We 
believe our method to engineer the best Tet Y3H reporter construct will be widely useful to 
synthetic biologists developing sophisticated in vivo assays that require fine-tuned reporter gene 
expression levels.   Finally, in Chapter 4, we demonstrate the versatility of the Y3H system by 
developing a screen for the detection of natural product biosynthesis. This assay should have an 
impact for metabolic engineers that are employing directed evolution techniques to generate large 
metabolic pathway libraries for the overproduction of high-value small molecules in heterologous 
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1.0 Chapter Outlook 
Directed evolution has revolutionized the engineering of designer enzymes for critical 
applications ranging from the production of therapeutics and biofuels to the detection of pathogens 
and environmental contaminants. Before directed evolution, the enzyme engineering field was 
severely limited by rational design, a method that requires extensive knowledge of how changes 
in an enzyme’s structure will affect its function. Directed evolution, on the other hand, is designed 
to mimic the natural selection process and only requires iterative rounds of mutagenesis and 
selection to generate a diverse library of variants and identify the most improved. Due to its relative 
simplicity, directed evolution has been used to carry out a number of complex enzyme engineering 
projects that have resulted in immense improvements in activity and altered substrate specificities.  
These advances in directed evolution highlight the importance of using a high-throughput assay in 
the selection step that can fully search the large, diverse libraries for the best variants. Growth 
selections have a strong track record of enhancing the efficacy of directed evolution by serving as 
an accessible method for developing high-throughput assays. While there are numerous 
applications that vouch for their potential, growth selections are not readily adapted for the 
evolution of enzymes that are not intrinsically linked to growth and/or require sensitive readouts.  
Here, we review the existing approaches to expand the scope of targets for growth selections and 
the strategies implemented to improve their throughput and sensitivity. The novel strategies 
discussed here bring growth selections to the forefront of enzyme directed evolution as a highly 








1.1 Exploiting Growth Selections for Directed Evolution 
Directed evolution is a powerful method that mimics the natural selection process to 
engineer biomolecules with improved and altered functionalities[1-6]. To harness natural selection 
in the laboratory, directed evolution includes the iterative performance of two steps: 1) 
mutagenesis of the biomolecules’s DNA to generate a diverse library and 2) the isolation of the 
most improved variants with the desired functionalities (Fig. 1-1)[7, 8]. The use of biomolecule 
libraries leverages directed evolution over the rational design method, which involves making 
specific mutations based on an extensive knowledge of how the biomolecule’s structure relates to 
its function[9, 10]. Being unrestricted by the need for this knowledge, directed evolution has been 
successfully used to engineer a wide variety of biomolecules including novel biocatalysts[11, 12], 
research reagents[13], and therapeutics[14]. Furthermore, directed evolution elevates the 
versatility of biomolecule engineering by providing access to targets with complex structures that 
were once deemed too difficult or impossible to rationally redesign. 
 
Figure 1-1. Directed evolution harnesses the power of natural selection to engineer proteins with improved 
and altered functionalities. First, a library of variants is generated through a mutagenesis step. The library 
of variants is then assayed en masse to identify those with the improved function of interest. These two 





Although directed evolution is extremely versatile, its success hinges on the search of large 
variant libraries with increased genetic diversity, particularly for the more challenging engineering 
efforts[15, 16]. In nature, genetic diversity perpetuates evolution, and directed evolution in the 
laboratory is no exception to this rule. Considering the major advances, the power of directed 
evolution is directly correlated with the size of the library that can be generated and searched. 
Libraries with upwards of 106 variants are required for demanding engineering efforts that aim to 
vastly improve or modify the biomolecules’s activity or substrate specificity[2, 17]. With the 
advent of recombinant DNA technology, the creation of large and diverse libraries that efficiently 
sample sequence space is achievable. However, the majority of these diverse libraries are 
composed of undesirable, inactive variants. Thus, employing an assay that is capable of fully 
searching and isolating the rare, valuable variants is imperative to the success of directed evolution. 
There are two approaches that can be used to search a library in directed evolution: 1) a 
screen or 2) a selection. In a screen, each variant in the library is spatially organized (e.g. agar 
plate or microtiter plate) and individually assayed. Albeit effective, screening each variant is time-
consuming and severely limits the library size.  In a selection; however, the variants are assayed 
simultaneously and it is designed such that only the variants with the desired function propagate 
(Fig. 1-2). By excluding variants that do not possess the desired function, selections allow 
researchers to adequately search larger libraries than those when standard screening methods are 
used (106- 1015 vs. 102-106, respectively)[18]. Although there are high-throughput screening 
methods, such as fluorescence-activated cell sorting (FACS) that can access larger libraries on the 
order of 109 [19], this technology requires expensive instrumentation. Selections– whether 





libraries required for demanding directed evolution experiments and are not necessarily dependent 
on expensive technologies. 
 
Figure 1-2. Methods to search the variant library in directed evolution. There are two methods to search a 
library of variants: screen and selection. The screen requires that every variant be analyzed individually, 
which limits the library size that can be practically searched between 103 and 105 variants. Selections can 
be used to search larger libraries greater than 106 because the variants are simultaneously assayed. 
Growth selections, for example, link the enzymatic function of interest to cell growth such that only the 
“winners” survive.  
 
In this chapter, we focus on the application of in vivo growth selections for the directed 
evolution of enzymes with improved or altered activities. We begin by presenting the different 
approaches that can be used to develop growth selections for a wide variety of targets. We then 





growth reporter genes, such as maintaining throughput and stringency. We limit our discussion to 
growth selections engineered in the well-studied microorganisms Escherichia coli and 
Saccharomyces cerevisiae. Due to their wide use and extensive characterization, these easily 
engineered microorganisms are and will likely continue to be the best hosts for in vivo growth 
selections. 
1.2 Approaches to Engineering Growth Selections  
Growth selections have expanded the power of directed evolution by increasing the library 
sizes that can be effectively searched. In the context of directed evolution, growth selections are 
implemented following the transformation of the variant library into the host cells (Fig. 1-1). To 
isolate the desired variants, growth selections link the enzyme function of interest to cell survival 
such that only cells with the desired variants are selected. Linking activity to cell survival, growth 
selections enable the desired variants to have a growth advantage and amplify their signal in a 
large library of unwanted variants. The growth advantage of the desired variants facilitates the 
exclusion of the mediocre ones and enables the feasible search of large variant libraries. Using S. 
cerevisiae or E. coli as the host cells, growth selections can be used to search libraries with as 
many as 108 and 1010 variants, respectively[20, 21]. In addition to searching large libraries, growth 
selections are advantageous for engineering structurally complex biomolecules that are difficult to 
purify or reconstitute outside of the cell[22]. Given their broad applicability, growth selections 
have been developed for the evolution of a plethora of enzymatic targets. The various adaptations 
of the growth selection will be discussed here.  
1.2.1 Genetic Complementation 
Genetic complementation- the traditional microbiological approach- has proven to be a 





function is intrinsically linked to a gene that is essential for cell growth. In the framework of 
directed evolution, genetic complementation requires that the library variants provide a growth 
advantage for a wildtype strain or a mutant strain engineered to have a metabolic defect.  
Genetic complementation has been instrumental for the directed evolution of detoxifying 
enzymes or enzymes that produce essential metabolites for improved catalytic activity. Castle and 
coworkers illustrated the power of growth selections to evolve an enzyme that detoxifies the 
herbicide, glyphosate[32]. Initially, libraries were screened, limiting the assay to only 5000 
variants in each round of directed evolution. Despite repeated rounds of directed evolution, the 
activity of the variants plateaued at a 100-fold improvement over the parent enzyme, which was 
not sufficient to confer glyphosate tolerance in transgenic plants. However, shifting to an E. coli 
growth selection on glyphosate enabled the search of libraries with more than 106 variants. The 
growth selection yielded a superior enzyme with a 10,000 fold improvement in activity that 
rendered transgenic plants glyphosate-tolerant. The adoption of glyphosate-tolerant transgenic 
plants has transformed the agricultural industry as glyphosate is not only effective, but inexpensive 
and environmentally-safe. In addition to the agricultural industry, the biofuel industry has 
benefitted from this approach as it has aided the directed evolution of monosaccharide 
transporters[33] and a xylose isomerase[34] that significantly improved xylose consumption and 
ethanol production in S. cerevisiae.  
Besides engineering enzymes with increased catalytic activity, genetic complementation 
can be used as a selection strategy for the directed evolution of enzymes with altered substrate 
specificities. Liu and coworkers evolved novel suppressor tRNA and aminoacyl tRNA synthetase 
pairs for the site-specific incorporation of non-canonical amino acids in proteins[35, 36]. Here, an 





Specifically, the desired variants containing the properly acylated suppressor tRNAs resulted in 
the suppression of a stop codon in a chloramphenicol efflux pump gene, conferring 
chloramphenicol resistance. Using a similar strategy that links the desired function to antibiotic 
resistance, Gaj and coworkers engineered recombinases with altered DNA sequence specificities. 
In this work, the best recombinases were selected by their ability to restore a β-lactamase gene 
essential for cell survival[37]. Implementing a different approach, DeSantis and coworkers 
expanded the substrate specificity of the industrially relevant 2-deoxyribose-5-phosphate aldolase 
(DERA), a prominent enzyme that catalyzes the reversible condensation of two aldehydes and has 
a strong bias towards phosphorylated substrates[38, 39]. To improve the activity of DERA with 
nonphosphorylated substrates, a mutant strain that is auxotrophic for acetaldehyde was engineered. 
Performing the growth selection in the mutant strain, the desired variants were isolated based on 
their conversion of the nonphosphorylated D-2-deoxyribose into acetaldehyde. 
Although genetic complementation is a powerful strategy for increasing catalytic activity 
and broadening substrate specificity, it is not readily applied to enzymatic reactions that are 
nonessential for cell growth. The limited flexibility of genetic complementation for such targets 
presents a challenge and requires ingenuity. For example, Boersma and colleagues developed a 
genetic selection for enantioselective lipases by using an engineered E. coli strain that is 
auxotrophic for aspartate[40]. The enantioselective lipases were selected based on their ability to 
hydrolyze the desired enantiomer of an aspartate ester and enable cell growth. To inactivate the 
nonenantioselective lipases, a suicide inhibitor of the opposite enantiomer was added, thus 
inhibiting cell growth. Another notable example was demonstrated by Wӧrsdӧrfer and coworkers 
in their work to evolve lumazine synthase capsids for trapping an HIV protease that is toxic to E. 





rates. This selection was successful and yielded capsids that had a 10-fold higher loading capacity. 
Although genetic complementation was suitable for these applications, the researchers were 
required to develop highly customized assays, which may be too difficult or nearly impossible for 
other important targets. Therefore, novel approaches are required to artificially couple enzymatic 
reactions to cell growth. 
1.2.2 Chemical Complementation 
The chemical complementation approach bolsters the applicability of growth selections 
because it does not revolve around the reaction pathway of the enzyme being evolved. Unlike 
genetic complementation, chemical complementation methods are designed to be universal and 
use the product of the targeted enzyme reaction to be the input for an unrelated reporter system 
that generates a growth readout. Thus, chemical complementation is only dependent on the product 
of the targeted enzyme and not its reaction pathway. Being unlimited by the enzyme’s reaction 
pathway, selections based on chemical complementation do not need to be redesigned for each 
target enzyme and can use well-studied reporter genes. More importantly, these growth selections 
can be applied to a wider variety of enzyme reactions, including those that are unnatural to the cell 
or incapable of producing measurable phenotypes. 
One of the pioneering examples of chemical complementation- performed in our 
laboratory- uses the yeast three-hybrid (Y3H) assay to link enzymatic activity to a growth readout. 
The Y3H assay joins the DNA-binding and activation domains of a transcription factor via a 
chemically synthesized linker, thereby activating a downstream reporter gene. To detect enzyme 
bond formation or cleavage, the Y3H assay was modified to incorporate the enzyme substrate into 
the chemical linker (Fig 1-3). This modification transforms the Y3H system into a general assay 





linker. The original chemical complementation assay was a LacZ screen designed to detect the 
bond cleavage of β-lactamases[42, 43]. However, this assay is modular and has been transformed 
into a growth selection by changing the reporter gene to well-known biosynthetic markers in S. 
cerevisiae. As a growth selection, this assay is quite versatile and has been used for the directed 
evolution of glycosynthases and cellulases, which are bond forming and cleaving enzymes, 
respectively[44-46]. The versatility of the Y3H approach has recently led to its adaptation for other 
relevant applications, such as the detection of natural product biosynthesis (See Chapter 4).  
 
 
Figure 1-3. Chemical complementation with the yeast three-hybrid system. In this Y3H assay, enzymatic 
activity is linked to the transcription of a reporter gene that is essential for yeast cell survival. This Y3H 
assay reconstitutes a transcriptional activator for a downstream reporter gene by linking the DNA-binding 
domain (DBD)-receptor fusion protein and activation domain (AD)-receptor fusion protein (shown in gray) 
via a chemically synthesized dimerizer. In this chemical complementation assay, the chemical dimerizer 
includes the enzyme substrate so that enzyme bond formation or cleavage creates or destroys the intact 
chemical dimerizer that controls transcription.  The assay is modular and can be applied to detect any bond 
forming or cleaving enzyme by simply modifying the chemical dimerizer.    
 
Another chemical complementation approach was developed based on transcription factors 
that activate reporter gene transcription upon binding the substrate or product of the enzyme target.  





production of benzoate and 2-hydroxybenzoate from their respective aldehydes with the 
benzaldehyde dehydrogenase, XylC from Pseudomonis putida[47]. Specifically, NahR activates 
reporter gene transcription from its cognate salicylate promoter upon binding benzoates. To 
engineer a growth selection for XylC, the salicylate promoter that is controlled by NahR was 
placed upstream of TetA, a gene that confers resistance to tetracycline. Thus, in the presence of 
the appropriate aldehyde substrates, only cells with the active XylC enzyme could produce the 
benzoates and grow in the presence of tetracycline. Because this selection system is not specific 
to the XylC reaction pathway, it has been employed for the detection of other enzymes that yield 
differentially substituted benzoates including a nitrilase, amidase, aldehyde oxidase, and aldehyde 
dehydrogenase[48]. This area of chemical complementation has been expanded to even more 
targets by engineering new promoters through directed evolution to detect the enzyme products of 
interest[49].   
1.3 Problems with Using Traditional Reporter Genes in Growth Selections 
The flexibility and accessibility of growth selections strongly supports their use in directed 
evolution; however, the engineering of these in vivo systems to have increased throughput and 
tunable stringency is not trivial[50]. The throughput of a selection corresponds to its ability to pull 
one cell with the desired function from a library of 10n. This feature is crucial for searching the 
large libraries required for demanding directed evolution experiments (See section 1.2). The 
stringency of a selection enables it to distinguish n-fold differences in activity, which is particularly 
valuable in the later rounds of directed evolution where the libraries have a higher proportion of 
superior variants. Although there are successful growth selections that provide the appropriate 





selections often need to be further engineered for each application to deliver the most suitable 
reporter gene readout (See Chapter 2). 
Traditional reporter genes are powerful in classic genetic assays; however, their efficacy is 
not guaranteed in more complex applications, such as growth selections. In conventional genetic 
assays, reporter genes are employed to deliver stark “on/off” outputs that are crucial for routine 
genetic experiments such as plasmid maintenance and gene knockouts. In these routine 
applications, the reporter gene is present and being expressed from its endogenous promoter or 
completely absent from the cell to give the “on” and “off” readouts, respectively. In this simple 
context, these traditional reporter genes can provide the appropriate throughput required, enabling 
the selection of one desired cell from over a million of those that are not wanted[51, 52]. However, 
growth selections, by contrast, require the functional reporter gene to present in all cells and 
desirable library variants are distinguished based on differing levels of reporter expression. In this 
framework, traditional reporter genes may intrinsically fail to provide the necessary difference in 
reporter gene levels to separate cells, especially when directly implanted into sophisticated growth 
selection systems[53].  
The removal of traditional reporter genes from their endogenous contexts can spark a series 
of complications that impede improvements by directed evolution. For example, the sensitivity of 
the selection can be crippled if a low threshold reporter gene level is sufficient for survival of the 
auxotrophic host, enabling the isolation of barely functioning variants[54]. In addition, the 
throughput of a selection is compromised when there is an insufficient difference between reporter 
gene levels when the enzyme is active or inactive, making it difficult to distinguish the desirable 





evolution with genetic or chemical complementation approaches. Thus, methods to engineer 
growth selections with increased throughput and tunable stringency are extremely valuable. 
1.4 Employing Transcriptional Regulation to Improve Throughput  
Although traditional reporter genes are not guaranteed to be as effective in complex in vivo 
systems, they serve as a frame of reference for engineering high-throughput growth selections. As 
mentioned earlier, the high-throughput nature of classic genetic assays relies on the ability of 
traditional reporter genes to deliver strict “on” or “off” readouts when present or absent from the 
cells, respectively. Given these strict readouts, the traditional reporter genes operate similarly to 
an on/off switch producing a digital “all-or-none” response. Thus, the throughput of a selection 
can be increased by engineering growth selection systems to function as an on/off switches in 
response to the desired activity being investigated (Fig 1-4).  
Naturally, living systems generate threshold all-or-none readouts with increased 
transcriptional regulation. Threshold transcriptional on/off readouts are essential for binary 
decisions in growth and differentiation, which if mis-regulated cause severe developmental 
problems [55-60]. One mechanism for generating a digital on/off switch in living systems is based 
on the competition between activators and repressors for the same DNA operator site. This 
competition between the activator and repressor enables the conversion of a graded response (to a 
particular inducer) into a threshold transcriptional switch. Rossi and coworkers illustrated this 
mechanism in eukaryotic cells by monitoring the GFP readout from a promoter controlled by a 
tetracycline-regulatable activator and repressor[61]. In the presence of either the activator or 
repressor, a graded homogeneous response was observed with increasing concentrations of 
tetracycline. However, a binary, all-or-none response occurred when the activator and repressor 





we incorporated this dual tetracycline activator/repressor system to increase transcriptional 
regulation for the URA3 reporter gene in the Y3H counter selection and essentially convert it to an 
on/off switch[62]. Using this strategy, the throughput of the Tet Y3H counter selection was greatly 
improved and enabled it to search libraries that were larger by 104-fold (See Chapter 3).  
 
Figure 1-4. Engineering high-throughput selections. Increased throughput (e.g. pulling one desired variant 
out of 10n) can be achieved by engineering the growth selections to produce a digital “all-or-none” response, 
which converts the reporter system into an on/off switch. 
 
Increased throughput is a necessary feature of growth selections and for some applications 
is the most important. For example, biodiversity mining, a strategy that searches for new enzymes 
by probing large libraries of environmental DNA, are simply trying to pull one active enzyme from 
a large pool of completely inactive enzymes[50, 63-65]. Thus, biodiversity mining can be 
performed with growth selections that offer superior throughput and minimal sensitivity. However, 
in directed evolution, the increased throughput alone will not aid efforts to distinguish between 
moderately or strongly performing enzymes.  Thus, methods for tunable stringency are required to 
develop growth selections that can detect intermediate levels of enzymatic activity. 
1.5 Approaches for Equipping Growth Selections with Tunable Stringency 
To develop selection systems with tunable stringency, the cells must be engineered to 
provide graded, analog reporter readouts in response to increasing levels of the desired enzymatic 





intermediate gene expression levels are crucial for separating enzymes with n-fold differences in 
activity. The stringency of the growth selection can be regulated by controlling the concentration 
of either the enzyme or its substrate.  
 
Figure 1-5. Engineering growth selections with Tunable Stringency. A) Stringency (e.g. distinguishing 
variants with n-fold differences in activity) requires growth selections to provide graded, analog readouts in 
response to increasing levels of enzymatic activity. The stringency, or selection pressure of the growth 
selection can be elevated by reducing enzyme or substrate concentrations. Enzymes with higher activity 
can survive in stringent growth selection conditions because they require lower enzyme inputs to fulfill the 
metabolic needs of the cell and thus confer lower growth thresholds for the host strain. B) Enabling lower 
growth thresholds, enzymes with higher activity make up a larger proportion of the culture in more stringent 
selection conditions. In low stringency conditions, cells expressing enzymes with various activity levels can 







1.5.1 Controlling Enzyme Concentration 
Ideally, a selection should couple the intracellular concentration of the enzyme with the 
level of activity needed to confer growth for the auxotrophic host strain. In such a selection, the 
strongly active enzymes are distinguished by conferring a faster growth rate at low concentrations, 
whereas the weakly active enzymes require high concentrations. By reducing enzyme 
concentrations, the selection pressure can be increased throughout the directed evolution process 
such that only the strongly active enzymes are isolated. The most common method to control 
enzyme concentrations is to link their expression to promoter systems that can provide a graded 
dose response profile[18]. 
Employing Weak Promoters to Increase Selection Pressure. 
One approach to regulate enzyme concentration involves interchanging well-studied 
constitutive promoters with varying expression strengths. Yano and coworkers demonstrated the 
success of this strategy in their work to transform an aspartate aminotransferase into a strongly 
active valine aminotransferase[66]. To evolve the valine aminotransferases, an E. coli strain was 
engineered without the branched-chain amino acid transferase that is responsible for the synthesis 
of valine, leucine, and isoleucine. To increase the stringency of the selection, the aspartate 
aminotransferase library variants were sequentially cloned into vectors that contained constitutive 
promoters with declining strength. Although this strategy was effective for evolving a highly 
efficient valine aminotransferase, the repeated cloning after each round of selection was extremely 
tedious and liable to lead to the loss of library variants. In addition, the effect of switching to 
weaker promoters on the selection pressure is based on their performance in different assays and 





Another example of this approach was demonstrated by the Hilvert laboratory to evolve 
the dimeric E.coli chorismate mutase (EcCM) into a better performing hexamer (hEcCM)[67]. To 
improve the activity of the weakly active hEcCM, Vamvaca and coworkers switched to a weaker 
promoter to reduce the protein levels and prevent the isolation of poor enzyme catalysts that could 
bypass the selection when present at higher intracellular concentrations[68]. Switching to a weaker 
promoter enabled the selection of a trimeric quaternary structure (tEcCM) that had a kcat/km that 
was improved by 400-fold. However, its kcat value, although improved, was still 14-fold lower 
than that of the wildtype EcCM. Unfortunately, the moderately performing tEcCM variant could 
not be further enhanced as its suboptimal activity, even at the low expression level afforded by the 
weaker promoter, was sufficient to confer wildtype levels of growth to the host strain. This 
problem, which is prevalent in growth selection development, calls for different gene expression 
methods, such as inducible promoter systems. 
Lowering enzyme concentration with inducible promoter systems and protein degradation.  
Inducible promoter systems are convenient because they provide graded transcriptional 
regulation and, unlike constitutive promoters, are controlled by an external stimulus. Although 
inducible promoter systems provide more flexibility than constitutive promoters, they are not 
trivial to engineer. A common problem associated with inducible promoter systems is that they 
often do not induce uniformly across a cell population.  For example, sub-saturating concentrations 
of the inducer do not lead to homogenous induction levels in all cells, but rather reduce the fraction 
of induced cells (e.g., 50% induction leads to 50% of the population with full induction and 50% 
with zero induction, not 100% of the population with 50% induction )[69]. This problem causes 
extreme cell-cell variability as a fraction of cells is fully induced, while the remainder of the cell 





each cell, which carries a unique variant, must experience the same conditions to ensure 
standardized testing of the library. The challenge in designing inducible promoter systems is to 
make certain that the reporter gene expression in individual cells is homogeneous and graded in 
response to varying concentrations of the inducer molecule.  
Bahl and coworkers successfully engineered an inducible promoter system with 
homogenous, graded reporter gene expression in their work to develop a biosensor for tetracycline 
in environmental samples[70]. Their tetracycline-inducible promoter system, which only includes 
the native TetR repressor that is inhibited by tetracycline, capitalizes on its autoregulatory function. 
Thus, in this system, the tetR gene and its adjacent promoter region are placed upstream of the 
reporter gene such that TetR controls its transcription and that of the reporter gene.  
Neuenschwander and coworkers adapted this tetracycline biosensor system to increase the 
stringency of the previously mentioned growth selection for the chorismate mutase (EcCM)[71]. 
Specifically, the tetracycline inducible promoter system was tested for its ability to distinguish the 
weakly active hEcCM, moderately active tEcCM, and the highly active wildtype EcCM.  The 
system only provided the proper dose-dependent growth readout for the weakly active hEcCM, 
which could only confer growth at increased tetracycline concentrations. The higher performing 
tEcCM and EcCM; however, were not distinguishable with this system as they both conferred 
wiltype levels of growth even in the absence of tetracycline. Although tetracycline inducible 
systems are known to have extremely tight regulation, the minimal enzyme concentrations present 
due to background expression were able to complement the chorismate mutase deficient host 
strain[72, 73]. Given the inability of tightened transcriptional regulation to demarcate the growth 
rates of host cells possessing the tEcCM and EcCM enzymes, a new approach was implemented 





transcriptional regulation provided by inducible promoter systems with targeted protein 
degradation.  
To couple graded transcriptional regulation with targeted protein degradation, 
Neuenschwander and coworkers fused the chorismate mutase variants with the SsrA sequence, 
which targets the enzymes for degradation by the intracellular ClpXP protease[71, 74]. Bearing 
the SsrA sequence, the more active tEcCM and EcCM variants were not able to grow in the absence 
of the tetracycline inducer. In addition, this graded transcription/degradation system enabled dose-
dependent growth in the presence of the inducer and properly matched the intracellular 
concentration with the specific activity of the enzyme. Thus, the fastest growth was observed with 
the best performing variant, EcCM, while cells with the weakly active hEcCM grew the slowest. 
Most importantly, at intermediate tetracycline concentrations, this improved system could separate 
the moderately performing tEcCM variant from the highly active EcCM. This graded 
transcription/degradation system was applied to the directed evolution of the weakly active 
hEcCM and effectively enriched a superior variant with catalytic activity on par with the wildtype 
EcCM. Moreover, the coupling of a tunable promoter with a degradation tag facilitated the 
selection of more active enzymes when compared to strategies that are based on weak constitutive 
promoters or tunable promoters alone.  
1.5.2 Controlling substrate concentrations 
The stringency of the growth selection can also be tuned by manipulating the enzyme 
substrate concentration in the cell. Although reducing enzyme concentrations is effective in 
producing variants with high kcat values, reducing substrate concentration leads to the selection 
of catalysts with high kcat/km values, which could be advantageous[18]. The substrate 





medium or by engineering the relevant metabolic pathways to direct the production (or breakdown) 
of a crucial substance. 
The substrate concentration is readily tunable if an externally added substance is critical 
for growth.  For example, if cell survival relies on the presence of an enzyme to degrade a toxic 
antibiotic, then the selection pressure can be adjusted by steadily increasing the antibiotic 
concentration. This strategy was successfully used to evolve a TEM-1 β-lactamase. Iterative cycles 
of DNA shuffling and selection on increasing concentrations of cefotaxime raised its minimum 
inhibitory concentration by 32,000-fold[75, 76]. This approach was also exploited to alter the 
substrate specificity in the aforementioned evolution experiment to convert an aspartate 
aminotransferase (AspAT) into a valine aminotransferase (ValAT)[66]. To increase the likelihood 
of finding an AspAT variant with minimal ValAT activity, the library was initially subjected to 
selection conditions with exogenously added 2-oxovaline, the substrate for the valine 
aminotransferase. Upon isolation of a viable variant with weak ValAT activity, the remaining 
selection rounds excluded exogenously added 2-oxovaline, forcing the evolution of enzyme 
variants efficient in transforming the limited source of biosynthetically produced 2-oxovaline.  
If the enzyme substrate of interest is a natural metabolite, then metabolic engineering 
techniques[77, 78] can be used to control its intracellular concentration and tune the stringency of 
the selection. For example, Kleeb and coworkers tuned the stringency of a growth selection system 
for the evolution of a prephenate dehydratase (PDT), which transforms prephenate to 
phenylpyruvate, a crucial step in the biosynthesis of L-phenylalanine[79]. In the cell, prephenate 
is diverted away from the production of phenylalanine by a prephenate dehydrogenase (PDH) that 
catalyzes the production of a precursor for L-tyrosine. Taking advantage of this metabolic branch 





regulating PDH expression with a tetracycline inducible promoter system. This tunable growth 
selection, performed in a phenylalanine auxotroph that lacked the endogenous PDT, was able to 
efficiently differentiate dehydratases with activities that varied over a 50,000 fold range.  Thus, 
strategies based on the development of metabolic shunts to divert the substrate of interest away 
from the selectable step have the potential to be a versatile approach for engineering growth 
selections based on an endogenous metabolite. However, engineering and optimization will be 
required for each new target. 
1.6 Conclusion 
Directed evolution has repeatedly demonstrated its power in the engineering of enzymes 
with greatly improved activity and altered substrate specificities. Growth selections have the 
potential to augment the power of enzyme directed evolution given their superior performance 
history in classic genetic assays. However, there are several challenges to the appropriation of 
growth selections based on traditional reporter genes for directed evolution and their high 
effectiveness in genetic assays is not guaranteed to translate in new, sophisticated contexts.   
In this review, we have discussed elegant approaches to engineering growth selections that 
are truly flexible and accessible to the needs of enzyme directed evolution. Historically, growth 
selections have achieved impressive functional upgrades in enzyme evolution; however, they were 
limited to targets that could satisfy only the genetic complementation approach. With the advent 
of chemical complementation approaches, growth selections can now be instrumental in the 
evolution of a wider variety of targets that are not intrinsically linked to growth. We also presented 
novel methods to enhance both the throughput and sensitivity of growth selections based on 





growth selections, when properly equipped to deliver digital or analog growth readouts, can search 
large libraries and/or differentiate enzymes with varying levels of activity, respectively.  
However, the examples discussed in this review required a great deal of optimization and 
were not effortlessly adapted to new, specific targets. Thus, there are still obstacles to developing 
growth selections that demand sophisticated readouts with traditional auxotrophic reporter genes. 
This difficulty is illustrated in our own work with the Y3H system, which is extremely effective 
and versatile in positive selections, but required complete reconstruction to be adapted to select 
against transcriptional activation as a counter selection. Our struggles with engineering the Y3H 
counter selection are not uncommon as researchers are constantly challenged to produce the 
appropriate readouts for their specific application even with established growth selection 
technologies. However, the advent of synthetic biology has equipped researchers with novel tools 
to engineer auxotrophic reporter genes that can steadily deliver their fine-tuned readout in a variety 
of contexts. As the field of synthetic biology continues to thrive, we anticipate that it will propel 
the development of growth selections that can reliably provide the tailored readouts that are 
essential for the ever-changing and increasingly complex field of enzyme directed evolution. 
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2.0 Chapter Outlook 
 The yeast three-hybrid (Y3H) assay expands the field of drug discovery and protein 
engineering by enabling the search of large variant libraries for targets that do not inherently 
produce a distinct, measurable phenotype. The Y3H assay links the DNA-binding and activation 
domains of a transcription factor via a chemically synthesized heterodimeric small molecule, 
thereby activating a downstream reporter gene. Although the Y3H assay has been successfully 
applied as a positive selection to discover novel drug targets and to evolve proteins with improved 
functions, its expansion into applications requiring a high-throughput, versatile selection against 
transcriptional activation has been hindered by its limited dynamic range as a counter selection. 
We previously characterized our original Y3H counter selection to develop a hypothesis as to why 
the system had a low dynamic range (see Appendix 1). Based on this work, we hypothesized that 
the key to improving the dynamic range was to rationally redesign the Y3H counter selection 
system to maximize the growth difference between cells with activated and basal levels of reporter 
gene expression. In this chapter, we describe our approaches to obtain high activation of the 
reporter gene in the presence of the chemical linker, while reducing basal expression in its absence. 
One approach included reducing intracellular concentrations of the URA3 reporter gene by 
recruiting a protein degradation system. Another approach incorporated an alternative fluorescent 
reporter gene that had tunable phototoxicity controlled by multiple factors including concentration, 
light intensity, and cell localization. The most successful approach, which is discussed in Chapter 
3, tightened URA3 expression on the transcriptional level with the dual tetracycline 
activator/repressor system. In this chapter, we focus on the rationale, design, and characterization 





The yeast three-hybrid (Y3H) assay brings small-molecule chemistry to the powerful n-
hybrid genetic assay, which links biomolecular interactions to the reconstitution of a 
transcriptional activator that drives a reporter gene. The Y3H assay has been used to identify the 
protein targets of small-molecule drugs[1, 2], evolve protein receptors for small molecules[3], and 
as the basis for high-throughput assays to detect enzyme catalysis in vivo[4, 5]. Because it can be 
linked to growth selections, the Y3H assay allows the search of large libraries on the order of 106 
variants or more, which is not feasible with medium-throughput screens that must explicitly 
analyze every variant (e.g., microtiter plate-based screens). In our laboratory, we extended the 
Y3H assay to develop “Chemical Complementation”[6], a reaction-independent assay that links 
enzyme catalysis to the transcription of a reporter gene. We have successfully used chemical 
complementation for in vivo directed evolution experiments aimed to evolve bond-forming and 
bond-cleaving enzymes with improved function and altered substrate specificities[7-9]. 
Our laboratory’s Y3H assay uses the chemical dimerizer dexamethasone-methotrexate 
(Dex-Mtx) to bridge the DNA-binding and activation domains of a transcription factor to activate 
a downstream reporter gene[10]. The LexA DNA binding domain (DBD) and B42 activation 
domain (AD) are expressed as fusion proteins with dihydrofolate reductase (DHFR) and the 
glucocorticoid receptor (GR), respectively. Dex-Mtx links the LexA DBD-DHFR and B42 AD-
GR fusion proteins to activate the transcription of an auxotrophic reporter gene. In our chemical 
complementation assay, we modified this Y3H system to artificially couple enzymatic activity to 
yeast cell survival by incorporating the enzyme substrate into the chemical dimerizer. By changing 
the chemical dimerizer and the reporter gene, our chemical complementation assay can be adapted 
to detect both bond forming and bond cleaving enzymes as a positive or counter selection, 
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respectively. Here, we focus on the development of a robust Y3H counter selection that selects 
against transcriptional activation for the engineering of bond-cleaving enzymes (Fig. 2-1). 
  
Figure 2-1. Chemical Complementation as a Y3H counter selection. Chemical complementation is a 
general assay that links enzyme activity to yeast cell survival in vivo.  This assay, which is based upon the 
yeast three hybrid (Y3H) system, detects enzyme-mediated bond formation or cleavage via transcriptional 
activation of a reporter gene. The reporter gene is activated upon linking the DNA binding and activation 
domains of a transcription factor, brought together by the chemical dimerizer, Dexamethasone-
Methotrexate (Dex-Mtx). For the detection of bond-cleavage enzymes, the Y3H counter selection includes 
a toxic reporter gene to select against transcriptional activation and allow only cells with disrupted Y3H 
systems to survive. 
 
Our Y3H counter selection, which selects for the disruption of the chemical dimerizer, is 
derived from the “gold standard” counter selection in yeast genetics that uses the URA3 reporter 
gene. The URA3 reporter gene can be applied in counter selections because it encodes orotidine 
5’-phosphate decarboxylase, which converts 5-fluoroorotic acid (5-FOA) into the toxic 5-
fluorouracil compound that inhibits cell growth. In the Y3H URA3 counter selection, Dex-Mtx 
links the LexA DBD-DHFR and B42 AD-GR fusion proteins to inhibit cell growth in the presence 
of 5-FOA. Based on the reverse yeast two-hybrid system, we constructed our Y3H system to have 
the URA3 reporter gene under the control of the tightly regulated LexAop-pSPO13 promoter to 
reduce basal transcription of URA3 and thus maintain the chemical dimerizer dependence of the 
assay.   
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Despite using components from the well-established reverse yeast two-hybrid system to 
create our Y3H counter selection, we observed that it had a low dynamic range. The dynamic range 
of the Y3H counter selection is assessed using mock selections that test its ability to enrich a single 
inactive Y3H cell that is incapable of reconstituting the transcriptional activator with the chemical 
dimerizer, Dex-Mtx, from a large excess of undesirable active Y3H cells. In these mock selections, 
which are designed to mimic our counter selections for directed evolution experiments, a library 
of cells is grown in liquid culture and cells with disrupted Y3H systems that cannot reconstitute 
the transcriptional activator are enriched. Following the selection, the enriched cells are plated and 
individually assayed (Fig. 2-2).  We discovered that our original Y3H counter selection was only 
effective when enriching the desired inactive Y3H cells from small mock libraries with only 102 
variants, a dynamic range that is not ideal for demanding directed evolution experiments. Even 
with the extensive optimization of conditions and screening of numerous strains, our adapted Y3H 
URA3 counter selection did not show significant growth inhibition when cells were treated with 
the chemical dimerizer. 
One explanation for the low dynamic range of the Y3H counter selection is that we are 
employing traditional reporter genes in more demanding contexts. For example, the URA3 reporter 
gene is very efficient in classic genetic assays to carry out plasmid maintenance or gene knockouts. 
In this context, the URA3 reporter gene is strictly used an on/off marker as it is either present or 
completely absent from the cell to deliver distinct “on” and “off” readouts. However, for our Y3H 
counter selection, we need the functional URA3 reporter gene to be present in all cells, which are 
then distinguished based on whether they have low or high levels of reporter gene transcription. 
Thus, we depend upon Y3H systems that can administer, with a single approach, sharply-defined 
on and off readouts in the presence and absence of the chemical dimerizer, respectively. In 
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particular, Y3H counter selections require extremely low off readouts as minimal expression of 
the toxic reporter gene can lead to cell death even in the absence of the chemical dimerizer, which 
compromises the rigor of the assay.  
 
Fig 2-2. Improving the throughput of the Y3H counter selection by increasing its dynamic range. The Y3H 
counter selection links the LexA DBD-DHFR and B42 AD-GR fusion proteins via the chemical dimerizer, 
Dex-Mtx, to reconstitute a transcriptional activator for a downstream toxic reporter gene.  We aimed to 
engineer a Y3H counter selection, which selects against transcriptional activation, with high dynamic range. 
In a Y3H counter selection with a low dynamic range, there is little difference between cells that produce 
the toxic reporter gene at low (solid line) and high levels (dashed line). With a low dynamic range, the Y3H 
counter selection is low-throughput and cannot distinguish the desirable cells with inactive Y3H systems 
from the undesirable ones. However, with a high dynamic range, the Y3H counter selection can enrich the 
desired cells that have inactive Y3H systems because there is a large growth difference between cells that 
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produce low and high levels of the toxic reporter gene. The dynamic range of the counter selection is 
assessed using mock selections that test its ability to enrich 1 inactive Y3H cell from 10n active Y3H cells. 
The selection includes mixing a mock library of inactive and active Y3H cells, enriching the desired inactive 
Y3H cells (gray) for 5 days, and plating the surviving cells for individualization. 
 
Thus, we undertook the design and construction of an improved Y3H counter selection 
with a high dynamic range (e.g., a large difference in growth rate between cells with active and 
inactive Y3H systems).  First, we characterized our original Y3H URA3 counter selection to 
develop a hypothesis as to why the system had a low dynamic range (see Appendix 1). We 
hypothesized that the key to improving the dynamic range of our Y3H counter selection was to 
rationally redesign the Y3H system to maximize the growth difference between cells with activated 
and basal levels of reporter gene expression.  
Based on our hypothesis, we set out to develop a Y3H system that with a single approach 
can deliver the high and low reporter gene levels required to provide the maximized growth 
difference in the presence and absence of the chemical dimerizer. Employing different strategies, 
three Y3H counter selections were developed: the URA3 degradation Y3H counter selection, the 
Killer Red Y3H counter selection, and the Tetracycline Y3H counter selection. These strategies 
aimed to provide Y3H counter selections that could obtain high activation of the reporter gene 
while maintaining tight regulation in the absence of the chemical dimerizer to hinder unwanted 
basal transcription.  In this chapter, we focus on the development of the URA3 degradation Y3H 
counter selection and the Killer Red Y3H counter selection. The more successful and extensively 
characterized tetracycline Y3H counter selection will be discussed in Chapter 3.  
The URA3 degradation Y3H counter selection was designed to maintain high activation of 
the URA3 reporter gene in the presence of the chemical dimerizer, Dex-Mtx, and restrict basal 
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transcription in the absence of the chemical dimerizer by destabilizing the Ura3p in the cell. To 
destabilize the URA3 reporter gene, this Y3H counter selection interfaced with the native N-end 
rule protein degradation pathway in S. cerevisiae.  By reducing the intracellular concentration of 
the URA3 reporter gene though a degradation pathway, we believed we could increase the 
stringency of the Y3H counter selection for cells overproducing the reporter gene through activated 
Y3H transcription.  
In the second approach, we began to develop a Y3H counter selection with Killer Red, a 
genetically encoded photosensitizer that generates oxygen-based reactive oxygen species (ROS) 
upon irradiation with green light. Photosensitizers are routinely used for the inactivation of specific 
proteins with chromophore-assisted light inactivation (CALI) and photodynamic therapy. Killer 
Red differs from all known photosensitizers, including those that are genetically targeted, in that 
it does not require the addition of exogenously added compounds to trigger phototoxicity. Killer 
Red is fully genetically encoded and grants activatable toxicity that can be tuned by several factors 
including concentration, irradiation time, irradiation intensity, and cell localization. Besides its 
tunable phototoxicity, the Killer Red gene is advantageous as a counter selectable marker because 
it does not require the addition of an inducer to the media, which can cause slow growth for the S. 
cerevisiae or be less effective due to the lack of cellular uptake. Thus, we aimed to incorporate 
Killer Red as the reporter gene in our Y3H counter selection because it had high potential to deliver 
the fine-tuned reporter gene levels necessary for increased dynamic range with the chemical 
dimerizer, Dex-Mtx. To our knowledge, this is the first attempt to develop Killer Red as a counter 
selectable marker.  Although unsuccessful, the design and characterization of these approaches are 




2.2.1 The URA3 Degradation Y3H Counter Selection 
In the URA3 degradation Y3H counter selection, the URA3 reporter gene was tagged with 
different destabilizing N-degrons to provide varying in vivo half-lives (Figure 2-3). We chose the 
N-degrons, which are referred to as “X,” that produced half-lives between 2 and 10 minutes. The 
N-degrons that produced in vivo half-lives above 10 minutes were avoided because they were 
classified as stabilizing residues[11]. The construction of the URA3 Y3H degradation strains was 
based on the ubiquitin fusion technique developed by Bachmair and coworkers. The ubiquitin 
fusion technique enables the reliable production of reporter genes that are identical with the 
exception of the N-terminal residue. The exposed N-terminal residue then dictates the half-life of 
the reporter protein and its targeting to the protein degradation machinery [12-14].  
Specifically, the ubiquitin was fused to the URA3 reporter gene with four different 
destabilizing N-terminal residues (Arginine, Leucine, Asparagine, and Glutamine) to generate the 
Ubiqutin-X-lacI-URA3 construct. To incorporate the Y3H system, the 8LexAop-pGAL fragment 
was inserted upstream of the ubiqutin-X-lacI-URA3 fragment. The minimal pGAL promoter was 
chosen because we previously demonstrated that it produced sufficient activation of the URA3 






Figure 2-3. The URA3 Degradation Y3H Strain Design. The URA3 Degradation Y3H strains interface with 
the native N-end rule protein degradation pathway in S. cerevisiae to vary the half-lives of URA3. The URA3 
reporter is expressed as fusion protein with Ubiquitin, which is immediately cleaved upon expression to 
expose the various N-degrons and target it for protein degradation. The half-life of URA3 is varied between 
2-10 minutes with the following residues: Arg, Leu, Asn, Glu.  
 
Following construction of the URA3 Y3H degradation strains, multiple colonies were tested 
for increased growth difference in the presence and absence of the chemical dimerizer. First, we 
eliminated strains with high basal expression of URA3 without Dex-Mtx--that is, those showing 
growth inhibition even without URA3 reporter gene expression. In the absence of the chemical 
dimerizer, Dex-Mtx, the strains were expected to grow to saturated cell densities as there is no 
Y3H activation and low levels of the toxic URA3 reporter gene produced by basal transcription 
are degraded.  The initial growth assays were performed in media that contained 5-FOA and 
excluded Dex-Mtx. As expected, all URA3 Y3H degradation strains grew to saturated cell densities 
in the absence of Dex-Mtx.  
Next, the URA3 Y3H degradation strains were tested for chemical dimerizer-dependent growth 
inhibition in media with 5-FOA and Dex-Mtx. In the presence of the chemical dimerizer, the Y3H 
URA3 degradation strains were expected to show growth inhibition. Here, the URA3 reporter gene 
is being overproduced by Y3H activation and present at a sufficiently high concentration to cause 
cell death in 5-FOA conditions. However, the URA3 degradation Y3H strains did not show 
significant growth inhibition in the presence of Dex-Mtx when compared to strains expressing 
only the endogenous URA3 reporter gene (Fig 2-4). For all strains, there was less than a 2-fold 
difference between cells in the presence and absence of Dex-Mtx, which was not an improvement 
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over our original Y3H counter selection.  Additionally, the variation in half-lives for the URA3 





Figure 2-4. Growth Comparison of the URA3 Degradation Y3H strains. The URA3 half-lives vary between 
approximately 2-10 minutes when expressed with the following N-degrons Arg, Leu, Asn, and Gln in 
ascending order. Cells were grown in the presence (open) and absence (closed) of Dex-Mtx for 4 days. 
The blue curve serves as a comparison and represents strains expressing the functional URA3 reporter 
gene without the N-degron degradation tag. Growth curves were performed with two independent colonies 
in triplicate. Shown is the mean growth, and the error bars represent the standard deviation from the mean.  
Considering these unexpected growth patterns, we tested if the URA3 reporter gene was 
properly targeted for degradation. The strains were tested for growth in media lacking uracil in the 
presence of Dex-Mtx. If the N-degron did not target the Ura3p for degradation, then the strains 
would be capable of complementing uracil auxotrophy. As expected, the strains did not confer 
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growth when serial dilutions were plated on media lacking uracil, suggesting the URA3 was 
properly degraded.  
2.2.2 The Killer Red Y3H Counter Selection 
Although Killer Red is a promising, versatile reporter gene for the Y3H counter selection, its 
phototoxicity has only been examined in E. coli and mammalian cells. Thus, the first task was to 
characterize the expression and phototoxicity of Killer Red in S. cerevisiae. A strain was 
constructed with the commercially available humanized Killer Red variant under the control of the 
inducible GAL1 promoter. To assay for expression, multiple colonies containing the Killer Red 
plasmid were grown in media containing galactose to induce expression of Killer Red. When 
induced by galactose, we expected the cells to express Killer Red and show red fluorescence. The 
majority of the tested colonies successfully expressed Killer Red and were further characterized 




Figure 2-5. The Killer Red Counter Selection employs the phototoxic Killer Red gene. A) In the Killer Red 
Y3H counter selection design, the Killer Red is directly under the control of the Y3H system. Killer Red 
generates oxygen-based reactive oxygen species (ROS) upon green light irradiation to initiate cell death.  
B) Cells expressing Killer Red when viewed under a confocal microscope with both white and green light 
irradiation.  
 
The phototoxicity of the chosen colonies was assayed by subjecting them to various conditions 
that included 0, 15, or 30 cycles of green light irradiation, which amounted to 0, 13, or 26 minutes 
of exposure, respectively. A cycle consisted of 100 flashes of light with a wavelength of 580nm 
and an estimated intensity of 1W/cm2. Based on previous reports with E. coli and mammalian 
cells, these light irradiation times were sufficient to initiate reactive oxygen species generation and 
inhibit cell growth. Following the light irradiation, the growth of the cells was monitored over a 
24 hour period, which was a sufficient time to observe growth inhibition based on E. coli and 
mammalian studies. As a negative control, this experiment was performed with a yeast strain that 
did not express Killer Red. After 24 hours, we expected the cells with the Killer Red to show 
growth inhibition compared to cells without the Killer Red due to reactive oxygen species 
exposure. However, all cells grew to saturated cell densities in all conditions and there was no 
growth inhibition compared to the negative control strain (Figure 2-6). With the conditions tested 






Fig 2-6. Phototoxicity of Killer Red in S. cerevisiae. Cells were exposed to different levels of green light 
irradiation and their growth was monitored by OD600 for 24 hours after exposure. Cells with (gray) or without 
(black) Killer Red were exposed to A) No Light Cycles or B) 15 Light Cycles or C) 30 Light Cycles. Growth 
of the strains was assayed in duplicate. Shown is the mean, and the error bars represent the standard 
deviation from the mean. 
 
2.3 Discussion 
The Y3H counter selection exemplifies the difficulty in adapting traditional reporter genes for 
complex assays that require fine-tuned readouts. We aimed to optimize the Y3H counter selection 
by employing diverse strategies to increase the dynamic range with the chemical dimerizer, Dex-
Mtx. Based on our previous characterization, we hypothesized that the growth difference in the 
presence and absence of Dex-Mtx needed to be maximized to improve the dynamic range, or 
throughput of the Y3H counter selection. In this chapter, we presented strategies that employ either 
a protein degradation system or the phototoxic reporter gene, Killer Red. These strategies did not 
improve the dynamic range of the Y3H counter selection, however, we discuss modifications that 
could increase their effectiveness.  
The inefficacy of the URA3 degradation Y3H counter selection may be attributed to rapid 
degradation of the URA3 reporter gene before initiating cell death. Given that all strains grew well 
in the absence of the chemical dimerizer, the URA3 degradation Y3H system successfully reduced 
unwanted basal transcription of the reporter gene to generate the low “off” readout. However, it 
was unable to deliver the high “on” readout as the cells also grew well in the presence of the 
chemical dimerizer, which suggests that the URA3 reporter gene was rapidly degraded before 
initiating cell death and was no longer toxic. Because the strains were able to grow in both the 
presence and absence of the chemical dimerizer, this Y3H counter selection had a low dynamic 
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range. The URA3 degradation Y3H counter selection could be improved by implementing 
inducible protein degradation systems[15, 16] that employ the TEV protease to provide controlled 
exposure of the N-degron upon cleavage of the TEV degradation sequence. To incorporate the 
inducible protein degradation system into the Y3H counter selection, the Y3H system could 
control the transcription of a repressor that blocks expression of the TEV protease. Thus, in the 
presence of the chemical dimerizer, the cells die because the repressed TEV protease does not 
expose the N-degron to initiate rapid degradation of URA3. However, in the absence of the 
chemical dimerizer, the repressor is not produced and the TEV protease can facilitate degradation 
of URA3 to enable cell survival.  
To improve the phototoxicity of Killer Red in S. cerevisiae, there are several conditions that 
can be modified. The Killer Red expressed here was localized to the cytosol, however, there are 
studies that prove mitochondrial and membrane localization significantly improve the efficacy of 
Killer Red in mammalian cells[17]. Thus, well-studied mitochondrial and membrane localization 
sequences in S. cerevisiae may improve the phototoxicity. In addition, we were limited by the light 
intensity of our fluorimeter, which was well below the reported intensity of 5.8 W/cm2 that killed 
approximately half the mammalian cells that expressed cytosolic Killer Red after only 10 minutes 
of irradiation [18]. With the estimated intensity of 1W/cm2 for our fluorimeter, we would need to 
carry out an excessive number of cycles of light irradiation to have the same effect as the 
previously reported intensities, which is not practical. Thus, an apparatus that facilitates continuous 
light irradiation with higher intensity could enable more efficient phototoxicity in S cerevisiae. 
With these modifications, the phototoxicity of Killer Red may be significantly enhanced in S. 
cerevisiae and thus become a promising reporter gene for the Y3H counter selection.  
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With the success of our third approach with the dual tetracycline Y3H counter selection, we 
did not continue to develop the Y3H counter selections based on URA3 degradation or the Killer 
Red reporter gene. However, we are still excited about these approaches and their potential in the 
development of Y3H counter selections. With the modifications discussed, these approaches could 
yield highly tunable counter selections and should be explored in more depth and further 
characterized. Although the Y3H counter selections discussed here were unsuccessful, the guided 
strategy we implemented based on the previous characterization of the URA3 reporter gene in its 
endogenous context and in the complex Y3H system was effective and ultimately led to the 
development of the Tetracycline Y3H counter selection (See Chapter 3). Thus, our work 
underscores the importance of thoroughly characterizing technologies based on the individual 
components, particularly those that are being extended beyond their normal application. This 
method enables the development of diverse approaches that can address the problems of the 
technology and produce the desired readout.  
 
2.4 Experimental Methods 
2.4.1 URA3 Degradation Y3H Counter Selection. 
Construction of the Ubiquitin (Ub)-X-LacI-URA3 plasmid. The Ubiquitin (Ub) sequence was 
amplified from pUB23 with primers MH001 and MH002 to create a Ub template. The Ub template 
was purified by gel extraction. Following gel purification, the Ub template was amplified in five 
different PCR reactions to add homology to the LexAop binding sites and introduce the varying 
N-degron sequences. The forward primer (MH003) introduced 30bp homology to a fragment that 
contained 8 LexAop binding sites upstream of the minimal GAL promoter. The reverse primers 
(MH004-MH008) introduced the varying N-degron sequences (X) for Arg, Leu, Asn, Gln, or Ile. 
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In addition, these reverse primers added a CviAII diagnostic restriction site and 30bp of homology 
to the ~40 residue LacI sequence. The LacI sequence was amplified from pUB23 with 30bp of 
homology to URA3 using primers MH009 and MH010. The URA3 fragment was amplified from 
pRS416 using primers MH011 and MH012, which added 30bp of homology to the LacI sequence 
and to the multiple cloning site (MCS) of pRS415 respectively. The 8 LexAop-pGAL fragment 
were amplified with primers MH013 and MH014 from pMW109 or pMW112, respectively. The 
MH013 and MH014 primers added 30bp of homology to the MCS of pRS415 and to the Ub 
template. All PCR fragments were gel purified and extracted. The pRS415 plasmid was digested 
with SacI and KpnI and gel  purified. 
Five different transformations were performed to generate plasmids with the varying N-
degrons (MH-8LexArgE, MH-8LexLeuE, MH-8LexAsnE, MH-8LexGluE). The 8 LexAop-
pGAL, Ub-X, LacI, and URA3 PCR products were mixed in an equimolar ratio and cotransformed 
with the digested pRS415 fragment into FY251. The transformants with the repaired pRS415 were 
selected on SC (L-, 2% glucose) plates. Correct assembly of gap repair was confirmed by 
sequencing.  
Construction of the URA3 Degradation Y3H strain. Plasmids with the Ubiquitin (Ub)-X-LacI-
URA3 fragment were cotransformed with pV398E into V704Y. This transformation yielded five 
different strains (MH-ArgY, MH-LeuY, MH-AsnY, MH-GluY) that contained the LexA-DHFR 
and B42-GR fusion proteins along with the LexAop-pGAL-URA3 gene tagged with the varying 
N-degrons (Arg, Leu, Gln, Asn).  
Growth Assays for URA3 Degradation Y3H Strains. Two colonies of each of the URA3 
degradations strains were inoculated into 100µL of SC(HTL-, 2% glucose) and grown overnight 
at 30°C. To begin the growth assay, 1µL of the overnight culture was inoculated into 199µL of   
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SC(HTL-, 2% galactose, 2% raffinose, 0.2% 5-FOA) +/- 5uM Dex-Mtx. The growth of the 
colonies was monitored for 5 days by UV absorbance at 600nm. All growth curves were performed 
in triplicate. To assess with the N-degrons targeted the URA3p for degradation, the strains were 
grown in SC(HTUL-, 2% galactose, 2% galactose) as a negative control. 
2.4.2 The Killer Red Y3H Counter Selection 
Construction of Killer Red Strain. The GAL1 promoter was amplified from pKB521 with 
MH021 and MH022. The Killer Red coding sequence was purchased from Evrogen as the KRed-
mem vector. The Killer Red coding sequence and N-terminal membrane targeting sequence were 
amplified with MH023 and MH031. The URA3 terminator was amplified with MH032 and 
MH026. The pRS415MET25 vector was digested with SacI and KpnI. The PCR products were 
cotransformed into FY251 along with the digested pRS415MET25 vector as a ratio of 100:1 to 
generate MHKRedY. The transformants were plated on SC(L-, 2% glucose). Colonies were 
miniprepped and sequenced to confirm proper assembly of pGAL1-Killer Red sequence. The 
properly assembled plasmid (pKRed) was transformed back into FY251 to assay for fluorescence 
of the Killer Redp.  
Growth Curves and Killer Red Phototoxicity Studies. Three colonies with pGAL1-Killer Red 
gene were inoculated into 100µL of SC(L-, 2% glucose) and grown overnight at 30°C. To induce 
Killer Red expression, 20µL of the overnight culture was inoculated into 180µL of   SC(L-, 2% 
galactose, 2% raffinose) and were grown for about 48 hours. The fluorescence of the Killer Red 
induced colonies was assayed with a fluorescent confocal microscope. As a control, the same 
procedure was performed with FY251 strains without the Killer Red.  
To begin the phototoxicity study, the three preinduced colonies were subjected to either 0, 
15, 30 cycles of 100 flashes of light with a wavelength of 585 nm for excitation. The emission was 
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collected at 625nm. Between each cycle, the Tecan fluorimeter was programmed to shake for 10 
seconds. The temperature of Tecan was also maintained at 30°C. Following the exposure to light, 
the cells were shaken 30°C for ~24hrs. The OD600 of the cells was monitored to determine if Killer 
Red phototoxicity was effective. This same procedure was performed with FY251 without Killer 
Red as a control. 
 
2.5 Strains, Plasmids, and Oligonucleotides Used in this Study 
Table 2-1. Strains used in this study  
Strain Genotype Source/Reference 
FY251 MATa trp1Δ63 his3Δ200 ura3-52 leu2Δ1 Gal+ with  M. Carlson[a] 
V704Y MATa trp1Δ63 his3Δ200 ura3-52 leu2Δ1 ade4::pGAL1-LexA-
eDHFR(HIS3) GAL+ 
K. Baker/[19] 
MH-ArgY V704Y with pV398E and MH-8LexArgE This study 
MH-LeuY V704Y with pV398E and MH-8LexLeuE This study 
MH-AsnY V704Y with pV398E and MH-8LexAsnE This study 
MH-GluY V704Y with pV398E and MH-8LexGluE This study 
MHKRedY FY251 with pKRed This study 
[a] M. Carlson, Columbia University, Genetics and Development Department 
 
Table 2-2. Plasmids used in this study 
Plasmid Details Source/Reference 
pRS415MET25  pMET25 CEN6/ARSH4 LEU2 pBIISK ori ampR ATCC 87322 
pKB521 pGAL1-LexA-eDHFR 2µ HIS3 pBR ori kanR K. Baker/[6] 
pV398E pGAL1-B42-(GSG)2-rGR2  TRP1 pUC ori kanR B. Carter/[20] 
pMW112 8lexAop-lacZ 2µ URA3 pBR ori kanR R. Brent/[21] 
pUB23 Ubquitin-Met-lacI-lacZ 2µ URA3 pBR  ori AmpR A. 
Varshavsky/[13] 
MH-8LexArgE Ubiquitin-Arg-lacI-URA3 2µ LEU2 pUC ori ampR This study 
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MH-8LexLeuE Ubiquitin-Leu-lacI-URA3 2µ LEU2 pUC ori ampR This study 
MH-8LexAsnE Ubiquitin-Asn-lacI-URA3 2µ LEU2 pUC ori ampR This study 
MH-8LexGluE Ubiquitin-Glu-lacI-URA3 2µ LEU2 pUC ori ampR This study 
pKRed pGAL1-KRed CEN6/ARSH4 LEU2 pBIISK ori ampR This study 
 
Table 2-3. Oligonucleotides used in this study 
Name Sequence (5’-3’) 
MH001 ATGCAGATTTTCGTCAAGAC 
MH002 ACCACCTCTTAGCCTTAG 
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3.0 Chapter Outlook 
 
 The yeast-three hybrid counter selection has the potential to be a high-throughput assay for 
engineering industrially relevant enzymes with methods that require the search of large variant 
libraries. We attempted to integrate our original Y3H counter selection into chemical 
complementation, a reaction-independent assay that links enzyme activity to yeast cell survival. 
However, the original Y3H system had a low dynamic range and was incapable of searching large 
libraries, impeding its use for demanding enzyme engineering efforts.  Here, we describe our final 
and most successful approach to improve the dynamic range of the Y3H counter selection. In this 
chapter, we present the development of a second-generation Y3H counter selection that uses the 
dual tetracycline (Tet) system to tighten transcriptional regulation of the URA3 reporter gene. We 
screened a small library of Tet Y3H reporter constructs using growth assays and mock selections. 
The best Tet Y3H counter selection has an improved dynamic range and provides enrichment from 
mock libraries of up to 106, a 104-fold improvement over our original Y3H counter selection. This 
enhanced dynamic range brings the Y3H counter selection to a standard that is suitable for real-
world protein engineering applications. In addition, the method we used to enhance the dynamic 
range of our Y3H counter selection should be widely useful to synthetic biologists developing 
sophisticated in vivo assays that require fine-tuned reporter gene expression levels. We 
demonstrate that using a guided strategy, based on a fusion of rational design and library screening, 










3.1 Introduction  
To improve the dynamic range of the Y3H counter selection (e.g., produce a larger growth 
difference between cells in the presence and absence of the chemical dimerizer), we turned to the 
well-established dual tetracycline system to provide an additional level of transcriptional 
regulation for the URA3 reporter gene. The dual tetracycline system enables the conditional 
expression of genes through a tetO minimal promoter that is controlled by both a tetracycline-
regulated activator and repressor. The activator and repressor are fused to a tetR component that 
controls their recognition of tetO binding sites within the tetO minimal promoter and response to 
tetracycline[1, 2]. There are two types of Tet systems: the Tet-repressible (direct) and Tet-
inducible (reverse) systems. In the tetracycline-repressible (direct) Tet system, the tetR-Activator 
enables tetO-driven transcription in the absence of tetracycline. In the tetracycline-inducible 
(reverse) Tet system, the activator is fused to a mutated tetR molecule (tetR’) that is activated 
rather than inactivated upon tetracycline binding. Thus, the activator allows tetO-driven gene 
transcription in the presence of tetracycline. To achieve tighter regulation, the dual Tet system 
typically includes an activator and repressor that respond conversely to the presence of tetracycline 
(e.g., the reverse Tet system includes the tetR’-Activator and tetR-Repressor) [19, 20].  
To achieve tighter regulation of URA3, the Tet Y3H counter selection was designed to have 
the Y3H system control the tetR’-Activator, which, along with the constitutively expressed tetR-
Repressor, directly provides an additional level of modulation through the tetO minimal promoter 
(Figure 3-1A). In addition, variations of the Tet Y3H counter selection fused the repressor to either 
the tetR or mutated tetR’ components to test two ways to potentially counteract basal URA3 
expression. In one case, the tetR-Repressor is functional in the absence of tetracycline, and basal 





Repressor competes with the tetR’-Activator for regulation of URA3 in the presence of 
tetracycline, and basal expression of URA3 is repressed until a threshold level of the tetR’-
Activator is produced by Y3H activation. 
To maximize our chances of finding a Tet Y3H system with precisely the right balance of 
activated and basal URA3 expression, we constructed a library of sixteen Tet Y3H URA3 counter 
selection strains that vary in components of both the Y3H and dual tetracycline systems that are 
known to modulate expression of the reporter gene.  The variations included: the identity of the 
tetR(’)-Repressor’s constitutive promoter (pCMV or pADH), the directionality of the tetR-
Repressor (tetR’ or tetR), the number of LexA operator (LexAop) binding sites upstream of the 
tetR’-Activator, and the number of tetO binding sites within the minimal tetO promoter upstream 
of URA3 (Figure 3-1B). This small, focused library represents all possible combinations of the 
available variable components from both the Y3H and dual tetracycline systems. Upon screening 
this library, a superior Tet Y3H construct with a significant growth difference in the presence and 






Figure 3-1. Sixteen variants of the Tet Y3H counter selection were screened for improved transcriptional 
regulation. A) Tet Y3H Counter Selection Design. The Y3H system directly controls the tetR’-Activator, 
which along with the constitutively expressed tetR-Repressor provides an additional level of regulation for 
URA3. B) Because of the complexity of optimizing transcriptional regulation, a focused library of Tet Y3H 
strains was screened. The library consisted of: two or eight LexA operators (LexAop) placed upstream of 
the tetR’-Activator to vary the degree of Y3H activation; pADH or pCMV promoters to vary the expression 
levels of the Tet-Repressor; fusion of the Tet-Repressor to the tetR or tetR’ components making it either 
repressed or activated by tetracycline, respectively; and finally two or seven tetO binding sites were placed 
upstream of URA3 to enable varying levels of regulation.  All 16 variants were constructed and screened 
(Figure A3-1 and A3-2). 
 
3.2 Results 
3.2.1 Growth Assay to Screen the Tetracycline Y3H Strains 
Multiple clones of the sixteen Tet Y3H strains were tested.  First, we eliminated strains 
with high basal expression of URA3 without Dex-Mtx--that is, those showing growth inhibition 
without tetR’-Activator expression. The initial growth assays excluded Dex-Mtx and were 
performed in media that contained 5-FOA and doxycycline, the more effective member of the 
tetracycline antibiotic family[1].  We expected strains to grow to a saturated cell density in these 
conditions as the tetR’-Activator was not expressed and the constitutively expressed tetR(’)-
Repressor turned off transcription of the toxic URA3 reporter gene product. With doxycycline and 
5-FOA present in the media, 75% of the strains showed the expected growth patterns (Figure A3-
1). The Tet Y3H strains that grew well in the absence of Dex-Mtx were tested for chemical 
dimerizer-dependent growth inhibition in media with doxycycline, 5-FOA, and Dex-Mtx (Figure 
A3-2). With Dex-Mtx, the tetR’-Activator is expressed and growth inhibition is expected. The 





cells treated with and without Dex-Mtx (maximum OD600 ratio (-/+)), and the time cells treated 
without Dex-Mtx reached an OD600 of 1 (Figure A3-3).  
Based on these metrics, the top-performing strains possessed common features of both the 
Y3H and Tet systems. The best strains were composed of the competing tetR’-Activator and tetR’-
Repressor, which are both activated upon binding to doxycycline. There was also a consistent 
connection between the number of LexAop binding sites within the Y3H system and the number 
of TetO boxes within the minimal TetO promoter upstream of the URA3 reporter gene. The top-
performing strains had the following combinations: 2LexAop-tetR’Activator/7TetO-URA3 or 
8LexAop-tetR’-Activator/2TetO-URA3. In addition, the best strains had the tetR’-Repressor under 
the control of the stronger pADH promoter as opposed to the pCMV promoter. The best strain with 
the pADH-tetR’-Repressor and 2LexAop-tetR’-Activator/7tetO-URA3 constructs showed the 
largest growth difference between cells treated with or without Dex-Mtx. The isolated Tet Y3H 
(gray) counter selection strain, MHTet24503, showed a maximum OD600 ratio (-Dex-Mtx/+Dex-
Mtx) of 7, which was an improvement over the maximum OD600 ratio of 2 for the original Y3H 
(black) counter selection (Figure 3-2C). 
3.2.2 Mock Selection to Characterize the Best Tetracycline Y3H Strain 
The dynamic range of the MHTet24503 strain was further characterized by a mock 
selection[3] that directly tested its ability to enrich inactive Tet Y3H cells with only the B42 AD 
from an excess of active Tet Y3H cells with the requisite B42 AD-GR fusion protein (Fig. A3-4). 
The inactive Tet Y3H cells cannot reconstitute the transcriptional activator for the URA3 reporter 
gene, and are thus enriched in the culture over time. Following effective selections, we expect the 
majority of plated cells that are individually assayed to contain inactive Y3H systems.  To 





mixed to give ratios of 1:102, 1:103, 1:104, 1:105, and 1:106 with an initial OD600 of 1 and subjected 
to Y3H selection conditions with doxycycline, 5-FOA, and Dex-Mtx. To improve the Tet Y3H 
counter selection, the cell mixtures were “reseeded,” or diluted into fresh selective media. 
Reseeding enabled the inactive Tet Y3H cells to more effectively overtake the selection. A few 
reseeding conditions were tested. The cell density at which the culture was reseeded and the 
number of reseedings per selection was varied. The best conditions included reseeding to a lower 
cell density (OD600=0.1) and performing two reseedings per selection. 
The Tet Y3H counter selection considerably outperformed our original Y3H counter 
selection.  With reseeding conditions, the MHTet24503 strain (gray) enriched the inactive Y3H 
cells in populations as high as 106 after 5 days, while the original Y3H strain (black) was only 
capable of enrichment from an excess of 102 active Y3H cells under similar conditions (Figure 3-
2D). Based on separate control experiments, the enrichment of the inactive Y3H cells depended 
on the presence of doxycycline and Dex-Mtx (Figure A3-5). With daily reseeding to lower cell 
densities (OD600=0.1) for the first two days, the percentage of the inactive Tet Y3H cells was 






Figure 3-2. Characterization of the best Tet Y3H URA3 counter selection strain (MH24503). A) The inactive 
Tet Y3H strain does not contain the requisite B42-GR fusion protein and cannot activate the tetR’-Activator, 
thus the tetR’-Repressor represses URA3 transcription and the cells survive. B) The active Tet Y3H strain 
activates the tetR’-Activator upon binding to Dex-Mtx. The tetR’-Activator outcompetes the tetR’-Repressor 
and thus activates URA3 transcription and the cells die in the presence of 5-FOA. C) Growth curves for the 
Tet Y3H (    ) and Original Y3H (    ) strains in selective media containing 2µg/mL doxycycline, 0.2% 5-FOA, 
and 5µM Dex-Mtx. The OD600 of 5 colonies was monitored in +Dex-Mtx (open symbols) and -Dex-Mtx 
(closed symbols) conditions. Shown is the mean growth and error bars represent the standard deviation 
from the mean. D) Mock selection with active and inactive Tet Y3H strains in media containing 2µg/mL 
doxycycline, 0.2% 5-FOA, and 5µM Dex-Mtx. Performance of the Tet (     ) and Original (    ) Y3H counter 
selection with daily reseeding to an OD600 of 0.1 in the first 2 days of a 5 day selection. Error bars represent 









The dynamic range of the Y3H counter selection was considerably enhanced by increasing 
transcriptional regulation of the URA3 reporter gene with the dual tetracycline system. By 
incorporating the dual tetracycline system, we engineered the Y3H counter selection to produce 
more of an all-or-none response in the presence of the chemical dimerizer, which successfully 
increased its throughput.  Starting with our original Y3H system, there was little growth difference 
between cells treated with or without Dex-Mtx, and we could only enrich inactive Y3H cells from 
mock libraries with an excess of 102 active Y3H cells. With the improved Tet Y3H strain, a 
significant growth difference is observed and it can enrich the inactive Y3H cells from mock 
libraries with an excess of 106 active Y3H cells. The enhanced Tet Y3H counter selection, as well 
as our approach for its development, should have an impact for many bioengineering applications 
where searching immense library sizes is essential.   
With our Tet Y3H counter selection, the laborious effort to isolate desirable variants from 
large libraries with mostly unfit variants is eminently reduced. Because the undesirable variants 
do not survive the selection conditions, they are excluded from the time-intensive plate-based 
assays performed to individualize the variants and less time is wasted individually assaying 
unsatisfactory variants. Therefore, we envision that our Tet Y3H counter selection will be highly 
useful as a high-throughput assay to search large libraries and enrich desirable variants that can 
then be differentiated with specialized low-throughput screens for the function of interest. We plan 
to incorporate this improved Tet Y3H URA3 counter selection into Chemical Complementation 
and apply it to the discovery of bond-cleaving enzymes (See Appendix 2).  
Critical to our success in discovering the appropriate Tet Y3H reporter gene construct were 





Y3H variants.  This approach allowed us to screen for a Tet Y3H URA3 construct with the precise 
activated and basal levels of URA3 expression required to produce the proper growth phenotypes 
in our selections. Our best Tet Y3H strain, MHTet24503,  included an arrangement of the variable 
components that was not apparent, such as more tetO boxes, fewer LexAop binding sites, and the 
non-standard combination of the tetracycline-inducible tetR’-Repressor and tetR’-Activator. By 
screening a small focused library, we discovered the most suitable Tet Y3H reporter gene construct 
and avoided the difficult optimization process often needed to appropriately adjust the 
transcriptional regulation of the reporter gene.  
Not only is the improved Tet Y3H URA3 counter selection useful for endeavors requiring 
a high-throughput assay, but its development process should broadly inspire similar solutions in 
the field of synthetic biology. As the advance of bioengineering technology requires in vivo genetic 
circuits with sophisticated read-outs tailored to the application, our results emphasize the 
importance of pursuing solutions that do not solely rely on the intrinsic dynamic range of 
traditional auxotrophic reporter genes. These reporter genes have the appropriate dynamic range 
for common yeast genetic techniques, but when integrated into advanced in vivo genetic circuits, 
such as the Y3H system, they can sometimes provide a dynamic range that is too constricted. Thus, 
technologies based on these traditional auxotrophic reporter genes may not provide the proper 
regulation for all bioengineering applications.  To improve and diversify these technologies, 
guided strategies based on a fusion of rational design and library approaches should be embraced. 
This method allows one to appropriately adjust the read-out of technologies based on traditional 
reporter genes and screen for a reporter gene construct with expression levels precisely fitted to 






3.4 Experimental Methods 
General Methods. All molecular biology in Saccharomyces cerevisiae and Escherichia coli was 
performed using standard methods[4, 5]. S. cerevisiae strains were grown at 30°C. Restriction 
enzymes, Vent DNA polymerase, T4 DNA Ligase, and dNTPs for PCR were purchased from New 
England Biolabs. Oligonucleotides were purchased from Integrated DNA Technologies. Plasmid 
DNA was purified using QIAprep mini- or maxiprep kits from Qiagen. PCR products and digested 
plasmids were purified by agarose gel electrophoresis and QIAquick spin columns from Gel 
Extraction Kits purchased from Qiagen. For growth curves, 5-Fluoroorotic acid (5-FOA) was 
purchased from Zymo Research. Doxycycline was purchased from Sigma Aldrich. For overlay 
assays, 5-bromo-4-chloro-3-indolyl-β-D-glucuronic acid, cyclohexylammonium salt (X-Gluc) and 
5-bromo-6-chloro-3-indolyl-β-D-galactopyranoside (Magenta-Gal) were purchased from 
Biosynth International. Plasmid concentrations were determined by absorption at 260nm, and all 
absorbance measurements were taken on the Tecan Infinite® PRO Nanoquant. All aqueous 
solutions were made with distilled water prepared from a Milli-Q Water system. For PCR, a MJ 
Research PTC-200 Pellier Thermal Cycler was used. E. coli transformations were carried out by a 
Bio-Rad Gene Pulser. Yeast electroporation was carried out using a Bio-Rad Gene pulser and a 
previously reported protocol[6]. Restriction digests were performed as recommended by New 
England Biolabs. DNA sequencing was performed by Genewiz. 
 
Growth Assay for the Tetracycline Y3H Strains. Five colonies of each of the sixteen Tet Y3H 
strains were inoculated into SC(HTL-), 2% glucose media and shaken overnight  at 30°C.  Cells 
were pre-induced for 24 hours in SC(HTL-), 2% galactose, 2% raffinose media and 2µg/mL of 





added to SC(HTL-), 2% galactose, 2% raffinose, 0.2%FOA, 2µg/mL  Dox, +/- 5μM Dex-Mtx 
media. Cells were shaken at 30°C and the OD600 was monitored.  
 
Mock Selection for the Isolated Tet Y3H Strain. Two colonies of the active Tet Y3H 
(MH24503_098) and inactive Tet Y3H (MH24503_082) strains were inoculated into 5mL and 
1mL of SC(HTL- ), 2% glucose media respectively and grown overnight at 30°C. Cells were pre-
induced in SC(HTL- ), 2% galactose, 2% raffinose, 2μg/mL Dox media for 24 hours.  Pre-induced 
cells were harvested (5 min, 2000rpm) and washed once with sterile water. Cells were resuspended 
in 500uL of SC(HTL- ), 2% galactose, 2% raffinose media. Based on the OD600, cells were mixed 
to give initial ratios of 1:102, 1:103, 1:104, 1:105, and 1:106 inactive Y3H to active Y3H cells in 
800uL of SC(HTL- ), 2% galactose, 2% raffinose, 0.2%FOA, 2μg/mL Dox, and 5μM Dex-Mtx 
media. Initial OD600 was equal to 1. Selections were shaken at 30°C and performed in triplicate. 
For reseeding, the selections were diluted to an OD600 of 0.1 two separate times. First, selections 
were allowed to grow for about 24 hours to an OD600 of 3.0 and reseeded to an OD600 of 0.1 into 
fresh selective media. These diluted cultures were allowed to grow for another 24 hours to an 
OD600 of 0.3 and reseeded again to OD600 of 0.1 into fresh selective media. Following the second 
reseeding, the selections were shaken at 30°C for three days. Selections were plated on SC(HTL-) 
, 2% glucose plates on days 0 and 5. After 2 days of growth, colonies were assayed for lacZ and 
gusA expression using the Magenta-Gal/X-Gluc Overlay assay. Blue (active Y3H) and pink 
(inactive Y3H) colonies were counted to determine the percentage of inactive Y3H cells.  
 
Magenta-Gal/X-Gluc Overlay Assay. To individually assay the color of the colonies during the 





follows. 0.5M potassium phosphate buffer at  pH=7.0 (50 mL), DMF(3.13 mL), 10% SDS (0.56 
mL), and low melting agarose (0.56g) were mixed and microwaved  until the SDS and low melting 
agarose dissolved. The mixture was cooled to 65°C and β-mercaptoethanol (19.45 uL), X-Gluc 
(8.59 mg dissolved in 52uL DMF), and Magenta-Gal (7.09 mg dissolved in 142uL DMF) were 
added. About 10 mL of the Magenta- Gal/X-Gluc cocktail was added to each plate. The plates 
were left at room temperature for a few hours to allow the colonies to develop color.  
 
Construction of Tetracycline Yeast Three-hybrid Strains. All molecular biology in 
Saccharomyces cerevisiae was performed using standard methods. FY251 (MATa leu2-Δ1 trp1-
Δ63 ura3-52 his3-Δ200) transformed with SpeI digested plasmid pLW2707 to integrate LexA-
DHFR-KanMX at the HO locus to generate LW2708Y. Transformants selected on YPD (G418) 
plates. Transformed LW2708Y with plasmid pLW2706 containing B42-GR-HIS3 and selected on 
SC(H-) plates (lacking histidine) to create LW2709Y. EcoRV digested integration plasmids 
pCM242, pCM244, pCM245, pCM247, which targeted tetR’-Ssn6 to the LEU2 locus, were 
transformed into LW2709Y. Transformants selected on SC(HL-) plates. BglII digested integration 
plasmids pLW2699, pLW2700, pLW2701, pLW2702, which targeted LexAop-tetR’-VP16, tetO-
URA3 to the TRP1 locus, were transformed into a pool of colonies from previous tetR’-Ssn6 
transformation. Transformants selected on SC(HTL-) plates to generate final 16 Tet Y3H strains. 
MH24503 mock selection color strains were constructed by curing pLW2706 from MH24503 and 
transforming plasmids pMH098E (B42-GR-pADH1-gusA) or pMH082E (B42-pADH1-lacZ) to 






Construction of Tetracycline Yeast Three-hybrid Plasmids. Plasmid pLW2707 was 
constructed by amplifying pGAL1-LexA-DHFR from pKB521 with primers LMW604 and 
LMW605 that added 5’ BsiWI and 3’ BamHI restriction sites. Digested integration plasmid 
pM4297 and the LexA-DHFR PCR product with BamHI and BsiWI. The digested pM4297 
plasmid and LexA-DHFR PCR product were ligated to generate pLW2707.  
Plasmid pLW2706 was constructed by in vivo gap repair in S. cerevisiae yeast as follows. 
HIS3 was amplified from pRS423 with primers LMW602 and LMW603 that added homology to 
pBC398E outside of its TRP1 marker. pBC398E was digested with PmII, which cuts only in the 
TRP1 marker. HIS3 PCR product and digested pBC398E co-transformed into S. cerevisae yeast to 
generate plasmid pLW2706.  
Integration plasmids pLW2699, pLW2700, pLW2701, pLW2702 were constructed as 
follows. First, the URA3 ORF was inserted after the 7tetO or 2tetO constructs. The URA3 ORF 
was amplified from pRS416 with primers LMW558 and LMW559 that added 5’ BamHI and 3’ 
SbfI sites. The URA3 PCR product and plasmids pCM251 and pCM252 were digested with BamHI 
and SbfI and ligated to generate plasmids pLW2693 and pLW2694. Second, the pCMV promoter 
was replaced with the 2LexAop-pGAL1 or 8LexAop-pGAL1 Y3H promoters by in vivo gap repair 
in S. cerevisiae. The 2LexAop-pGAL1 and 8LexAop-pGAL1 promoters were amplified from 
plasmids pMW109 and pMW112, respectively, with primers LMW560 and LMW561 that add 
homology to pLW2693 and pLW2694. Digested plasmids pLW2693 and pLW2694 with SnaBI, 
which cuts only in the pCMV promoter. The 2 or 8LexAop-pGAL1 PCR products and 
pLW2693/pLW2694 plasmid digests were co-transformed into S. cerevisiae yeast to create 
plasmids pLW2695, pLW2696, pLW2697, and pLW2698. The sequences of these plasmids are 





pLW2697, and pLW2698 from centromeric to integration plasmids. Digested plasmids pLW2695, 
pLW2696, pLW2697, and pLW2698 with NheI and SpeI. Plasmid digests were self-ligated to 
generate plasmids pLW2699, pLW2700, pLW2701, pLW2702. 
Tetracycline Y3H Color strain plasmids pMH098E and pMH082E were constructed by in 
vivo gap repair in S. cerevisiae. HIS3 was amplified from pRS423 with primers LMW602 and 
LMW603 that added homology outside the TRP1 marker. Plasmids pLW2578E and pLW2577E 
were digested with PmII, which only cuts in the TRP1 marker. HIS3 PCR product and digested 
plasmids were co-transformed into S. cerevisae yeast to generate plasmids pMH098E and 
pMH082E. 
 
3.5 Strains, Plasmids, and Oligonucleotides Used in this Study 
 
Table 3-1. Strains used in this study 
Strain Genotype Source/Reference 
FY251 MATa trp1Δ63 his3Δ200 ura3-52 leu2Δ1 Gal+ M. Carlson[a] 
V2169Y MATa trp1Δ63 his3Δ200 URA3 leu2Δ1 Gal+ P. Peralta-
Yahya/[7] 
LW2708Y FY251 with HO:: pGAL1-eLexA-DHFR (KanMX4) This study 
LW2709Y LW2708Y with pLW2706 This study 
MH24503Active Cured MH24503 with MH098E This study 
MH24503Inactive Cured MH24503 with MH082E This study 
MHTet24201 LW2709Y with LEU2::pCMV- tetR-Ssn6 and  
TRP1:: 2LexAop-TetR’-VP16, 2tetO-URA3 
This study 
MHTet24202 LW2709Y with LEU2::pCMV- tetR-Ssn6 and  
TRP1:: 8LexAop-TetR’-VP16, 2tetO-URA3 
This study 







MHTet24204 LW2709Y with LEU2::pCMV- tetR-Ssn6 and 
TRP1::8LexAop-TetR’-VP16, 7tetO-URA3 
This study 
MHTet24401 LW2709Y with LEU2::pCMV- tetR’-Ssn6 and 
TRP1::2LexAop-TetR’-VP16, 2tetO-URA3 
This study 
MHTet24402 LW2709Y with LEU2::pCMV- tetR’-Ssn6 and 
TRP1::8LexAop-TetR’-VP16, 2tetO-URA3 
This study 
MHTet24403 LW2709Y with LEU2::pCMV- tetR’-Ssn6 and 
TRP1::2LexAop-TetR’-VP16, 7tetO-URA3 
This study 
MHTet24404 LW2709Y with LEU2::pCMV- tetR’-Ssn6 and 
TRP1::8LexAop-TetR’-VP16, 7tetO-URA3 
This study 
MHTet24501 LW2709Y with LEU2::pADH- tetR’-Ssn6 and 
TRP1::2LexAop-TetR’-VP16, 2tetO-URA3 
This study 
MHTet24502 LW2709Y with LEU2::pADH- tetR’-Ssn6 and 
TRP1::8LexAop-TetR’-VP16, 2tetO-URA3 
This study 
MHTet24503 LW2709Y with LEU2::pADH- tetR’-Ssn6 and 
TRP1::2LexAop-TetR’-VP16, 7tetO-URA3 
This study 
MHTet24504 LW2709Y with LEU2::pADH- tetR’-Ssn6 and 
TRP1::8LexAop-TetR’-VP16, 7tetO-URA3 
This study 
MHTet24701 LW2709Y with LEU2::pADH- tetR-Ssn6 and 
TRP1::2LexAop-TetR’-VP16, 2tetO-URA3 
This study 
MHTet24702 LW2709Y with LEU2::pADH- tetR-Ssn6 and 
TRP1::8LexAop-TetR’-VP16, 2tetO-URA3 
This study 
MHTet24703 LW2709Y with LEU2::pADH- tetR-Ssn6 and 
TRP1::2LexAop-TetR’-VP16, 7tetO-URA3 
This study 
MHTet24704 LW2709Y with LEU2::pADH- tetR-Ssn6 and 
TRP1::8LexAop-TetR’-VP16, 7tetO-URA3 
This study 









Table 3-2. Plasmids used in this study. 
Plasmids Details Source/Reference 
pRS416GAL pGAL1 CEN6/ARSH4 URA3 pBIISK ori ampR ATCC 87332 
pRS423 2µ HIS3 pUC ori ampR ATCC 77104 
pMW103 pADH-LexA 2µ HIS3 pUC ori kanR R. Brent/[8] 
pMW109 2lexAop-lacZ 2URA3 pBR ori kanR R. Brent/[9] 
pMW112 8lexAop-lacZ 2µ URA3 pBR ori kanR R. Brent/[9] 
pKB521 pGAL1-LexA-eDHFR 2µ HIS3 pBR ori kanR K. Baker/[10] 
pBC398E pGAL1-B42-(GSG)2-rGR2 2µ TRP1 pUC ori kanR B. Carter/[11] 
pM4297 HO-poly-KanMX4-HO pMB1 ori ampR ATCC 87804 
pCM251 pCMV-tetR’-VP16, 2tetO-MCS CEN4 TRP1 pBR322 ori 
ampR 
E. Herrero/[1] 
pCM252 pCMV-tetR’-VP16, 7tetO-MCS CEN4 TRP1 pBR322 ori 
ampR 
E. Herrero/[1] 
pCM242 pCMV-tetR-Ssn6 LEU2  pBR322 ori ampR E. Herrero/[1] 
pCM244 pCMV-tetR’-Ssn6 LEU2  pBR322 ori ampR E. Herrero/[1] 
pCM245 pADH-tetR’-Ssn6 LEU2  pBR322 ori ampR E. Herrero/[1] 
pCM247 pADH-tetR-Ssn6 LEU2  pBR322 ori ampR E. Herrero/[1] 
pLW2577E pGAL1-B42 and pADH-lacZ 2µ TRP1 pUC ori ampR L. Wingler/[3] 
pLW2578E pBC398E with pADH-gusA inserted L. Wingler/[3] 
pLW2706 pGAL1-B42-(GSG)2-rGR2 2µ HIS3 pUC ori kanR This study 
pLW2707 pGAL1-LexA-eDHFR-KanMX4 pMB1 ori ampR This study 
pLW2693  pCM251 with pCMV-tetR’-VP16, 2tetO-URA3 This study 
pLW2694 pCM252 with pCMV-tetR’-VP16, 7tetO-URA3 This study 
pLW2695 pCM251 with 2LexAop- tetR’-VP16, 2tetO-URA3 This study 
pLW2696 pCM251 with 8LexAop- tetR’-VP16, 2tetO-URA3 This study 
pLW2697 pCM252 with 2LexAop-tetR’-VP16, 7tetO-URA3 This study 
pLW2698 pCM252 with 8LexAop-tetR’-VP16, 7tetO-URA3 This study 







pLW2700 8LexAop- tetR’-VP16, 2tetO-URA3 TRP1 pBR322 ori 
ampR 
This study 
pLW2701 2LexAop-tetR’-VP16, 7tetO-URA3 TRP1 pBR322 ori 
ampR 
This study 
pLW2702 8LexAop-tetR’-VP16, 7tetO-URA3 TRP1 pBR322 ori 
ampR 
This study 
pMH082E pLW2577E with HIS3 replacing  TRP1  This study 




Table 3-3. Oligonucleotides used in this study. 
 









LMW605 CTGGCAGGATCCCATGCCGGTAGAGGTGT       
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4.0 Chapter Outlook 
The therapeutic potential of many natural products, particularly polyketides, has not been 
realized due to their intrinsically low production from natural hosts and laborious chemical 
synthesis. Given the expanding toolkit for DNA manipulation, metabolic engineering is an 
increasingly useful method to improve the production of natural product therapeutics in favored 
heterologous hosts. The efficacy of metabolic engineering can be significantly raised by using a 
directed evolution approach to generate metabolic pathway libraries. However, the search of large 
metabolic pathway libraries for increased natural product biosynthesis is impeded by the lack of a 
high-throughput screen to detect their production in favored heterologous hosts. To address this 
bottleneck, we developed a yeast-three hybrid screen that links the presence of the natural product 
to reporter gene transcription via its competitive displacement of the chemical dimerizer that joins 
the DNA-binding and activation domains. In this chapter, we present the design, development, and 
characterization of a Y3H screen for the detection of tacrolimus (FK506)--a polyketide whose 
biosynthesis is well-characterized in Streptomyces producer strains. First, we constructed and 
tested various Y3H systems for the detection of commercial FK506.  Next, we determined the 
optimal method to administer the biosynthesized FK506 for detection by the selected Y3H strain. 
Finally, we challenged the Y3H screen to detect FK506 from the extracts of a well-characterized 
Streptomyces producer strain. Our work illustrates the genetic tractability of the Y3H assay and its 
potential to be a versatile technology for the metabolic engineering of microbes for the 









Polyketides are a diverse group of natural products that serve as a leading source for 
antibiotic[1-3], anti-cancer[4, 5], anti-inflammatory[6], and anti-cholesterol[7] drugs. Although 
polyketides are in high demand, their large-scale production is severely hindered because they are 
not practically generated by chemical synthesis[8, 9] or extraction from natural hosts[10-12]. 
However, the metabolic engineering of heterologous microbes for the overproduction of 
polyketides has transformed the pharmaceutical industry by providing access to these structurally 
complex targets through fermentation[13-17]. The power of metabolic engineering can be further 
elevated through the directed evolution of pathway libraries that can yield efficient heterologous 
host strains for the production of both existing and novel polyketides[18-23]. A persistent 
stumbling block for the development of these strains is the lack of a high-throughput screen or 
selection for polyketide production. Polyketides are not intrinsically linked to a readily assayable 
phenotype[24]; thus, the directed evolution of microbes for their overproduction is limited to low-
throughput analytical screens, such as liquid or gas chromatography, which can only search 
libraries between 102-103 variants[25]. With such small searchable library sizes, the genetic 
diversity afforded by modern engineering methods remains largely untapped and the potential of 
heterologous production is gravely diminished. 
To address this bottleneck, we undertook the design and construction of an in vivo yeast 
three-hybrid (Y3H) screen that couples the presence of the target natural product to an independent 
reporter.  Thus, this Y3H screen can be applied to the overproduction of natural products that do 
not possess distinct, measurable phenotypes. In our Y3H screen, a chemical dimerizer links the 
DNA-binding and activation domains of the Y3H system, which control expression of a reporter 





dimerizer and disrupts reporter gene expression. The specificity of the Y3H screen requires that 
either the activation or DNA-binding receptor fusion proteins bind both the chemical dimerizer 
and the target molecule. Thus, by modifying the chemical dimerizer and employing the appropriate 




Figure 4-1. An in vivo Y3H screen for the detection of natural product biosynthesis. The Y3H screen couples 
the presence of the target natural product to reporter gene expression through its competitive displacement 
of the chemical dimerizer bridging the DNA binding and activation domains of the Y3H system. The natural 
product is detected by isolating cells with the reporter gene output disrupted.  
 
We envision the Y3H screen serving as a detection module following the biosynthesis of 
the natural product from dedicated producer strains. As shown in Fig 4-2, our assay requires 
fermenting the producer strain in the appropriate media and then collecting the supernatant to 
isolate the target natural product. The supernatant is then added to a culture containing our Y3H 
screen strain that links the presence of the natural product to a detectable readout. As a microtiter 





which would be a significant improvement over the currently used low-throughput analytical 
screens[24]. 
 
Figure 4-2. An assay to detect natural product biosynthesis from the extracts of dedicated producer strains. 
We envisage an assay that includes fermentation of the target molecule from a producer strain followed by 
isolation of the supernatant, which contains the target molecule. Next, the supernatant is introduced to the 
Y3H strain that links the presence of the target molecule to a detectable readout. With the microtiter plate 
format, this assay can be applied to search libraries on the order of 105 variants. 
 
We chose to develop the Y3H screen with FKBP12, a protein that is known to bind the 
relevant polyketide, tacrolimus (FK506) [26-28]. Our Y3H screen uses the previously developed 
chemical dimerizer methotrexate-SLF (Mtx-SLF) to bridge the DNA-binding and activation 
domains of a transcription factor to activate a downstream reporter gene. SLF is a well-
characterized synthetic analogue of FK506 and has been previously used in our laboratory [29-
32]. Specifically, in the Y3H-FKBP12 system, the LexA DNA binding domain (DBD) and B42 
activation domain (AD) are expressed as fusion proteins with FKBP12 and the dihydrofolate 
reductase (DHFR), respectively. Mtx-SLF links the LexA DBD-FKBP12 and B42 AD-DHFR 
fusion proteins to activate the transcription of the LEU2 reporter gene. The Y3H system detects 





leading to the disruption of LEU2 transcription. Thus, in the presence of FK506 cell growth is 
inhibited in media lacking leucine. 
To maximize our chances of developing a sensitive screen for FK506, various Y3H-
FKBP12 strains were constructed and tested.  The Y3H-FKBP12 strains varied in components 
expected to affect the competition between the chemical dimerizer and FK506. All strains included 
the FKBP12-DBD fusion protein given the previous unsuccessful competition assays with the 
FKBP12-AD fusion protein [32]. Besides the FKBP12-DBD fusion protein, the Y3H-FKBP12 
strains differed in the binding affinity of the FKBP12 receptor and the copy number of the 
activation domain plasmid (Table 4-1). 
 
Strain Name DBD Fusion Protein AD Fusion Protein AD Plasmid Copy number 
MH-H87L  LexA-FKBP12* B42-DHFR High 
MH-WT LexA-FKBP12 B42-DHFR High 
MH-H87L-L LexA-FKBP12* B42-DHFR Low 
MH-WT-L LexA-FKBP12 B42-DHFR Low 
 
Table 4-1. Construction of various Y3H-FKBP12 strains. The FKBP12* protein has an H87L mutation that 
enables it to have a higher binding affinity than the wild-type FKBP12. It was engineered by rational 
design[32].  
 
In this chapter, we present our work to characterize the detection of FK506 by the Y3H–
FKBP12 system. First, the various Y3H-FKBP12 systems were constructed and tested for the 
detection of FK506. The best strains were then assayed for their sensitivity towards FK506. Next, 





FK506 from the Streptomyces extracts. Finally, we examined the ability of the Y3H-FKBP12 
system to detect FK506 biosynthesized by a well-studied Streptomyces producer strain. A screen 
of four candidate Y3H constructs yielded two strains that could effectively detect commercial 
FK506 with concentrations as low as 10nM. Unfortunately, these strains were not able to detect 
FK506 biosynthesized by the Streptomyces producer strain. However, we discuss explanations for 
these unsatisfactory results and methods to improve the Y3H screen technology.  
4.2 Results 
4.2.1 Competition assay with Y3H-FKBP12 system and Commercial FK506 
Multiple clones of the four Y3H-FKBP12 strains were tested.  First, we performed a growth 
assay to determine which strains showed increased growth inhibition in the presence of 100nM 
and 5µM FK506. The Y3H-FKBP12 strains were expected to show growth inhibition in the 
presence of FK506 as the chemical dimerizer, Mtx-SLF, is displaced and LEU2 transcription is 
prevented. All the Y3H-FKBP12 systems were able to detect FK506, however, only strains with 
the activation domain on a high copy plasmid (MH-WT and MH-H87L) reached saturated cell 
densities after 6 days (Fig. 4-3). In the presence and absence of 5µM FK506, the MH-WT and 






Figure 4-3. The Y3H-FKBP12 strains detect commercially purified FK506. The Y3H-FKBP12 strains were 
developed with A) the FKBP12* (purple) or B) the wild-type FKBP12 (gold) protein fused to the DNA-binding 
domain to generate MH-H87L and MH-WT, respectively. Growth of the C) MH-H87L and D) MH-WT strains 
in the presence of Mtx-SLF with 0nM, 100nM, and 5uM FK506. Shown is the mean growth after 6 days and 
error bars represent the standard deviation from the mean. Growth curves were performed in triplicate with 
two separate colonies. 
 
These strains were further characterized for their sensitivity towards FK506. The growth 
inhibition of MH-WT and MH-H87L were assayed with the following FK506 concentrations: 
0nM, 10nM, 100nM, and 1uM. As shown in Figure 4-4, the MH-WT strain demonstrated increased 
sensitivity and showed clear differences in growth for all FK506 concentrations after 3 days. The 
MH-H87L strain was considerably less sensitive and could not detect the 10nM concentration or 





Figure 4-4. Sensitivity of the selected Y3H-FKBP12 strains towards FK506. Growth of the A) MH-H87L and 
B) MH-WT in the presence of increasing concentrations of FK506 (0nM, 10nM, 100nM, and 1uM). Shown 
is the mean growth after 3 days and error bars represent the standard deviation from the mean. Growth 
curves were performed in triplicate. 
 
4.2.2 Evaluation of Biosynthetic FK506 Administration Methods 
Here, we tested whether the direct addition of the Streptomyces unfermented media would 
impair the growth of the Y3H-FKBP12 strains. The initial growth assay was performed with MH-
H87L in the presence or absence of Mtx-SLF and with or without the addition of fresh, 
unfermented Streptomyces media. We expected the MH-H87L strain to grow to saturated cell 
densities with similar growth rates in all conditions with the Mtx-SLF present (even with the 
unfermented Streptomyces media) as there was no FK506 present to cause growth inhibition. 
However, the growth of the MH-H87L strain was severely impaired by the presence of the 








Figure 4-5. Assessing the effect of different solvents on the growth of S. cerevisiae. The MH-H87L strain 
was grown in the presence of Mtx-SLF and unfermented Streptomyces media that was either unaltered, 
extracted with ethyl acetate, or rotary evaporated and dissolved in ethanol or methanol. The strains were 
also grown in the absence of Mtx-SLF. Shown is the mean growth after 6 days and error bars represent the 
standard deviation from the mean. Growth curves performed in triplicate. 
 
We then investigated other solvents for introducing the Streptomyces extracts to the Y3H-
FKBP12 strains as this was imperative for the assay. We chose to test the compatibility of various 
solvents with S. cerevisiae that are known to effectively dissolve FK506, such as ethyl acetate, 
ethanol, and methanol. The MH-H87L strain was grown in the presence of Mtx-SLF with the 
addition of unfermented Streptomyces media that had been unmodified, extracted by ethyl acetate, 
or rotary evaporated and dissolved in either ethanol or methanol. The MH-H87L strain was also 
grown in the presence and absence of Mtx-SLF without ethyl actetate, ethanol, or methanol to 
serve as a comparison. In the presence of Mtx-SLF, we expected the cells to grow to saturated cell 
densities and have similar growth rates as to when no FK506 was present. Interestingly, the MH-





acetate extracted Streptomyces media. However, in the presence of media that was rotary 
evaporated and then dissolved in either ethanol or methanol, the MH-H87L strain showed medium 
to severe growth inhibition, respectively (Figure 4-5). Although the MH-H87L strain demonstrated 
minimal growth inhibition in the presence of ethyl acetate extracted Streptomyces media, the more 
sensitive MH-WT strain showed severely decreased growth (See Fig. 4-6). Thus, we continued 
with the MH-H87L strain to further study whether FK506 could be detected from fermented 
Streptomyces media. 
 
Figure 4-6. The performance of the selected strains in ethyl acetate extracted Streptomyces media that 
was unfermented. Growth of the MH-H87L (purple) and MH-WT (gold) in the presence and absence of Mtx-
SLF. In the presence of Mtx-SLF, the strains were exposed to ethyl acetate extracted Streptomyces media. 
Shown is the mean growth after 6 days and error bars represent the standard deviation from the mean. 
Growth curves were performed in triplicate. 
 
4.2.3 Competition Assay with Biosynthesized FK506 from Streptomyces Producer Strain. 
Having verified the optimal conditions for introducing the Streptomyces extracts to the 
MH-H87L strain, we tested if it could detect the presence of FK506 in ethyl acetate extracted 
fermented media. The MH-H87L strain was grown in the presence and absence of Mtx-SLF and 
treated with ethyl acetate extracted Streptomyces media that was previously fermented to produce 
FK506 for 0, 1 or 8 days. We confirmed by analytical characterization that only the 8 day 





in the 1 day fermented media, we expected the cells to grow as well as controls that were treated 
with unfermented media as there was minimal FK506 produced. By contrast, upon exposure to the 
8 day fermented media, the MH-H87L strain was expected to show growth inhibition. 
Unfortunately, we were not able to distinguish the growth rates between cells treated with the 1 or 
8 day fermented media in the presence of Mtx-SLF. Additionally, in the absence of Mtx-SLF, the 
cells treated with the 8 day fermented media grew as well as those cells treated with the fermented 
media in the presence of Mtx-SLF. In general, the cells treated with the 1 or 8 day fermented media 
exhibited some growth inhibition in the presence of Mtx-SLF compared to those cells that were 
untreated. However, the cells treated with the 1 day fermented media produced the predicted 
readouts in the presence and absence of Mtx-SLF.  Thus, the unanticipated performance of cells 
treated with the 8 day fermented media, particularly in the absence of Mtx-SLF, is most likely 
unrelated to the assay conditions. 
 
Figure 4-7. Growth of MH-H87L with 0, 1 or 8 day fermented Streptomyces extracts. MH-H87L was grown 
in the presence and absence of Mtx-SLF and treated with 0, 1 or 8 day fermented Streptomyces media that 
was previously extracted with ethyl acetate. Shown is the mean growth after 9 days and error bars represent 






4.3 Discussion  
 In this work, we expanded the versatility of the Y3H assay by applying it to the detection 
of natural product biosynthesis from dedicated producer strains. First, we constructed and screened 
four Y3H strains based on the FKBP12 receptor to detect FK506, a relevant natural product whose 
biosynthesis has been optimized in a well-studied Streptomyces producer strain[28]. By screening 
the Y3H-FKBP12 strains, we identified two that were able to effectively detect 100nM and 5uM 
FK506 concentrations. In addition, by varying the FKBP12 binding affinity through rational 
design, we discovered that the lower binding affinity of the wild-type FKBP12 resulted in 
increased sensitivity for the Y3H, successfully detecting FK506 concentrations as low as 10nM. 
The elevated sensitivity of this strain suggests that a lower binding affinity is more conducive to 
the competitive displacement of the chemical dimerizer, Mtx-SLF by FK506. This observation is 
plausible as a higher binding affinity to the chemical dimerizer most likely requires increased 
natural product concentrations to displace the chemical dimerizer and ultimately affect reporter 
transcription.  
Although Y3H systems with the wild-type FKBP12 fusion protein were more sensitive to 
the presence of FK506, this advantage was not suitable for our studies with the Streptomyces 
extracts. The increased sensitivity caused the Y3H system to experience growth inhibition even in 
the absence of FK506. Interestingly, the less sensitive strains with the higher binding H87L 
FKBP12 variant were more compatible with the Streptomyces extracts, and thus chosen for our 
efforts to detect biosynthesized FK506. Moreover, our work here highlights the difficulty of 
rationally anticipating metabolic processes, and hence the importance of testing multiple variations 





Following the identification of the best Y3H-FKBP12 strain (MH-H87L), we then 
challenged it to detect FK506 from the extracts of a Streptomyces producer strain. First, we 
determined the optimal conditions for adding the Streptomyces extracts to the MH-H87L strain. 
Initially, we discovered that the MH-H87L strain was severely growth inhibited in unfermented 
Streptomyces media. To decouple detection from the harmful Streptomyces media, we tested the 
growth of the Y3H strains in solvents that effectively dissolve FK506. Fortunately, the MH-H87L 
strain was able to grow well in Streptomyces media extracted with ethyl acetate. Although this 
modification adds an extra step to our envisioned assay, the biosynthesis of natural products from 
producer strains fermented in different conditions can potentially be tested in a more standardized 
fashion without the unpredictable fluctuations in readout caused by varying media conditions.  
Next, we tested for growth inhibition in the presence of Streptomyces media that had been 
fermented for 1 or 8 days. Unfortunately, there was no growth difference in the presence of Mtx-
SLF between the cells treated with the 1 or 8 day fermented Streptomyces media. This unexpected 
result initially suggested that the Y3H-FKBP12 strain was unable to detect FK506. However, the 
performance of the cells in the absence of Mtx-SLF suggests another explanation for the negligible 
growth difference. Notably, the cells treated with the 8 day fermented media were able to grow to 
high cell densities even in the absence of Mtx-SLF. This chemical dimerizer independent growth 
was not observed when cells were treated with the 1 day fermented media or unfermented media. 
A possible explanation for this result is that the Streptomyces producer strain was able to produce 
not only FK506 throughout the 8 day fermentation, but an unknown compound that enhances S. 
cerevisiae growth. Thus, the presence of FK506 in the 8 day fermented media may not be detected 
by growth inhibition because it is cancelled out by the growth enhancement afforded by the 





Given the sensitivity to unknown variables from the producer strain, improving the Y3H 
screen necessitates transitioning away from the growth readout. An alternative readout that does 
not depend on growth, such as the green fluorescent protein (GFP), may enable the detection of 
FK506 even with the growth advantage afforded by the Streptomyces fermented media. Adopting 
GFP would also enable quantification of the read out per cell with each fermentation time point, 
which helps to dissociate FK506 detection from S. cerevisiae growth. Additionally, GFP 
incorporation shortens the length of our assay as it can be detected much faster than a growth 
readout.  However, even if the GFP resolves the readout issue, we are interested in pinpointing the 
reason for the growth advantage caused by the 8 day fermented media. We plan to carry out a 
thorough analysis of the molecules present before and after the 8 day fermentation with analytical 
methods, such as LC-MS. Moreover, adapting the GFP readout, will improve the compatibility of 
the Y3H screen for the metabolic engineering of other high-value natural products from various 
producer strains.  
The impact of directed evolution on the metabolic engineering of microbes for increased 
natural product biosynthesis hinges on the development of general assays that can reliably screen 
large library sizes.  Using the highly adaptable Y3H assay, we have engineered a screen that can 
potentially fill this void as a high-throughput, versatile assay linking natural product biosynthesis 
to a detectable readout. This assay could play a vital role in strain development by winnowing out 









4.4 Experimental Methods 
Construction of Y3H-FKBP12 LEU2 Strains  
All molecular biology in Saccharomyces cerevisiae was performed using standard 
methods. EGY48 (MATa trp1 his3 ura3 6LexAop-LEU2 GAL+) was transformed with plasmids 
MH423B42-eDHFR or MH413B42-eDHFR and selected for on SC(H-, 2% glucose) plates. Next, 
these strains were transformed with plasmids MH414LexA-FKBP12 or MH414LexA-FKBP12* 
to generate the following strains: MH-WT, MH-H87L, MH-WT-L, and MHH87L-L. Successful 
transformants were selected on SC(HT-, 2% glucose) plates. 
Construction of Y3H-FKBP12 LEU2 Plasmids 
Plasmids MH414LexA-FKBP12 and MH414LexA-FKBP12* were constructed by Gibson 
Assembly and transformed into E. coli as follows. The pGAL1-LexA fragment was amplified from 
pKB521 with primers MH162 and MH164 that added homology to pRS414GAL1 and the 
FKBP12-tADH fragment. The FKBP12-tADH fragment was amplified from V358E or 1054E 
with primers MH165 and MH163 to generate MH414LexA-FKBP12 or MH414LexA-FKBP12*, 
respectively. MH165 and MH163 added homology to pRS414GAL1 and pGAL1-LexA fragment. 
pRS414GAL1 was digested with SacI and XhoI, which cuts in its multiple cloning site. The Gibson 
Assembly reaction was performed by mixing the digested pRS414GAL1 plasmid with the pGAL1-
LexA and various FKBP12-tADH PCR inserts in a 1:3 ratio followed by incubation at 50°C for 1 
hour. The Gibson Assembly reaction was transformed into E. coli by electroporation. 
Transformants were selected on LB/ampicillin plates and characterized by sequencing. 
Plasmids MH423B42-eDHFR or MH413B42-eDHFR were constructed by Gibson 
Assembly and transformed into E. coli as follows. The pGAL1-B42-eDHFR fragment was 





pRS423. pRS413 and pRS423 were digested with SacI and XhoI, which cuts in the multiple 
cloning site. The Gibson Assembly reaction was performed by mixing the digested pRS413 or 
pRS423 plasmids with the pGAL1-B42-eDHFR PCR inserts in a 1:3 ratio followed by incubation 
at 50°C for 1 hour. The Gibson Assembly reaction was transformed into E. coli by electroporation. 
Transformants were selected on LB/ampicillin plates and characterized by sequencing. 
Competition Growth Assay with Commercial FK506 
Three colonies of the MH-WT, MH-H87L, MH-WT-L, and MH-H87L-L strains were 
inoculated into SC(HT-), 2% glucose media and shaken overnight  at 30°C.  Cells were pre-induced 
for 24 hours in SC(HT-), 2% galactose, 2% raffinose media. The pre-induced cells were added to 
SC(HTL-), 2% galactose, 2% raffinose, +/- 5μM Mtx-SLF media to have a starting OD600 of 0.1.  
The first growth assay was performed in SC(HTL-), 2% galactose, 2% raffinose, 5µM Mtx-SLF 
with 100nM or 5uM FK-506. To test the sensitivity of MH-WT and MH-H87L the same growth 
assay was performed with the following concentrations: 0nM, 10nM, 100nM, and 1µM. A 100uM 
FK506 in DMSO stock was prepared and diluted in the growth media to produce the appropriate 
concentrations the Cells were shaken at 30°C and the OD600 was monitored for about 6 days. All 
growth curves were performed in duplicate with three technical replicates. 
Optimizing Biosynthetic FK506 Administration Methods 
The MH-H87L strain was inoculated into SC(HT-), 2% glucose media and shaken 
overnight  at 30°C.  Cells were pre-induced for 24 hours in SC(HT-), 2% galactose, 2% raffinose 
media. The pre-induced cells were added SC(HTL-), 2% galactose, 2% raffinose, +/- 5μM Mtx-
SLF, and 5uL of Streptomyces unfermented media that was 1) extracted by ethyl acetate or 2) 
rotary evaporated and then dissolved in either ethanol or methanol. The growth assay was started 





Competition Growth Assay with Biosynthesized FK506 Extracted from Streptomyces 
The MH-H87L strains were inoculated into SC(HT-), 2% glucose media and shaken 
overnight  at 30°C.  Cells were pre-induced for 24 hours in SC(HT-), 2% galactose, 2% raffinose 
media. The pre-induced cells were added to SC(HTL-), 2% galactose, 2% raffinose, +/- 5μM Mtx-
SLF media, and ethyl acetate extracted Streptomyces media that was fermented for 0, 1 or 8 days. 
Growth assays were started with an OD600 of 0.1 in total volume of 200uL. Next, 10uL of the ethyl 
acetate extracted Streptomyces media was added. Cells were shaken at 30°C and the OD600 was 
monitored for about 9 days. All growth curves were performed in triplicate.  
The ‘Streptomyces tsukubaensis’ producer strain (obtained from NRRL #18488) was 
fermented in “ISP4” media according to a modified protocol based on work by Martinez-Castro 
and coworkers[28].  First, a starter culture was created by inoculating 2 mL of “BaSa” media with 
a frozen glycerol spore stock.  The culture was shaken in a 14 mL culture tube (28 ºC, 250 rpm) 
for 2 days.  200 uL of saturated starter culture was used to inoculate 1.8 mL of “ISP4” media in a 
14 mL culture tube and incubated for up to 8 days. The fermentation cultures were analyzed by 
LC-MS and determined to have 0 mg/L or 20 mg/L (25 uM) for the 1 and 8 day fermentations, 
respectively. 
 
4.5 Strains, Plasmids, and Oligonucleotides used in this study 
Table 4-2. Strains used in this study 
Strain Genotype Source/Reference 
EGY48 MATa trp1 his3 ura3 6LexAop-LEU2 GAL+ R. Brent/[33] 












EGY48 with MH414LexA-FKBP12* and MH413B42-
eDHFR 
This study 




Table 4-3. Plasmids used in this study 
Plasmid Details Source/Reference 
pRS414GAL1 pGAL1 CEN6/ARSH4 TRP1 pBIISK ori ampR ATCC 87328 
pRS413GAL1 pGAL1 CEN6/ARSH4 HIS3 pBIISK ori ampR ATCC 87326 
pRS423GAL1 pGAL1 2µ  HIS3 pBIISK ori ampR ATCC 87327 
pKB521 pGAL1-LexA-eDHFR 2µ HIS3 pBR ori kanR K. Baker/[34] 
V358E  pGAL1 B42-FKBP12 2µ kanR TRP1 pUC ori  R. Brent/[35] 
V1054E pGAL1 B42-FKBP12 with H87L mutation 2µ kanR TRP1 
pUC ori 
B. Carter/[32] 
pBC1034E pGAL1 B42-eDHFR 2µ kanR TRP1 pUC ori B. Carter/[36] 
MH414LexA-
FKBP12* 
pRS414GAL1 with pGAL1-LexA-FKBP12 (H87L) This study 
MH414LexA-
FKBP12 
pRS414GAL1 with pGAL1-LexA-FKBP12 (WT) This study 
MH423B42-
eDHFR 
pRS423GAL1 with pGAL1- B42-eDHFR This study 
MH413B42-
eDHFR 









Table 4-4. Oligonucleotides used in this study. 
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A1.1 Appendix Summary 
 
Here, we elaborate on the characterization of the original Y3H counter selection, which 
guided our approaches for improving its dynamic range in Chapter 2 and 3. We characterized the 
original Y3H counter selection to determine whether the URA3 reporter gene was impaired when 
placed under the control of the Y3H system. The performance of the URA3 counter selection in 
growth assays and mock selections was compared for when URA3 was under the control of its 
endogenous promoter or the Y3H system.  
A1.2 Performance of URA3 as a Marker Gene and in the Y3H System 
To test the URA3 reporter gene in its traditional context as a marker gene, we constructed 
a strain with a wildtype URA3 and an inactive allele, ura3-52 under the control of its endogenous 
promoter.  When regulated by its endogenous promoter, the URA3 counter selection exhibited a 
significant growth difference between cells with a wild-type copy of URA3 versus cells with the 
inactive allele ura3-52, which produces no functional Ura3p. In mock selections, the URA3 
counter selection enriched cells with the inactive ura3-52 allele from an excess of 105 cells 




Figure A1-1. Characterization of the URA3 counter selection under the control of the endogenous URA3 
promoter. Cells contained A) the ura3-52 allele that produced no functional URA3 protein or B) wild-type 
URA3. C) Growth Curves for cells with a wild-type copy of URA3 (black) or the inactive allele, ura3-52 
(gray). The OD600 of 4 independent colonies was monitored in SC(HT-), 2% galactose, 2% raffinose, 0.2% 
FOA media.  Each curve represents the results for a unique, randomly selected colony. Error bars represent 
the standard error in the OD600 readings for duplicate cultures. Standard error for duplicate cultures of a 
unique colony is below 0.03. D) Mock selection for enrichment of cells with the inactive ura3-52 allele from 
a large excess of cells with wild-type URA3. With URA3 as simply a marker gene, the URA3 counter 
selection enriched cells with the inactive ura3-52 from an excess of 105 wild-type URA3 cells after 6 days. 
 
Under analogous conditions, the Y3H URA3 counter selection showed a negligible growth 
difference between active and inactive Y3H cells, which both grew to a saturated cell density and 
had indistinguishable growth rates. The lack of a growth difference led to the enrichment of the 
inactive Y3H cells in mock selections with only an excess of 102 active Y3H cells after 9 days of 




Figure A1-2.  Characterization of the URA3 counter selection under the control of the Y3H system. A) 
Active Y3H binds Dex-Mtx and reconstitutes the transcriptional activator for the URA3 reporter gene. B) 
Growth Curves for Active Y3H URA3 cells in conditions with or without 5μM Dex-Mtx. The OD600 of 4 
independent colonies was monitored in SC(HT-), 2% galactose, 2% raffinose, 0.2% FOA media +/- 5uM 
Dex-Mtx. Each curve represents the results for a unique, randomly selected colony. Error bars represent 
standard error in the OD600 readings for duplicate cultures. Standard error for duplicate cultures for a unique 
colony is below 0.03. C) Mock selection for enrichment of inactive Y3H cells without the requisite B42-GR 
fusion protein from large excess of active Y3H cells.  
 
Based on this characterization, the low dynamic range of the Y3H counter selection could 
have been caused by 1) excessive basal expression of URA3 in the absence of Dex-Mtx or 2) 
insufficient activation of URA3 through the tightly regulated LexAop-pSPO13 promoter in the 
presence of Dex-Mtx. The active Y3H strain grew comparably to the inactive ura3-52 strain in the 
absence of Dex-Mtx (Figure A1-3), which is inconsistent with high basal URA3 expression.  If 
basal URA3 expression was occurring, then the active Y3H cells would exhibit impaired growth 
in the absence of Dex-Mtx. Therefore, we inferred that the minimal growth difference observed 
between active Y3H cells treated with or without Dex-Mtx was caused by insufficient activation 
of URA3 when controlled by the LexAop-pSPO13 promoter. The tightly regulated LexAop-
pSPO13 promoter effectively reduced basal expression of URA3. However, it hindered chemical 
dimerizer-dependent activation and resulted in low URA3 expression that caused minimal growth 
inhibition of the active Y3H cells treated with Dex-Mtx. Based on this work, we hypothesized that 
the key to improving the dynamic range of our Y3H counter selection was to rationally redesign 
the Y3H system to maximize the growth difference between cells with activated and basal levels 





Figure A1-3. Growth curves in the absence of Dex-Mtx for cells with A) inactive ura3-52 allele under the 
control of the endogenous URA3 promoter or the B) URA3 reporter gene under the control of the Y3H 
system. C) The OD600 of 4 independent colonies was monitored in SC(HT-), 2% galactose, 2% raffinose, 
0.2% 5-FOA media (lacking histidine and tryptophan). Each curve represents the results for a unique, 
randomly selected colony. Error bars represent the standard error in OD600 readings for duplicate cultures. 
Standard error for duplicate cultures of a unique colony below 0.03. Without Dex-Mtx, the Active Y3H cells 
grow comparably to cells with the inactive ura3-52 allele indicating basal expression is not occurring.  
 
A1.3 Experimental Methods 
Construction of the Original Yeast Three-hybrid Counter Selection Strain. VC2240Y was 
cured of plasmids pKB521 and pBC398E to generate LW2635Y. For active Y3H strains, 
LW2635Y was transformed with plasmids pKB521 and pBC398E to create LW2635YActive. For 
inactive Y3H strains, LW2635Y was transformed with plasmids pMW103 and pBC398E to create 
LW2635YInactive. For the mock selection Y3H color strains, plasmids pLW2578E and pKB521 
were co-transformed into LW2635Y to create the active Y3H color strain, LW2636Y, and 
plasmids pLW2577E and pKB521 were co-transformed into LW2635Y to create the inactive Y3H 




Construction of isogenic Y3H Strains with endogenous URA3 promoter. V2169Y was 
transformed with plasmids pKB521 and pBC398E to create isogenic Y3H strains with the 
endogenous URA3 promoter controlling the URA3 reporter gene. FY251 was transformed with 
pKB521 and pBC398E to create isogenic Y3H strains with the endogenous URA3 promoter 
controlling the ura3-52 inactive allele, which produces no functional Ura3p.  
 
Growth Assays. For the original Y3H growth curves, four colonies of the wild-type URA3  
(V2169Y), inactive ura3-52  (FY251), active original Y3H (LW2635YActive), and inactive 
original Y3H (LW2635YInactive) strains were inoculated into SC(HT-), 2% glucose media and 
shaken overnight at 30°C. Growth curves were performed in SC(HT- ), 2% galactose, 2% raffinose, 
0.2%FOA media. We added 5μM Dex-Mtx for the Y3H strains only. All growth curves were 
performed in duplicate. 
 
Mock Selections. For the original Y3H counter selection, two colonies from the active Y3H 
(LW2637Y) and inactive Y3H (LW2636Y) strains were used. Cells were pre-induced for 24 hours 
in SC(HT- ), 2% galactose, 2% raffinose media. Mock selections were setup in SC(HT- ), 2% 









A1.4 Strains, plasmids, primers used in this study 
Table A1-1. Strains used in this study 
Strain Genotype Source/Reference 
FY251 MATa trp1Δ63 his3Δ200 ura3-52 leu2Δ1 Gal+ M. Carlson[a] 
V2169Y MATa trp1Δ63 his3Δ200 URA3 leu2Δ1 Gal+ P. Peralta-
Yahya/[1] 
LW2635Y MATa trp1Δ63 his3Δ200 8lexAop-Spo13-URA3 
leu2Δ1 Gal+ 
This study 
LW2635YActive LW2635Y with pKB521 and pBC398E This study 
LW2635YInactive LW2635Y with pMW103 and pBC398E This study 
LW2636Y LW2635Y with LW2629Y and pKB521 This study 
LW2637Y LW2635Y with LW2570E and pKB521 This study 
[a] M. Carlson, Columbia University, Genetics and Development Department 
 
Table A1-2. Plasmids used in this study. 
Plasmid Details Source/Reference 
pKB521 pGAL1-LexA-eDHFR 2µ HIS3 pBR ori kanR K. Baker/[2] 
pBC398E pGAL1-B42-(GSG)2-rGR2 2µ TRP1 pUC ori kanR B. Carter/[3] 
pLW2577E pGAL1-B42 and pADH-lacZ 2µ TRP1 pUC ori ampR L. Wingler/[4] 
pLW2578E pBC398E with pADH-gusA inserted L. Wingler/[4] 
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Adaptation of the Tet Y3H Counter Selection for the  

















In this section, we expand on the adaptation of the improved Tet Y3H counter selection 
(discussed in Chapter 3) for the detection of enzymatic activity. We aimed to apply the Tet Y3H 
counter selection to detect the activity of cellulases and β-lactamases, which are well-studied bond 
cleavage enzymes previously used in our chemical complementation systems[1-4]. We present an 
assay to determine the cleavage activity of the cellulase and β-lactamase enzymes to their 
respective chemical linkers, Dex-Cel-Lac-Mtx and Dex-Cephem-Mtx. We continued our studies 
with the β-lactamase enzyme since it effectively cleaved its chemical linker, whereas the cellulase 
did not. The Tet Y3H strains were then tested for β-lactamase cleavage-dependent growth with the 
Dex-Cephem-Mtx chemical linker. However, there was less than a 2-fold growth advantage for 
Tet Y3H strains expressing the active β-lactamase. To optimize the selection conditions, we tested 
various concentrations of 5-FOA and Dex-Cephem-Mtx, however, these modifications did not 
improve the dynamic range of the counter selection with Dex-Cephem-Mtx. Implementing a 
different approach, we present a Tet Y3H counter selection that includes a β-lactamase fusion to 
the LexA-DNA binding domain to increase the local concentration of the enzyme. Unfortunately, 
the β-lactamase triple fusion strain did not lead to cleavage-dependent growth in the presence of 
Dex-Cephem-Mtx for the active and inactive variants. We discuss potential approaches to improve 
the detection of β-lactamase activity by the Tet Y3H counter selection.  
A2.1 Assessing Enzyme Cleavage Activity with a Y3H LacZ Assay 
 The cleavage activity of the cellulase and β-lactamase towards their respective chemical 
linkers, Dex-Cel-Lac-Mtx and Dex-Cephem-Mtx, was directly determined using a Y3H LacZ 
assay. In the assay, the chemical linker joins the LexA-DNA-binding and B42-activation domains 




appropriate chemical linker by the active cellulase or β-lactamase, the LacZ expression is expected 
to decrease resulting in lower β-galactosidase units. The cleavage of Dex-Cel-Lac-Mtx and Dex-
Cephem-Mtx was assayed with strains expressing the active and inactive enzymes of the cellulase 
and β-lactamase, respectively. To ensure the Y3H LacZ strain was functioning properly, a positive 
control was performed with the Dex-Mtx linker. As shown in figure A3-1, the β-lactamases 
effectively cleaved the Dex-Cephem-Mtx linker and demonstrated a 2-fold difference in β-
galactosidase units between strains expressing the active and inactive enzymes. Although the β-
lactamase demonstrated effective cleavage of Dex-Cephem-Mtx, the β-galactosidase units were 
not as low as for those cells treated with no small molecule, suggesting that the β-lactamase was 
unable to cleave all the Dex-Cephem-Mtx present in the cell.  However, the active β-lactamase 
performed significantly better than the active cellulase, which demonstrated no cleavage of Dex-
Cel-Lac-Mtx when compared to the inactive enzyme. Thus, we continued our studies with the β-
lactamase enzyme.  
 
Figure A2-1. A cleavage assay with the Y3H-LacZ reporter system. The Y3H LacZ assay links enzyme 
cleavage to LacZ reporter transcription. A) Performance of the Y3H-LacZ strain with no enzymes in the 
presence (red) and absence (blue) of Dex-Mtx (DM). B) Performance of the active and inactive β-lactamase 
in the presence (green) and absence (blue) of the Dex-Cephem-Mtx. C) Performance of the active and 
inactive cellulase in the presence (purple) and absence (blue) of Dex-Cel-Lac-Mtx. The assay was 
performed with two colonies in duplicate. Shown is the mean, and the error bars represent the standard 





A2.2 Growth Assay to Determine if Tet Y3H counter selection Detects β-lactamase Activity 
 To adapt the Tet Y3H counter selection for the detection of β-lactamase activity, it was 
reconstructed to include the active or inactive β-lactamase on a high copy plasmid. Following this 
reconstruction, the growth of Tet Y3H strains expressing either the active or inactive β-lactamase 
enzymes was compared in the presence and absence of Dex-Mtx or Dex-Cephem-Mtx. In the 
absence of a chemical linker, all Tet Y3H strains were expected to grow to saturated cell densities 
as the URA3 reporter gene is not expressed. In the presence of the chemical linker, Dex-Mtx, all 
Tet Y3H strains were expected to be severely growth-inhibited. However, the opposite growth 
pattern is expected in the presence of Dex-Cephem-Mtx, which does contain the β-lactamase 
substrate. Here, the Tet Y3H strains expressing the active β-lactamase are expected to show a 
growth advantage compared to strains expressing the inactive β-lactamase. 
 In un-optimized selection conditions, the Tet Y3H strains demonstrated the expected 
growth patterns in the presence and absence of Dex-Mtx. However, in the presence of Dex-
Cephem-Mtx, the Tet Y3H strains expressing the active or inactive β-lactamases produced growth 
differences lower than 1.5-fold, which was not expected given the characterization of the Tet Y3H 
strains without enzymes (see Chapter 3). Additionally, the active β-lactamase strains were growth 
inhibited in the presence of Dex-Cephem-Mtx compared to those cells grown in the absence of the 
chemical linkers. To optimize the selection conditions, the 5-FOA and Dex-Cephem 
concentrations were varied. These modifications, however, did not improve the dynamic range of 
the Tet Y3H counter selection with the β-lactamases. Lowering the 5-FOA concentrations to 
0.15% or 0.1% led to growth even in the presence of the chemical dimerizers and increased 




Dex-Cephem-Mtx concentration was raised to 10uM in the best 5-FOA concentration of 0.2%, 
however, the growth advantage for the active β-lactamase strains was increased to only 2-fold.  
 
Figure A2-2. Detection of β-lactamase activity with the Tet Y3H counter selection. A) Performance of Tet 
Y3H counter selection with the active (closed circles) and inactive (open circles) β-lactamase in the 
presence (purple) and absence (black) of Dex-Mtx. B) Performance of Tet Y3H counter selection with the 
active (closed circles) and inactive (open circles) β-lactamase in the presence (green) and absence (black) 
of Dex-Cephem-Mtx. The assay was performed in duplicate. Shown is the mean, and error bars represent 
the standard deviation from mean. 
 
A2.3 Increasing the Local Concentration of the β-lactamase to Chemical Linker 
 To improve the dynamic range of the Tet Y3H counter selection with Dex-Cephem-Mtx, 
we aimed to increase the local concentration of the β-lactamase. Our approach included fusing the 
β-lactamase to the LexA-DHFR DNA binding domain to create a triple fusion protein (Figure A2-
3). We envisioned that the triple fusion protein would increase the local concentration of the β-
lactamase to the Dex-Cephem-Mtx molecules that are directly involved in reconstituting the 
transcriptional activation of the URA3 reporter gene. The triple fusion was designed by fusing the 
active or inactive β-lactamases to a circular permutant of DHFR that was engineered to have new 
protein termini. Using the established circular permutation strategy [5-8], we engineered a DHFR 




binding site. This work was largely based on modeling with an X-ray crystal structure of 
methotrexate binding to DHFR[9, 10]. The chosen DHFR circular permutant (DHFR*) was 
previously demonstrated to retain its catalytic activity[11], and thus we expected it to maintain 
high binding affinity with Dex-Cephem-Mtx. To construct this variation of the Tet Y3H counter 
selection, the LexA-DHFR*- β-lactamase triple fusion protein was integrated into the chromosome 
to replace the original LexA-DHFR receptor fusion protein. 
 
  
Figure A2-3. Design of the Tet Y3H counter selection with the triple fusion β-lactamase strain. To increase 
the local concentration of the β-lactamase to the chemical dimerizer, it was fused to a mutated circular 
permutant of DHFR to generate the LexA-DHFR*- β-lactamase triple fusion protein. Upon cleavage of the 
Dex-Cephem-Mtx by the fused β-lactamase, the URA3 reporter gene is not transcribed and the cells 
survive.  
 
The performance of the LexA-DHFR*- β-lactamase triple fusion protein in the Tet Y3H 
strains was examined in the presence and absence of Dex-Mtx or Dex-Cephem-Mtx. In the 
presence of Dex-Mtx, the Tet Y3H strains were expected to be growth inhibited with both the 
active and inactive β-lactamase triple fusion proteins. However, in the presence of Dex-Cephem-
Mtx the strains with the active β- lactamase fusion should have a faster growth rate. The Tet Y3H 




Interestingly, there was a 6.5-fold difference between cells treated with and without Dex-Mtx, 
which was higher than the 4-fold growth difference that was observed with strains that expressed 
the β-lactamase enzymes on high-copy plasmids. In the presence of Dex-Cephem-Mtx, there was 
no growth advantage for strains with the active β-lactamase fusion. However, the growth 
difference between active and inactive β-lactamase strains treated with and without Dex-Cephem-
Mtx was increased to about 4.5-fold, which was an improvement over the 2.5-fold difference 
previously observed. 
 
Figure A2-4. Performance of the Tet Y3H strains with the triple fusion LexA-DHFR- β-lactamase protein. A) 
Performance of Tet Y3H counter selection with the active (closed circles) and inactive (open circles) β-
lactamase fusion protein in the presence (purple) and absence (black) of Dex-Mtx. B) Performance of Tet 
Y3H counter selection with the active (closed circles) and inactive (open circles) β-lactamase fusion in the 
presence (green) and absence (black) of Dex-Cephem-Mtx. The assay was performed in duplicate. Shown 





Given the larger dynamic range in the presence of Dex-Cephem-Mtx with the triple fusion 
Tet Y3H strains, the β-lactamase enzymes were reintroduced on the high copy plasmid, which 
previously showed a distinction between the active and inactive enzymes. However, when the β-
lactamase enzymes were expressed on high copy plasmids in the triple fusion Tet Y3H strains, the 
4.5-fold growth difference between cells in the presence and absence of Dex-Cephem-Mtx was 
not maintained. Additionally, there was a negligible difference in the growth patterns between the 
active and inactive β-lactamase strains treated with Dex-Mtx or Dex-Cephem-Mtx. 
    
Figure A2-5. Performance of the Tet Y3H strains with the triple fusion LexA-DHFR- β-lactamase protein 
and the β-lactamase enzymes expressed on high copy plasmids.  A) Performance of Tet Y3H counter 
selection with the active (closed circles) and inactive (open circles) β-lactamase plasmid in the presence 
(purple) and absence (black) of Dex-Mtx. B) Performance of Tet Y3H counter selection with the active 




(black) of Dex-Cephem-Mtx. The assay was performed in duplicate. Shown is the mean, and error bars 
represent the standard deviation from mean. 
A2.4 Conclusion 
Here, we applied the Tet Y3H counter selection to the detection of enzymatic activity, 
which is imperative for its successful application in enzyme engineering. We focused on the 
detection of β-lactamase activity since it demonstrated effective cleavage of its chemical dimerizer, 
Dex-Cephem-Mtx, compared to the inactive β-lactamase. Although the β-lactamase has a high 
catalytic efficiency for degrading Dex-Cephem-Mtx, it was unable to cleave all the Dex-Cephem-
Mtx that was present in the cell. Unfortunately, the remaining Dex-Cephem-Mtx was able to 
activate a sufficient level of the URA3 reporter gene to cause significant growth inhibition for the 
active β-lactamase strains and lower the dynamic range of the Tet Y3H counter selection. Although 
the active β-lactamase maintained a small growth advantage over the inactive β-lactamase 
enzymes, the observed 1.5-fold growth difference is not adequate for demanding enzyme 
engineering applications based on our previous work with the original Y3H counter selection[12].  
We aimed to optimize the Tet Y3H counter selection by redesigning it to include a triple 
fusion protein that brings the β-lactamase in closer proximity to the chemical dimerizer. However, 
we did not see an improvement in the dynamic range of the Tet Y3H counter selection. The poor 
performance of the triple fusion Tet Y3H strains may be attributed to the β-lactamase being unable 
to access the Dex-Cephem-Mtx that is buried in the receptor binding pockets. Additionally, we 
only tested one circular permutant for this study and more DHFR triple fusion proteins should be 
screened before ruling out this approach.   
In addition, the inadequate performance of the Tet Y3H counter selection upon 
transformation with two high copy plasmids expressing either the B42-activation domain fusion 




stable. Even in the presence and absence of Dex-Mtx, the Tet Y3H counter selection shows a low 
dynamic range, which is not expected based on our previous characterization without the β-
lactamase enzymes (See Chapter 3). Recent single cell studies indicate that the balanced 
expression of two proteins is compromised when they are expressed from two separate high-copy 
plasmids[13]. Thus, the unsatisfactory performance of the Tet Y3H counter selection with the β-
lactamase may be caused by 1) lower expression of the activation domain that activates the Y3H 
system or 2) low β-lactamase cleavage of Dex-Cephem-Mtx due to its poor expression. This work 
suggests that the dynamic range of the Tet Y3H counter selection with the β-lactamase could be 
improved by integrating the β-lactamase gene into the chromosome or expressing the activation 
domain and the β-lactamase on the same high-copy plasmid.  
Although we present promising solutions to improve the Tet Y3H counter selection for the 
detection of β-lactamase activity, we cannot rule out the possibility that the URA3 reporter gene 
may be too stringent for our chemical complementation technology. It is surprising that enzymes 
with high catalytic efficiency, such as the β-lactamase, do not cleave a sufficient amount of the 
chemical dimerizer to produce growth rates on par with cells grown in no small molecule 
conditions. Therefore, we need to continue to develop Y3H counter selections with alternative 
reporter genes that can provide more tunable toxicity.  
A2-6. Experimental Methods. 
Construction of Tetracycline Y3H Strains with the β-lactamase on Plasmid. All molecular 
biology in Saccharomyces cerevisiae was performed using standard methods. The MH24503 Tet 
Y3H strain was modified to include a MET15 gene knockout using delitto perfetto to generate 




pMHBL-I which express the active or inactive β-lactamase genes to generate MHTetY3HBLA or 
MHTetY3HBLI, respectively. Transformants were selected on SC(HTLM-) plates. 
Construction of MH24503Met15 strain. The standard delitto perfetto protocol developed by 
Storici and coworkers was used to generate a LYS2 and MET15 knockout in MH24503. The 
MH24503 strain was first modified to include a LYS2 knockout. The hyg-K. lactis CORE cassette 
was amplified from plasmid MHhygK.lURA3 with inner primers MH089 and MH090. The PCR 
product was then amplified with outer primers MH091 and MH092 to add the SceI restriction site 
and 50 bp of homology to the region outside of LYS2 marker. The cassette was purified by gel 
extraction. Next, 6ug of this cassette was transformed into MH24503 via electroporation. 
Transformants were selected on SC(U-). The successful integration of the CORE cassette and 
knockout of LYS2 was confirmed by plating on (Lys-) plates. Plasmid DR029, which expresses the 
SceI restriction enzyme under the control of the pGAL promoter, was transformed into a pool of 
colonies from the previous transformation to generate MH24503_29. Transformants were selected 
on (Lys-) plates. MH24503_29 was grown up in SC(Lys-, 2% galactose) media to induce 
expression of the SceI restriction enzyme and generate a double strand break (DSB). The CORE 
cassette was removed by the transformation of integrative recombinant oligonucleotides (IROs) 
[14]. The 100bp IROs were generated by creating a template with two primers that have the 
appropriate homology to the region outside the LYS2 region and to each other.  The extension was 
performed with MH094 and MH095 with the following PCR protocol: 1 min at 94°C and 30 s at 
68°C. To generate more of the IROS, the extended template was amplified with MH096 and 
MH097. The standard lithium acetate protocol detailed by Storici and coworkers was followed to 
remove the CORE cassette. Successful knockout strains were then grown in SC(TL-) to cure the 




To generate the MET15 knockout to create MH24503Met15 strain, the same delitto perfetto 
protocol outlined above was followed. The hyg-K. lactis CORE cassette was first amplified from 
plasmid MHhygK.lURA3with inner primers MH168 and MH170 then  outer primers MH169 and 
MH171 to add the SceI restriction site and 50 bp of homology and the to the region outside of 
MET15 marker. Transformants were selected on SC(U-) plates A pool of the transformants was 
transformed with plasmid DR029 to generate MH24503_29Met. The IROs were generated by 
extending MH176 and MH173. The extended template was amplified with MH177 and MH175. 
The standard lithium acetate protocol detailed by Storici and coworkers was followed to remove 
the CORE cassette. Successful knockout strains were then grown in SC(TL-) to cure the DR029 
plasmid.   
 
Construction of Plasmid MHBL-A or pMHBL-I. Plasmids MHBL-A or MHBL-I were 
constructed by in vivo gap repair in S. cerevisiae yeast as follows. The GAL1 promoter was 
amplified from pRS416GAL1 with primers MH239 and MH240 to add homology to pRS421 and 
the β-lactamase sequence. The active β-lactamase (WT) and the inactive β-lactamase mutant 
(S64A) were amplified with primers MH247 and MH242 from plasmids VC172 or V687E, 
respectively. The MH247 and MH242 primers added homology to GAL1 promoter and pRS421. 
pRS421 was digested with SalI and PstI. The GAL1 promoter PCR product and digested pRS421 
plasmid were cotransformed with either the wildtype or inactive β-lactamase fragment into 






Construction of Triple Fusion β-lactamase Strains. MHGA1(+2706)Y, a variant of the 
MH24503Met15 strain was transformed with either SpeI digested plasmids pMH2707BL-A or 
PMH2707BL-I to integrate LexA-*DHFR- β-lactamase (WT)-KanMX or LexA-*DHFR- β-
lactamase (S64A)-KanMX at the HO locus to generate MHTFBL-A or MHTFBL-I, respectively. 
Transformants were selected on YPD (G418) plates. 
 
Construction of the pMH2707BL plasmids. Plasmids pMH2707BL-A and PMH2707BL-I were 
constructed by Gibson Assembly and transformed into E. coli as follows. The LexA-*DHFR 
fragment was amplified from MHGA1E with primers MH212 and MH254 to add homology to the 
GAL1 promoter and the β-lactamase (WT or S64A) as well as to add the Gly-Ser-GlyGly-Ser-Gly 
(GSG2) linker. The active and inactive β-lactamases were amplified with MH255 and MH261 to 
add homology to LexA-*DHFR-(GSG2) and the KanMX marker. pLW2707 was digested with 
HpaI and BamHI, which cuts after the GAL1 promoter and before the KanMX marker. The Gibson 
Assembly reaction was performed by mixing the digested pLW2707 plasmid with the LexA-
*DHFR and the active/inactive β-lactamase PCR products in a 1:3 ratio followed by incubation at 
50°C for 1 hour. The Gibson Assembly reaction was transformed into E. coli by electroporation. 
Transformants were selected on LB/ampicillin plates and characterized by sequencing. 
 
Construction of Y3H LacZ strains to Detect Cellulase or β-lactamase activity. To create the 
Y3H LacZ strain to detect cellulase activity, V947Y was transformed with plasmids pMW112 and 
either pPPY2297 (active cellulase) or pPPY2298 (inactive cellulase). To create the Y3H LacZ 
strain with the β-lactamase, V947Y was transformed with plasmids pMW112 and either pVC172 




Tet Y3H Growth Assays with the β-lactamase on Plasmid. First, multiple colonies 
MHTetY3HBLA or MHTetY3HBLI strains were inoculated into SC(HTLM-), 2% glucose media 
and shaken overnight  at 30°C. Cells were pre-induced for 24 hours in SC(HTLM-), 2% galactose, 
2% raffinose media and 2µg/mL of doxycycline (Dox). Pre-induced cells were added to 
SC(HTLM-), 2% galactose, 2% raffinose, 0.2%FOA, 2µg/mL  Dox, +/- 5μM Dex-Mtx media. 
Cells were shaken at 30°C for ~5 days and the OD600 was monitored. The colony with the largest 
growth difference in in+/- Dex-Mtx was selected for further studies with Dex-Cephem-Mtx. 
Growth curves were performed in duplicate. 
A single colony was inoculated into SC(HTLM-), 2% glucose media and shaken overnight  
at 30°C. Cells were pre-induced for 24 hours in SC(HTLM-), 2% galactose, 2% raffinose media 
and 2µg/mL of doxycycline (Dox). Pre-induced cells were added to SC(HTLM-), 2% galactose, 
2% raffinose, 0.2%FOA, 2µg/mL  Dox, +/- 5μM Dex-Mtx, and +/- 5μM or 10 μM Dex-Cephem-
Mtx media. Cells were shaken at 30°C for ~5 days and the OD600 was monitored. Growth curves 
were performed in duplicate 
 
Tet Y3H Growth Assays with the Triple fusion β-lactamase. 
First, multiple colonies MHTFBL-A or MHTFBL-I strains were inoculated into SC(HTL-), 2% 
glucose media and shaken overnight  at 30°C. Cells were pre-induced for 24 hours in SC(HTL-), 
2% galactose, 2% raffinose media and 2µg/mL of doxycycline (Dox). Pre-induced cells were 
added to SC(HTL-), 2% galactose, 2% raffinose, 0.2%FOA, 2µg/mL  Dox, +/- 5μM Dex-Mtx 
media. Cells were shaken at 30°C for ~5 days and the OD600 was monitored. The colony with the 
largest growth difference in in+/- Dex-Mtx was selected for further studies with Dex-Cephem-




A single colony was inoculated into SC(HTL-), 2% glucose media and shaken overnight  
at 30°C. Cells were pre-induced for 24 hours in SC(HTL-), 2% galactose, 2% raffinose media and 
2µg/mL of doxycycline (Dox). Pre-induced cells were added to SC(HTLM-), 2% galactose, 2% 
raffinose, 0.2%FOA, 2µg/mL  Dox, +/- 5μM Dex-Mtx or Dex-Cephem-Mtx media. Cells were 
shaken at 30°C for ~5 days and the OD600 was monitored. 
LacZ assay with the Y3H strains Expressing the Cellulase or β-lactamase. Two colonies of 
each Y3H LacZ strain were grown for ~48 hours in 1 mL of SC(HTUL-) 2% galactose, 2% 
raffinose media at 30°C. Next, the OD600 of each culture was measured and 200µL of the culture 
was harvested by centrifugation. The pelleted cells were resuspended in 100µL of Z-Buffer and 
harvested by centrifugation. The pelleted cells were resuspended in Y-PER lysis buffer and shaken 
for 30 minutes at room temperature. Next, 8.5µL of an ONPG solution (10mg/mL in Z Buffer) 
was added to each culture in 30 second intervals. After 15 minutes, 100µL of a 1M Na2CO3 was 
added to quench the reaction in the 30 second intervals. The cells were centrifuged to pellet the 
debris and the OD420 was measured. The β-galactosidase units were calculated with the following 
equation: (OD420*1000)/(OD600*mL*min). Z-Buffer (1L in ddH2O, pH=7): 16.1g 
Na2HPO4·7H2O, 5.5g NaH2PO4·H2O, 0.75 KCl, 0.246 MgSO4·7H2O, 2.7 mL β-mercaptoethanol.  
 
A2-7. Strains, plasmids, and oligonucleotides used in this study. 
Table A2-1. Strains used in this study. 
Strain Genotype Source/Reference 
LW2708Y FY251 with HO:: pGAL1-eLexA-DHFR-KanMX4 M.Harton/[12] 
LW2709Y LW2708Y with pLW2706 M.Harton /[12] 






LW2589Y MATa-inc his3Δ200 leu2Δ0 met15Δ0 trp1Δ63 ura3Δ0 L. Wingler/[15] 
V947Y MATa ade4::Pgal1-lexA-DHFR(HIS3) ade2::P gal1-B42- 
GR(TRP1) ura3-52 leu2∆1 GAL+ 
D. Sengupta/[2] 
MH24503_29 MHTet24503 with Plasmid DR029 This study 
MH24503Met
15 
MHTet24503 with lys2Δ0 and met15Δ0 This study 
MHTFBL-A  MH24503Met15 with HO:: pGAL1-LexA-DHFR*-β-
lactamase (WT)- MET15 and PLW2706 
This study 
MHTFBL-I MH24503Met15 with HO:: pGAL1-LexA-DHFR*-β-




MH24503Met15 with HO:: pGAL1-LexA-DHFR* 




MH24503Met15 with MHTFBL-A This study 
MHTetY3HB
LI 
MH24503Met15 with MHTFBL-I This study 
 
Table A2-2. Plasmids used in this study. 
Plasmid Details Source/Reference 
pRS416GAL1 pGAL1 CEN6/ARSH4 URA3 pBIISK ori ampR ATCC 87332 
pRS414GAL1 pGAL1 CEN6/ARSH4 TRP1 pBIISK ori ampR ATCC 87328 
pRS421GAL1 pGAL1 2µ MET15 pUC ori ampR M. Shandell 
pRS425MET
25 
pMET25 2µ LEU2  pUC ori ampR ATCC 87323 
pMW112 8lexAop-lacZ 2µ URA3 pBR ori kanR R. Brent/[16] 
pLW2706 pGAL1-B42-(GSG)2-rGR2 2µ HIS3 pUC ori kanR L. Wingler/[12] 
pLW2707 pGAL1-LexA-eDHFR-KanMX4 pMB1 ori ampR L. Wingler/[12] 





pPPY2298 p425MET425 with Cel7B:E197A (inactive cellulase) P. Peralta-
Yahya/[4] 
VC172  pMET25 with β-lactamase (WT) 2µ specR LEU2 pUC ori K. Baker/[1] 
V687E pMET25 with β-lactamase (S64A) 2µ specR LEU2 pUC 
ori 
K. Baker/[1] 
DR029 pGALL-SceI gene  CEN6/ARSH4 LYS2 pBR ori ampR D. Romanini/[17] 
MHhygK.lUR
A3 
pMET25-hyg and K. lactis URA3 gene CEN6/ARSH4 
LEU2 pBR ori ampR 
This study 
pMHBL-A pRS421 with pGAL1-β-lactamase (WT) This study 
pMHBL-I pRS421 with pGAL1-β-lactamase (S64A) This study 
pMH2707BL-
A  





pLW2707 with pGAL1-LexA-*DHFR-(GSG2)- β-
lactamase (S64A) 
This study 
MHGA1E pRS414 with pGAL1-LexA-*DHFR-(GSG2) This study 
 
Table A2-3. Oligonucleotides used in this study. 
Name Sequence (5’-3’) 
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Figure A3-1. Growth of Tet Y3H strains in the absence of Dex-Mtx. 5 independent colonies from the 4 
strains including A) pADH-tetR’-Repressor B) pADH-tetR-Repressor C) pCMV-tetR’-Repressor D) pCMV-
tetR-Repressor were grown in SC(HTL- ), 2% galactose, 2% raffinose, 0.2% FOA, and 2μg/mL Dox. Each 
curve represents a single variation of the Tet Y3H counter selection.  Strains with 2LexAop-tetR’-Activator, 
2tetO-URA3 (     ); 8LexAop-tetR’-Activator, 2tetO-URA3 (      ); 2LexAop-tetR’-Activator, 7tetO-URA3 (     ); 
8LexAop-tetR’-Activator, 7tetO-URA3 ( X ) are represented. Shown is the mean growth and error bars 
represent standard deviation from the mean. All strains grew to an OD600 of 1 except for strains with the 













Figure A3-2. Growth of Tet Y3H strains in 
the presence of Dex-Mtx. 5 independent 
colonies from the 3 strains including A) 
pADH-tetR’-Repressor B) pADH-tetR-
Repressor C) pCMV-tetR’-Repressor were 
grown in SC(HTL-), 2% galactose, 2% 
raffinose, 0.2% FOA, 2μg/mL Dox, +5μM 
Dex-Mtx. Each curve represents a single 
variation of the Tet Y3H counter selection.  
Strains with 2LexAop-tetR’-Activator, 2tetO-
URA3 (  ); 8LexAop-tetR’-Activator, 2tetO-
URA3 (  ); 2LexAop-tetR’-Activator, 7tetO-
URA3 (  ); 8LexAop-tetR’-Activator, 7tetO-
URA3 ( X ) are represented. Shown is the 
mean growth and error bars represent 
standard deviation from the mean. All 
strains showed some growth inhibition in the 





Figure A3-3. Comparison of the tetracycline and original Y3H constructs. The 11 Tet Y3H strains that 
reached an OD600 of 1 in the absence of Dex-Mtx were compared based on maximum OD600 ratio (-Dex-
Mtx/+Dex-Mtx). The best performing strains had a large OD600 and took less time to reach an OD600 of 1 in 
the absence of Dex-Mtx. The highest performing and isolated Tet Y3H strain is shown in purple. The original 













Figure A3-4. An experimental framework for selection characterization and optimization. The dynamic 
range of the Y3H counter selection is assessed using mock selections that test its ability to enrich a single 
inactive Y3H cell (with only the B42 AD) that is incapable of reconstituting the transcriptional activator with 
the chemical dimerizer, Dex-Mtx, from a large excess of undesirable active Y3H cells with the requisite B42 
AD-GR fusion protein.  A library of cells is grown in liquid culture and cells with disrupted Y3H systems that 
cannot reconstitute the transcriptional activator are enriched. Following the selection, the enriched cells are 
plated and individually assayed. inactive Tet Y3H cells and active Tet Y3H cells are distinguished by 
constitutively expressing genes that lead to pink or blue coloration, respectively. The enrichment of inactive 
Y3H cells is determined by counting pink colonies. In a successful mock selection, the majority of cells after 







Figure A3-5. Performance of the Tet Y3H URA3 counter selection in the absence of doxycycline and Dex-
Mtx. The 104, 105, and 106 selections were monitored in selective media containing only doxycycline, only 
Dex-Mtx, or both doxycycline and Dex-Mtx. The selections were started at initial OD600 of 1 and monitored 
for 5 days without reseeding conditions. Error bars represent the standard error in the percentage of the 
inactive Y3H cells for duplicate selections. Enrichment of the inactive Y3H cells was only observed when 










Figure A3-6. Reseeding mock selections improves the enrichment of inactive Y3H cells. Reseeding 
involves diluting the selection into fresh selective media. The initial OD600 after reseeding and the number 
of times the selection was reseeded were varied. The 10^4, 10^5, and 10^6 selections were started with 
an initial OD600 of 1 and monitored for 5 days in SC(HT-), 2%galactose, 2% raffinose, 0.2% 5-FOA, 2ug/mL 
dox, and 5uM Dex-Mtx media. Error bars represent standard error in the percentage of the inactive Y3H 
cells between duplicate selections. The best results for inactive Y3H enrichment were achieved when the 












A3-7. Tet Y3H Integration Plasmid Sequences 
 
pLW2695_pCM251-URA3_TetO2_2LexAop-pGAL1 7690 bp 
 
FEATURES   Location/Qualifiers 
CDS    complement(28..1035) 
/label=TetR'-Activator 
Promoter   complement(1036..1325) 
/label=2LexAop-pGAL1 
Terminator   1337..1548 
/label="ADH1 transcriptional terminator" 
Binding_site  1554..1653 
/label="2 TetO boxes" 
TATA_box   1654..1806 
/label="Cyc1 Tata region" 
CDS    1815..2618 
/label=URA3 
Terminator   2626..2887 
/label="CYC1 terminator" 
Misc._feature  2888..7690 
/label="YCplac22 centromeric vector with the TRP1 marker" 
 
1 GAATTCTTAT TACGATCCTC GCGCCCCcta CCCACCGTAC TCGTCAATTC CAAGGGCATC 
61 GGTAAACATC TGCTCAAACT CGAAGTCGGC CATATCCAGA GCGCCGTAGG GGGCGGAGTC 
121 GTGGGGGGTA AATCCCGGAC CCGGGGAATC CCCGTCCCCC AACATGTCCA GATCGAAATC 
181 GTCTAGCGCG TCGGCATGCG CCATCGCCAC GTCCTCGCCG TCTAAGTGGA GCTCGTCCCC 
241 CAGGCTGACA TCGGTCGGGG GGGCCGTCGA CAGTCTGCGC GTGTGTCCCG CGGGGAGAAA 
301 GGACAGGCGC GGAGCCGCCA GCCCCGCCTC TTCGGGGGCG TCGTCGTCCG GGAGATCGAG 
361 CAGGCCCTCG ATGGTAGACC CGTAATTGTT TTTCGTACGC GCGCGGCTGT ACGCGGACCC 
421 ACTTTCACAT TTAAGTTGTT TTTCTAATCC GCATATGATC AATTCAAGGC CGAATAAGAA 
481 GGCTGGCTCT GCACCTTGGT GATCAAATAA TTCGATAGCT TGTCGTAATA ATGGCGGCAT 
541 ACTATCAGTA GTAGGTGTTT CCCTTTCTTC TTTAGCGACT TGATGCTCTT GATCTTCCAA 
601 TACGCAACCT AAAGTAAAAT GCCCCACAGC GCTGAGTGCA TATAAcGCgT TCTCTAGTGA 
661 AAAACCTTGT TGGCATAAAA AGGCTAATTG ATTTTCGAGA GTTTCATACT GTTTTTCTGT 
721 AGGCCGTGTA tCTgAATGTA CTTTTGCTCC ATtGCGATGA CTTAGTAAAG CACATCTAAA 
781 ACTTTTAGCG TTATTgCGTA AAAAATCTTG CCAGCTTTCC CCTTtTAAAG GGCAAAAGTG 
841 AGTATGGTGC CTATCTAACA TCTCAATGGC TAAGGCGTCG AGCAAAGCCC GCTTATTTTT 
901 TACATGCCAA TACAgTGTAG GCTGCTCTAC ACCaAGCTTC TGGGCGAGTT TACGGGTTGT 
961 TAAACCTTCG ATTCCGACCT CATTAAGCAG CTCTAATGCG CTGTTAATCA CTTTACTTTT 
1021 ATCTAATCTA GAcatTATAG TTTTTTCTCC TTGACGTTAA AGTATAGAGG TATATTAACA 
1081 ATTTTTTGTT GATACTTTTA TTACATTTGA ATAAGAAGTA ATACAAACCG AAAATGTTGA 
1141 AAGTATTAGT TAAAGTGGTT ATGCAGTTTT TGCATTTATA TATCTGTTAA TAGATCAAAA 
1201 ATCATCGCTT CGCTGATTAA TTACCCCAGA AATAAGGCTA AAAAACTAAT CGCATTATCA 
1261 TCCCctcgaG TACTGTACAT ATAACCACTG GTTTTATATA CAGCATCGAG GTAAGATTAG 
1321 ATATGCTCGA GTAATTCGCG CCACTTCTAA ATAAGCGAAT TTCTTATGAT TTATGATTTT 
1381 TATTATTAAA TAAGTTATAA AAAAAATAAG TGTATACAAA TTTTAAAGTG ACTCTTAGGT 
1441 TTTAAAACGA AAATTCTTGT TCTTGAGTAA CTCTTTCCTG TAGGTCAGGT TGCTTTCTCA 
1501 GGTATAGCAT GAGGTCGCTC TTATTGACCA CACCTCTACC GGCAGATCAA TTCCTCGATC 
1561 CCTATCAGTG ATAGAGAGTC GACAAAGTCG AGTTTCTCGA TCCCTATCAG TGATAGAGAG 
1621 TCGACAAAGT CGAGTTTCTC GATCGAGACC ACTGCATGCA TGTGCTCTGT ATGTATATAA 
1681 AACTCTTGTT TTCTTCTTTT CTCTAAATAT TCTTTCCTTA TACATTAGGT CCTTTGTAGC 
1741 ATAAATTACT ATACTTCTAT AGACACGCAA ACACAAATAC ACACACTAAA TTACCGGATC 
1801 AATTCGGGGG ATCCATGTCG AAAGCTACAT ATAAGGAACG TGCTGCTACT CATCCTAGTC 
1861 CTGTTGCTGC CAAGCTATTT AATATCATGC ACGAAAAGCA AACAAACTTG TGTGCTTCAT 
1921 TGGATGTTCG TACCACCAAG GAATTACTGG AGTTAGTTGA AGCATTAGGT CCCAAAATTT 
1981 GTTTACTAAA AACACATGTG GATATCTTGA CTGATTTTTC CATGGAGGGC ACAGTTAAGC 
2041 CGCTAAAGGC ATTATCCGCC AAGTACAATT TTTTACTCTT CGAAGACAGA AAATTTGCTG 
2101 ACATTGGTAA TACAGTCAAA TTGCAGTACT CTGCGGGTGT ATACAGAATA GCAGAATGGG 
2161 CAGACATTAC GAATGCACAC GGTGTGGTGG GCCCAGGTAT TGTTAGCGGT TTGAAGCAGG 
2221 CGGCaGAAGA AGTAACAAAG GAACCTAGAG GCCTTTTGAT GTTAGCAGAA TTGTCATGCA 
2281 AGGGCTCCCT AtCTACTGGA GAATATACTA AGGGTACTGT TGACATTGCG AAGAGCGACA 
2341 AAGATTTTGT TATCGGCTTT ATTGCTCAAA GAGACATGGG TGGAAGAGAT GAAGGTTACG 
128 
 
2401 ATTGGTTGAT TATGACACCC GGTGTGGGTT TAGATGACAA GGGAGACGCA TTGGGTCAAC 
2461 AGTATAGAAC CGTGGATGAT GTGGTCTCTA CAGGATCTGA CATTATTATT GTTGGAAGAG 
2521 GACTATTTGC AAAGGGAAGG GATGCTAAGG TAGAGGGTGA ACGTTACAGA AAAGCAGGCT 
2581 GGGAAGCATA TTTGAGAAGA TGCGGCCAGC AAAACTAACC TGCAGGAGGG CCGCATCATG 
2641 TAATTAGTTA TGTCACGCTT ACATTCACGC CCTCCCCCCA CATCCGCTCT AACCGAAAAG 
2701 GAAGGAGTTA GACAACCTGA AGTCTAGGTC CCTATTTATT TTTTTATAGT TATGTTAGTA 
2761 TTAAGAACGT TATTTATATT TCAAATTTTT CTTTTTTTTC TGTACAGACG CGTGTACGCA 
2821 TGTAACATTA TACTGAAAAC CTTGCTTGAG AAGGTTTTGG GACGCTCGAA GGCTTTAATT 
2881 TGCGGCCAAG CTTGGCGTAA TCATGGTCAT AGCTGTTTCC TGTGTGAAAT TGTTATCCGC 
2941 TCACAATTCC ACACAACATA CGAGCCGGAA GCATAAAGTG TAAAGCCTGG GGTGCCTAAT 
3001 GAGTGAGCTA ACTCACATTA ATTGCGTTGC GCTCACTGCC CGCTTTCCAG TCGGGAAACC 
3061 TGTCGTGCCA GCTGCATTAA TGAATCGGCC AACGCGCGGG GAGAGGCGGT TTGCGTATTG 
3121 GGCGCTCTTC CGCTTCCTCG CTCACTGACT CGCTGCGCTC GGTCGTTCGG CTGCGGCGAG 
3181 CGGTATCAGC TCACTCAAAG GCGGTAATAC GGTTATCCAC AGAATCAGGG GATAACGCAG 
3241 GAAAGAACAT GTGAGCAAAA GGCCAGCAAA AGGCCAGGAA CCGTAAAAAG GCCGCGTTGC 
3301 TGGCGTTTTT CCATAGGCTC CGCCCCCCTG ACGAGCATCA CAAAAATCGA CGCTCAAGTC 
3361 AGAGGTGGCG AAACCCGACA GGACTATAAA GATACCAGGC GTTTCCCCCT GGAAGCTCCC 
3421 TCGTGCGCTC TCCTGTTCCG ACCCTGCCGC TTACCGGATA CCTGTCCGCC TTTCTCCCTT 
3481 CGGGAAGCGT GGCGCTTTCT CATAGCTCAC GCTGTAGGTA TCTCAGTTCG GTGTAGGTCG 
3541 TTCGCTCCAA GCTGGGCTGT GTGCACGAAC CCCCCGTTCA GCCCGACCGC TGCGCCTTAT 
3601 CCGGTAACTA TCGTCTTGAG TCCAACCCGG TAAGACACGA CTTATCGCCA CTGGCAGCAG 
3661 CCACTGGTAA CAGGATTAGC AGAGCGAGGT ATGTAGGCGG TGCTACAGAG TTCTTGAAGT 
3721 GGTGGCCTAA CTACGGCTAC ACTAGAAGGA CAGTATTTGG TATCTGCGCT CTGCTGAAGC 
3781 CAGTTACCTT CGGAAAAAGA GTTGGTAGCT CTTGATCCGG CAAACAAACC ACCGCTGGTA 
3841 GCGGTGGTTT TTTTGTTTGC AAGCAGCAGA TTACGCGCAG AAAAAAAGGA TCTCAAGAAG 
3901 ATCCTTTGAT CTTTTCTACG GGGTCTGACG CTCAGTGGAA CGAAAACTCA CGTTAAGGGA 
3961 TTTTGGTCAT GAGATTATCA AAAAGGATCT TCACCTAGAT CCTTTTAAAT TAAAAATGAA 
4021 GTTTTAAATC AATCTAAAGT ATATATGAGT AAACTTGGTC TGACAGTTAC CAATGCTTAA 
4081 TCAGTGAGGC ACCTATCTCA GCGATCTGTC TATTTCGTTC ATCCATAGTT GCCTGACTCC 
4141 CCGTCGTGTA GATAACTACG ATACGGGAGG GCTTACCATC TGGCCCCAGT GCTGCAATGA 
4201 TACCGCGAGA CCCACGCTCA CCGGCTCCAG ATTTATCAGC AATAAACCAG CCAGCCGGAA 
4261 GGGCCGAGCG CAGAAGTGGT CCTGCAACTT TATCCGCCTC CATCCAGTCT ATTAATTGTT 
4321 GCCGGGAAGC TAGAGTAAGT AGTTCGCCAG TTAATAGTTT GCGCAACGTT GTTGCCATTG 
4381 CTACAGGCAT CGTGGTGTCA CGCTCGTCGT TTGGTATGGC TTCATTCAGC TCCGGTTCCC 
4441 AACGATCAAG GCGAGTTACA TGATCCCCCA TGTTGTGCAA AAAAGCGGTT AGCTCCTTCG 
4501 GTCCTCCGAT CGTTGTCAGA AGTAAGTTGG CCGCAGTGTT ATCACTCATG GTTATGGCAG 
4561 CACTGCATAA TTCTCTTACT GTCATGCCAT CCGTAAGATG CTTTTCTGTG ACTGGTGAGT 
4621 ACTCAACCAA GTCATTCTGA GAATAGTGTA TGCGGCGACC GAGTTGCTCT TGCCCGGCGT 
4681 CAATACGGGA TAATACCGCG CCACATAGCA GAACTTTAAA AGTGCTCATC ATTGGAAAAC 
4741 GTTCTTCGGG GCGAAAACTC TCAAGGATCT TACCGCTGTT GAGATCCAGT TCGATGTAAC 
4801 CCACTCGTGC ACCCAACTGA TCTTCAGCAT CTTTTACTTT CACCAGCGTT TCTGGGTGAG 
4861 CAAAAACAGG AAGGCAAAAT GCCGCAAAAA AGGGAATAAG GGCGACACGG AAATGTTGAA 
4921 TACTCATACT CTTCCTTTTT CAATATTATT GAAGCATTTA TCAGGGTTAT TGTCTCATGA 
4981 GCGGATACAT ATTTGAATGT ATTTAGAAAA ATAAACAAAT AGGGGTTCCG CGCACATTTC 
5041 CCCGAAAAGT GCCACCTGAC GTCTAAGAAA CCATTATTAT CATGACATTA ACCTATAAAA 
5101 ATAGGCGTAT CACGAGGCCC TTTCGTCTTC AAGAATTAAT TCGGTCGAAA AAAGAAAAGG 
5161 AGAGGGCCAA GAGGGAGGGC ATTGGTGACT ATTGAGCACG TGAGTATACG TGATTAAGCA 
5221 CACAAAGGCA GCTTGGAGTA TGTCTGTTAT TAATTTCACA GGTAGTTCTG GTCCATTGGT 
5281 GAAAGTTTGC GGCTTGCAGA GCACAGAGGC CGCAGAATGT GCACTAGATT CCGATGCTGA 
5341 CTTGCTGGGT ATTATATGTG TGCCCAATAG AAAGAGAACA ATTGACCCGG TTATTGCAAG 
5401 GAAAATTTCA AGTCTTGTAA AAGCATATAA AAATAGTTCA GGCACTCCGA AATACTTGGT 
5461 TGGCGTGTTT CGTAATCAAC CTAAGGAGGA TGTTTTGGCT CTGGTCAATG ATTACGGCAT 
5521 TGATATCGTC CAACTGCATG GAGATGAGTC GTGGCAAGAA TACCAAGAGT TCCTCGGTTT 
5581 GCCAGTTATT AAAAGACTCG TATTTCCAAA AGACTGCAAC ATACTACTCA GTGCAGCTTC 
5641 ACAGAAACCT CATTCGTTTA TTCCCTTGTT TGATTCAGAA GCAGGTGGGA CAGGTGAACT 
5701 TTTGGATTGG AACTCGATTT CTGACTGGGT TGGAAGGCAA GAGAGCCCCG AGAGCTTACA 
5761 TTTTATGTTA GCTGGTGGAC TGACGCCAGA AAATGTTGGT GATGCGCTTA GATTAAATGG 
5821 CGTTATTGGT GTTGATGTAA GCGGAGGTGT GGAGACAAAT GGTGTAAAAG ACTCTAACAA 
5881 AATAGCAAAT TTCGTCAAAA ATGCTAAGAA ATAGGTTATT ACTGAGTAGT ATTTATTTAA 
5941 GTATTGTTTG TGCACTTGCC TGCAAGCCTT TTGAAAAGCA AGCATAAAAG ATCTAAACAT 
6001 AAAATCTGTA AAATAACAAG ATGTAAAGAT AATGCTAAAT CATTTGGCTT TTTGATTGAT 
6061 TGTACAGGAA AATATACATC GCAGGGGGTT GACTTTTACC ATTTCACCGC AATGGAATCA 
6121 AACTTGTTGA AGAGAATGTT CACAGGCGCA TACGCTACAA TGACCCGATT CTTGCTAGCC 
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6181 TTTTCTCGGT CTTGCAAACA ACCGCCGGCA GCTTAGTATA TAAATACACA TGTACATACC 
6241 TCTCTCCGTA TCCTCGTAAT CATTTTCTTG TATTTATCGT CTTTTCGCTG TAAAAACTTT 
6301 ATCACACTTA TCTCAAATAC ACTTATTAAC CGCTTTTACT ATTATCTTCT ACGCTGACAG 
6361 TAATATCAAA CAGTGACACA TATTAAACAC AGTGGTTTCT TTGCATAAAC ACCATCAGCC 
6421 TCAAGTCGTC AAGTAAAGAT TTCGTGTTCA TGCAGATAGA TAACAATCTA TATGTTGATA 
6481 ATTAGCGTTG CCTCATCAAT GCGAGATCCG TTTAACCGGA CCCTAGTGCA CTTACCCCAC 
6541 GTTCGGTCCA CTGTGTGCCG AACATGCTCC TTCACTATTT TAACATGTGG AATTAATTCT 
6601 CATGTTTGAC AGCTTATCAT CGAACTCTAA GAGGTGATAC TTATTTACTG TAAAACTGTG 
6661 ACGATAAAAC CGGAAGGAAG AATAAGAAAA CTCGAACTGA TCTATAATGC CTATTTTCTG 
6721 TAAAGAGTTT AAGCTATGAA AGCCTCGGCA TTTTGGCCGC TCCTAGGTAG TGCTTTTTTT 
6781 CCAAGGACAA AACAGTTTCT TTTTCTTGAG CAGGTTTTAT GTTTCGGTAA TCATAAACAA 
6841 TAAATAAATT ATTTCATTTA TGTTTAAAAA TAAAAAATAA AAAAGTATTT TAAATTTTTA 
6901 AAAAAGTTGA TTATAAGCAT GTGACCTTTT GCAAGCAATT AAATTTTGCA ATTTGTGATT 
6961 TTAGGCAAAA GTTACAATTT CTGGCTCGTG TAATATATGT ATGCTAAAGT GAACTTTTAC 
7021 AAAGTCGATA TGGACTTAGT CAAAAGAAAT TTTCTTAAAA ATATATAGCA CTAGCCAATT 
7081 TAGCACTTCT TTATGAGATA TATTATAGAC TTTATTAAGC CAGATTTGTG TATTATATGT 
7141 ATTTACCCGG CGAATCATGG ACATACATTC TGAAATAGGT AATATTCTCT ATGGTGAGAC 
7201 AGCATAGATA ACCTAGGATA CAAGTTAAAA GCTAGTACTG TTTTGCAGTA ATTTTTTTCT 
7261 TTTTTATAAG AATGTTACCA CCTAAATAAG TTATAAAGTC AATAGTTAAG TTTGATATTT 
7321 GATTGTAAAA TACCGTAATA TATTTGCATG ATCAAAAGGC TCAATGTTGA CTAGCCAGCA 
7381 TGTCAACCAC TATATTGATC ACCGATATAT GGACTTCCAC ACCAACTAGT AATATGACAA 
7441 TAAATTCAAG ATATTCTTCA TGAGAATGGC CCAGCGATAT ATGCGGTGTG AAATACCGCA 
7501 CAGATGCGTA AGGAGAAAAT ACCGCATCAG GCGCCATTCG CCATTCAGGC TGCGCAACTG 
7561 TTGGGAAGGG CGATCGGTGC GGGCCTCTTC GCTATTACGC CAGCTGGCGA AAGGGGGATG 
7621 TGCTGCAAGG CGATTAAGTT GGGTAACGCC AGGGTTTTCC CAGTCACGAC GTTGTAAAAC 
7681 GACGGCCAGT 
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1 GAATTCTTAT TACGATCCTC GCGCCCCcta CCCACCGTAC TCGTCAATTC CAAGGGCATC 
61 GGTAAACATC TGCTCAAACT CGAAGTCGGC CATATCCAGA GCGCCGTAGG GGGCGGAGTC 
121 GTGGGGGGTA AATCCCGGAC CCGGGGAATC CCCGTCCCCC AACATGTCCA GATCGAAATC 
181 GTCTAGCGCG TCGGCATGCG CCATCGCCAC GTCCTCGCCG TCTAAGTGGA GCTCGTCCCC 
241 CAGGCTGACA TCGGTCGGGG GGGCCGTCGA CAGTCTGCGC GTGTGTCCCG CGGGGAGAAA 
301 GGACAGGCGC GGAGCCGCCA GCCCCGCCTC TTCGGGGGCG TCGTCGTCCG GGAGATCGAG 
361 CAGGCCCTCG ATGGTAGACC CGTAATTGTT TTTCGTACGC GCGCGGCTGT ACGCGGACCC 
421 ACTTTCACAT TTAAGTTGTT TTTCTAATCC GCATATGATC AATTCAAGGC CGAATAAGAA 
481 GGCTGGCTCT GCACCTTGGT GATCAAATAA TTCGATAGCT TGTCGTAATA ATGGCGGCAT 
541 ACTATCAGTA GTAGGTGTTT CCCTTTCTTC TTTAGCGACT TGATGCTCTT GATCTTCCAA 
601 TACGCAACCT AAAGTAAAAT GCCCCACAGC GCTGAGTGCA TATAAcGCgT TCTCTAGTGA 
661 AAAACCTTGT TGGCATAAAA AGGCTAATTG ATTTTCGAGA GTTTCATACT GTTTTTCTGT 
721 AGGCCGTGTA tCTgAATGTA CTTTTGCTCC ATtGCGATGA CTTAGTAAAG CACATCTAAA 
781 ACTTTTAGCG TTATTgCGTA AAAAATCTTG CCAGCTTTCC CCTTtTAAAG GGCAAAAGTG 
841 AGTATGGTGC CTATCTAACA TCTCAATGGC TAAGGCGTCG AGCAAAGCCC GCTTATTTTT 
130 
 
901 TACATGCCAA TACAgTGTAG GCTGCTCTAC ACCaAGCTTC TGGGCGAGTT TACGGGTTGT 
961 TAAACCTTCG ATTCCGACCT CATTAAGCAG CTCTAATGCG CTGTTAATCA CTTTACTTTT 
1021 ATCTAATCTA GAcatTATAG TTTTTTCTCC TTGACGTTAA AGTATAGAGG TATATTAACA 
1081 ATTTTTTGTT GATACTTTTA TTACATTTGA ATAAGAAGTA ATACAAACCG AAAATGTTGA 
1141 AAGTATTAGT TAAAGTGGTT ATGCAGTTTT TGCATTTATA TATCTGTTAA TAGATCAAAA 
1201 ATCATCGCTT CGCTGATTAA TTACCCCAGA AATAAGGCTA AAAAACTAAT CGCATTATCA 
1261 TCCCcTCGAC GTACTGTACA TATAACCACT GGTTTTATAT ACAGCAGTAC TGTACATATA 
1321 ACCACTGGTT TTATATACAG CAGTCGACGT ACTGTACATA TAACCACTGG TTTTATATAC 
1381 AGCAGTACTG gACATATAAC CACTGGTTTT ATATACAGCA GTCGAGGTAA GATTAGATAT 
1441 GCTCGAGTAA TTCGCGCCAC TTCTAAATAA GCGAATTTCT TATGATTTAT GATTTTTATT 
1501 ATTAAATAAG TTATAAAAAA AATAAGTGTA TACAAATTTT AAAGTGACTC TTAGGTTTTA 
1561 AAACGAAAAT TCTTGTTCTT GAGTAACTCT TTCCTGTAGG TCAGGTTGCT TTCTCAGGTA 
1621 TAGCATGAGG TCGCTCTTAT TGACCACACC TCTACCGGCA GATCAATTCC TCGATCCCTA 
1681 TCAGTGATAG AGAGTCGACA AAGTCGAGTT TCTCGATCCC TATCAGTGAT AGAGAGTCGA 
1741 CAAAGTCGAG TTTCTCGATC GAGACCACTG CATGCATGTG CTCTGTATGT ATATAAAACT 
1801 CTTGTTTTCT TCTTTTCTCT AAATATTCTT TCCTTATACA TTAGGTCCTT TGTAGCATAA 
1861 ATTACTATAC TTCTATAGAC ACGCAAACAC AAATACACAC ACTAAATTAC CGGATCAATT 
1921 CGGGGGATCC ATGTCGAAAG CTACATATAA GGAACGTGCT GCTACTCATC CTAGTCCTGT 
1981 TGCTGCCAAG CTATTTAATA TCATGCACGA AAAGCAAACA AACTTGTGTG CTTCATTGGA 
2041 TGTTCGTACC ACCAAGGAAT TACTGGAGTT AGTTGAAGCA TTAGGTCCCA AAATTTGTTT 
2101 ACTAAAAACA CATGTGGATA TCTTGACTGA TTTTTCCATG GAGGGCACAG TTAAGCCGCT 
2161 AAAGGCATTA TCCGCCAAGT ACAATTTTTT ACTCTTCGAA GACAGAAAAT TTGCTGACAT 
2221 TGGTAATACA GTCAAATTGC AGTACTCTGC GGGTGTATAC AGAATAGCAG AATGGGCAGA 
2281 CATTACGAAT GCACACGGTG TGGTGGGCCC AGGTATTGTT AGCGGTTTGA AGCAGGCGGC 
2341 aGAAGAAGTA ACAAAGGAAC CTAGAGGCCT TTTGATGTTA GCAGAATTGT CATGCAAGGG 
2401 CTCCCTAtCT ACTGGAGAAT ATACTAAGGG TACTGTTGAC ATTGCGAAGA GCGACAAAGA 
2461 TTTTGTTATC GGCTTTATTG CTCAAAGAGA CATGGGTGGA AGAGATGAAG GTTACGATTG 
2521 GTTGATTATG ACACCCGGTG TGGGTTTAGA TGACAAGGGA GACGCATTGG GTCAACAGTA 
2581 TAGAACCGTG GATGATGTGG TCTCTACAGG ATCTGACATT ATTATTGTTG GAAGAGGACT 
2641 ATTTGCAAAG GGAAGGGATG CTAAGGTAGA GGGTGAACGT TACAGAAAAG CAGGCTGGGA 
2701 AGCATATTTG AGAAGATGCG GCCAGCAAAA CTAACCTGCA GGAGGGCCGC ATCATGTAAT 
2761 TAGTTATGTC ACGCTTACAT TCACGCCCTC CCCCCACATC CGCTCTAACC GAAAAGGAAG 
2821 GAGTTAGACA ACCTGAAGTC TAGGTCCCTA TTTATTTTTT TATAGTTATG TTAGTATTAA 
2881 GAACGTTATT TATATTTCAA ATTTTTCTTT TTTTTCTGTA CAGACGCGTG TACGCATGTA 
2941 ACATTATACT GAAAACCTTG CTTGAGAAGG TTTTGGGACG CTCGAAGGCT TTAATTTGCG 
3001 GCCAAGCTTG GCGTAATCAT GGTCATAGCT GTTTCCTGTG TGAAATTGTT ATCCGCTCAC 
3061 AATTCCACAC AACATACGAG CCGGAAGCAT AAAGTGTAAA GCCTGGGGTG CCTAATGAGT 
3121 GAGCTAACTC ACATTAATTG CGTTGCGCTC ACTGCCCGCT TTCCAGTCGG GAAACCTGTC 
3181 GTGCCAGCTG CATTAATGAA TCGGCCAACG CGCGGGGAGA GGCGGTTTGC GTATTGGGCG 
3241 CTCTTCCGCT TCCTCGCTCA CTGACTCGCT GCGCTCGGTC GTTCGGCTGC GGCGAGCGGT 
3301 ATCAGCTCAC TCAAAGGCGG TAATACGGTT ATCCACAGAA TCAGGGGATA ACGCAGGAAA 
3361 GAACATGTGA GCAAAAGGCC AGCAAAAGGC CAGGAACCGT AAAAAGGCCG CGTTGCTGGC 
3421 GTTTTTCCAT AGGCTCCGCC CCCCTGACGA GCATCACAAA AATCGACGCT CAAGTCAGAG 
3481 GTGGCGAAAC CCGACAGGAC TATAAAGATA CCAGGCGTTT CCCCCTGGAA GCTCCCTCGT 
3541 GCGCTCTCCT GTTCCGACCC TGCCGCTTAC CGGATACCTG TCCGCCTTTC TCCCTTCGGG 
3601 AAGCGTGGCG CTTTCTCATA GCTCACGCTG TAGGTATCTC AGTTCGGTGT AGGTCGTTCG 
3661 CTCCAAGCTG GGCTGTGTGC ACGAACCCCC CGTTCAGCCC GACCGCTGCG CCTTATCCGG 
3721 TAACTATCGT CTTGAGTCCA ACCCGGTAAG ACACGACTTA TCGCCACTGG CAGCAGCCAC 
3781 TGGTAACAGG ATTAGCAGAG CGAGGTATGT AGGCGGTGCT ACAGAGTTCT TGAAGTGGTG 
3841 GCCTAACTAC GGCTACACTA GAAGGACAGT ATTTGGTATC TGCGCTCTGC TGAAGCCAGT 
3901 TACCTTCGGA AAAAGAGTTG GTAGCTCTTG ATCCGGCAAA CAAACCACCG CTGGTAGCGG 
3961 TGGTTTTTTT GTTTGCAAGC AGCAGATTAC GCGCAGAAAA AAAGGATCTC AAGAAGATCC 
4021 TTTGATCTTT TCTACGGGGT CTGACGCTCA GTGGAACGAA AACTCACGTT AAGGGATTTT 
4081 GGTCATGAGA TTATCAAAAA GGATCTTCAC CTAGATCCTT TTAAATTAAA AATGAAGTTT 
4141 TAAATCAATC TAAAGTATAT ATGAGTAAAC TTGGTCTGAC AGTTACCAAT GCTTAATCAG 
4201 TGAGGCACCT ATCTCAGCGA TCTGTCTATT TCGTTCATCC ATAGTTGCCT GACTCCCCGT 
4261 CGTGTAGATA ACTACGATAC GGGAGGGCTT ACCATCTGGC CCCAGTGCTG CAATGATACC 
4321 GCGAGACCCA CGCTCACCGG CTCCAGATTT ATCAGCAATA AACCAGCCAG CCGGAAGGGC 
4381 CGAGCGCAGA AGTGGTCCTG CAACTTTATC CGCCTCCATC CAGTCTATTA ATTGTTGCCG 
4441 GGAAGCTAGA GTAAGTAGTT CGCCAGTTAA TAGTTTGCGC AACGTTGTTG CCATTGCTAC 
4501 AGGCATCGTG GTGTCACGCT CGTCGTTTGG TATGGCTTCA TTCAGCTCCG GTTCCCAACG 
4561 ATCAAGGCGA GTTACATGAT CCCCCATGTT GTGCAAAAAA GCGGTTAGCT CCTTCGGTCC 
4621 TCCGATCGTT GTCAGAAGTA AGTTGGCCGC AGTGTTATCA CTCATGGTTA TGGCAGCACT 
131 
 
4681 GCATAATTCT CTTACTGTCA TGCCATCCGT AAGATGCTTT TCTGTGACTG GTGAGTACTC 
4741 AACCAAGTCA TTCTGAGAAT AGTGTATGCG GCGACCGAGT TGCTCTTGCC CGGCGTCAAT 
4801 ACGGGATAAT ACCGCGCCAC ATAGCAGAAC TTTAAAAGTG CTCATCATTG GAAAACGTTC 
4861 TTCGGGGCGA AAACTCTCAA GGATCTTACC GCTGTTGAGA TCCAGTTCGA TGTAACCCAC 
4921 TCGTGCACCC AACTGATCTT CAGCATCTTT TACTTTCACC AGCGTTTCTG GGTGAGCAAA 
4981 AACAGGAAGG CAAAATGCCG CAAAAAAGGG AATAAGGGCG ACACGGAAAT GTTGAATACT 
5041 CATACTCTTC CTTTTTCAAT ATTATTGAAG CATTTATCAG GGTTATTGTC TCATGAGCGG 
5101 ATACATATTT GAATGTATTT AGAAAAATAA ACAAATAGGG GTTCCGCGCA CATTTCCCCG 
5161 AAAAGTGCCA CCTGACGTCT AAGAAACCAT TATTATCATG ACATTAACCT ATAAAAATAG 
5221 GCGTATCACG AGGCCCTTTC GTCTTCAAGA ATTAATTCGG TCGAAAAAAG AAAAGGAGAG 
5281 GGCCAAGAGG GAGGGCATTG GTGACTATTG AGCACGTGAG TATACGTGAT TAAGCACACA 
5341 AAGGCAGCTT GGAGTATGTC TGTTATTAAT TTCACAGGTA GTTCTGGTCC ATTGGTGAAA 
5401 GTTTGCGGCT TGCAGAGCAC AGAGGCCGCA GAATGTGCAC TAGATTCCGA TGCTGACTTG 
5461 CTGGGTATTA TATGTGTGCC CAATAGAAAG AGAACAATTG ACCCGGTTAT TGCAAGGAAA 
5521 ATTTCAAGTC TTGTAAAAGC ATATAAAAAT AGTTCAGGCA CTCCGAAATA CTTGGTTGGC 
5581 GTGTTTCGTA ATCAACCTAA GGAGGATGTT TTGGCTCTGG TCAATGATTA CGGCATTGAT 
5641 ATCGTCCAAC TGCATGGAGA TGAGTCGTGG CAAGAATACC AAGAGTTCCT CGGTTTGCCA 
5701 GTTATTAAAA GACTCGTATT TCCAAAAGAC TGCAACATAC TACTCAGTGC AGCTTCACAG 
5761 AAACCTCATT CGTTTATTCC CTTGTTTGAT TCAGAAGCAG GTGGGACAGG TGAACTTTTG 
5821 GATTGGAACT CGATTTCTGA CTGGGTTGGA AGGCAAGAGA GCCCCGAGAG CTTACATTTT 
5881 ATGTTAGCTG GTGGACTGAC GCCAGAAAAT GTTGGTGATG CGCTTAGATT AAATGGCGTT 
5941 ATTGGTGTTG ATGTAAGCGG AGGTGTGGAG ACAAATGGTG TAAAAGACTC TAACAAAATA 
6001 GCAAATTTCG TCAAAAATGC TAAGAAATAG GTTATTACTG AGTAGTATTT ATTTAAGTAT 
6061 TGTTTGTGCA CTTGCCTGCA AGCCTTTTGA AAAGCAAGCA TAAAAGATCT AAACATAAAA 
6121 TCTGTAAAAT AACAAGATGT AAAGATAATG CTAAATCATT TGGCTTTTTG ATTGATTGTA 
6181 CAGGAAAATA TACATCGCAG GGGGTTGACT TTTACCATTT CACCGCAATG GAATCAAACT 
6241 TGTTGAAGAG AATGTTCACA GGCGCATACG CTACAATGAC CCGATTCTTG CTAGCCTTTT 
6301 CTCGGTCTTG CAAACAACCG CCGGCAGCTT AGTATATAAA TACACATGTA CATACCTCTC 
6361 TCCGTATCCT CGTAATCATT TTCTTGTATT TATCGTCTTT TCGCTGTAAA AACTTTATCA 
6421 CACTTATCTC AAATACACTT ATTAACCGCT TTTACTATTA TCTTCTACGC TGACAGTAAT 
6481 ATCAAACAGT GACACATATT AAACACAGTG GTTTCTTTGC ATAAACACCA TCAGCCTCAA 
6541 GTCGTCAAGT AAAGATTTCG TGTTCATGCA GATAGATAAC AATCTATATG TTGATAATTA 
6601 GCGTTGCCTC ATCAATGCGA GATCCGTTTA ACCGGACCCT AGTGCACTTA CCCCACGTTC 
6661 GGTCCACTGT GTGCCGAACA TGCTCCTTCA CTATTTTAAC ATGTGGAATT AATTCTCATG 
6721 TTTGACAGCT TATCATCGAA CTCTAAGAGG TGATACTTAT TTACTGTAAA ACTGTGACGA 
6781 TAAAACCGGA AGGAAGAATA AGAAAACTCG AACTGATCTA TAATGCCTAT TTTCTGTAAA 
6841 GAGTTTAAGC TATGAAAGCC TCGGCATTTT GGCCGCTCCT AGGTAGTGCT TTTTTTCCAA 
6901 GGACAAAACA GTTTCTTTTT CTTGAGCAGG TTTTATGTTT CGGTAATCAT AAACAATAAA 
6961 TAAATTATTT CATTTATGTT TAAAAATAAA AAATAAAAAA GTATTTTAAA TTTTTAAAAA 
7021 AGTTGATTAT AAGCATGTGA CCTTTTGCAA GCAATTAAAT TTTGCAATTT GTGATTTTAG 
7081 GCAAAAGTTA CAATTTCTGG CTCGTGTAAT ATATGTATGC TAAAGTGAAC TTTTACAAAG 
7141 TCGATATGGA CTTAGTCAAA AGAAATTTTC TTAAAAATAT ATAGCACTAG CCAATTTAGC 
7201 ACTTCTTTAT GAGATATATT ATAGACTTTA TTAAGCCAGA TTTGTGTATT ATATGTATTT 
7261 ACCCGGCGAA TCATGGACAT ACATTCTGAA ATAGGTAATA TTCTCTATGG TGAGACAGCA 
7321 TAGATAACCT AGGATACAAG TTAAAAGCTA GTACTGTTTT GCAGTAATTT TTTTCTTTTT 
7381 TATAAGAATG TTACCACCTA AATAAGTTAT AAAGTCAATA GTTAAGTTTG ATATTTGATT 
7441 GTAAAATACC GTAATATATT TGCATGATCA AAAGGCTCAA TGTTGACTAG CCAGCATGTC 
7501 AACCACTATA TTGATCACCG ATATATGGAC TTCCACACCA ACTAGTAATA TGACAATAAA 
7561 TTCAAGATAT TCTTCATGAG AATGGCCCAG CGATATATGC GGTGTGAAAT ACCGCACAGA 
7621 TGCGTAAGGA GAAAATACCG CATCAGGCGC CATTCGCCAT TCAGGCTGCG CAACTGTTGG 
7681 GAAGGGCGAT CGGTGCGGGC CTCTTCGCTA TTACGCCAGC TGGCGAAAGG GGGATGTGCT 
7741 GCAAGGCGAT TAAGTTGGGT AACGCCAGGG TTTTCCCAGT CACGACGTTG TAAAACGACG 
7801 GCCAGT 
// 
pLW2697_pCM252_URA3_TetO7_2LexAop-pGAL1 7908 bp 
 
FEATURES   Location/Qualifiers 
CDS    complement(28..1035) 
/label=TetR'-Activator 
promoter   complement(1036..1325) 
/label=2LexAop-pGAL1 
promoter   1337..1548 
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/label="ADH1 transcriptional terminator" 
binding_site  1549..1867 
/label="7 TetO binding site" 
TATA_box   1868..2024 
/label="CYC1 TATA region" 
CDS    2033..2836 
/label=URA3 
terminator   2844..3105 
/label="CYC1 transcriptional terminator" 
Misc._feature  3106..7908 
/label="YCplac22 centromeric vector with the TRP1 marker" 
 
1 GAATTCTTAT TACGATCCTC GCGCCCCcta CCCACCGTAC TCGTCAATTC CAAGGGCATC 
61 GGTAAACATC TGCTCAAACT CGAAGTCGGC CATATCCAGA GCGCCGTAGG GGGCGGAGTC 
121 GTGGGGGGTA AATCCCGGAC CCGGGGAATC CCCGTCCCCC AACATGTCCA GATCGAAATC 
181 GTCTAGCGCG TCGGCATGCG CCATCGCCAC GTCCTCGCCG TCTAAGTGGA GCTCGTCCCC 
241 CAGGCTGACA TCGGTCGGGG GGGCCGTCGA CAGTCTGCGC GTGTGTCCCG CGGGGAGAAA 
301 GGACAGGCGC GGAGCCGCCA GCCCCGCCTC TTCGGGGGCG TCGTCGTCCG GGAGATCGAG 
361 CAGGCCCTCG ATGGTAGACC CGTAATTGTT TTTCGTACGC GCGCGGCTGT ACGCGGACCC 
421 ACTTTCACAT TTAAGTTGTT TTTCTAATCC GCATATGATC AATTCAAGGC CGAATAAGAA 
481 GGCTGGCTCT GCACCTTGGT GATCAAATAA TTCGATAGCT TGTCGTAATA ATGGCGGCAT 
541 ACTATCAGTA GTAGGTGTTT CCCTTTCTTC TTTAGCGACT TGATGCTCTT GATCTTCCAA 
601 TACGCAACCT AAAGTAAAAT GCCCCACAGC GCTGAGTGCA TATAAcGCgT TCTCTAGTGA 
661 AAAACCTTGT TGGCATAAAA AGGCTAATTG ATTTTCGAGA GTTTCATACT GTTTTTCTGT 
721 AGGCCGTGTA tCTgAATGTA CTTTTGCTCC ATtGCGATGA CTTAGTAAAG CACATCTAAA 
781 ACTTTTAGCG TTATTgCGTA AAAAATCTTG CCAGCTTTCC CCTTtTAAAG GGCAAAAGTG 
841 AGTATGGTGC CTATCTAACA TCTCAATGGC TAAGGCGTCG AGCAAAGCCC GCTTATTTTT 
901 TACATGCCAA TACAgTGTAG GCTGCTCTAC ACCaAGCTTC TGGGCGAGTT TACGGGTTGT 
961 TAAACCTTCG ATTCCGACCT CATTAAGCAG CTCTAATGCG CTGTTAATCA CTTTACTTTT 
1021 ATCTAATCTA GAcatTATAG TTTTTTCTCC TTGACGTTAA AGTATAGAGG TATATTAACA 
1081 ATTTTTTGTT GATACTTTTA TTACATTTGA ATAAGAAGTA ATACAAACCG AAAATGTTGA 
1141 AAGTATTAGT TAAAGTGGTT ATGCAGTTTT TGCATTTATA TATCTGTTAA TAGATCAAAA 
1201 ATCATCGCTT CGCTGATTAA TTACCCCAGA AATAAGGCTA AAAAACTAAT CGCATTATCA 
1261 TCCCctcgaG TACTGTACAT ATAACCACTG GTTTTATATA CAGCATCGAG GTAAGATTAG 
1321 ATATGCTCGA GTAATTCGCG CCACTTCTAA ATAAGCGAAT TTCTTATGAT TTATGATTTT 
1381 TATTATTAAA TAAGTTATAA AAAAAATAAG TGTATACAAA TTTTAAAGTG ACTCTTAGGT 
1441 TTTAAAACGA AAATTCTTGT TCTTGAGTAA CTCTTTCCTG TAGGTCAGGT TGCTTTCTCA 
1501 GGTATAGCAT GAGGTCGCTC TTATTGACCA CACCTCTACC GGCAGATCAA TTCCTCGATC 
1561 GAGTTTACCA CTCCCTATCA GTGATAGAGA AAAGTGAAAG TCGAGTTTAC CACTCCCTAT 
1621 CAGTGATAGA GAAAAGTGAA AGTCGAGTTT ACCACTCCCT ATCAGTGATA GAGAAAAGTG 
1681 AAAGTCGAGT TTACCACTCC TCAGTGACTA TAGAGAAAAG TGAAAGTCGA GTTTACCACT 
1741 CCCTATCAGT GATAGAGAAA AGTGAAAGTC GAGTTTACCA CTCCCTATCA GTGATAGAGA 
1801 AAAGTGAAAG TCGAGTTTAC CACTCCCTAT CAGTGATAGA GAAAAGTGAA AGTCGAGCTC 
1861 GGTACCCTAT GGCATGCATG TGCTCTGTAT GTATATAAAA CTCTTGTTTT CTTCTTTTCT 
1921 CTAAATATTC TTTCCTTATA CATTAGGTCC TTTGTAGCAT AAATTACTAT ACTTCTATAG 
1981 ACACGCAAAC ACAAATACAC ACACTAAATT ACCGGATCAA TTCGGGGGAT CCATGTCGAA 
2041 AGCTACATAT AAGGAACGTG CTGCTACTCA TCCTAGTCCT GTTGCTGCCA AGCTATTTAA 
2101 TATCATGCAC GAAAAGCAAA CAAACTTGTG TGCTTCATTG GATGTTCGTA CCACCAAGGA 
2161 ATTACTGGAG TTAGTTGAAG CATTAGGTCC CAAAATTTGT TTACTAAAAA CACATGTGGA 
2221 TATCTTGACT GATTTTTCCA TGGAGGGCAC AGTTAAGCCG CTAAAGGCAT TATCCGCCAA 
2281 GTACAATTTT TTACTCTTCG AAGACAGAAA ATTTGCTGAC ATTGGTAATA CAGTCAAATT 
2341 GCAGTACTCT GCGGGTGTAT ACAGAATAGC AGAATGGGCA GACATTACGA ATGCACACGG 
2401 TGTGGTGGGC CCAGGTATTG TTAGCGGTTT GAAGCAGGCG GCaGAAGAAG TAACAAAGGA 
2461 ACCTAGAGGC CTTTTGATGT TAGCAGAATT GTCATGCAAG GGCTCCCTAt CTACTGGAGA 
2521 ATATACTAAG GGTACTGTTG ACATTGCGAA GAGCGACAAA GATTTTGTTA TCGGCTTTAT 
2581 TGCTCAAAGA GACATGGGTG GAAGAGATGA AGGTTACGAT TGGTTGATTA TGACACCCGG 
2641 TGTGGGTTTA GATGACAAGG GAGACGCATT GGGTCAACAG TATAGAACCG TGGATGATGT 
2701 GGTCTCTACA GGATCTGACA TTATTATTGT TGGAAGAGGA CTATTTGCAA AGGGAAGGGA 
2761 TGCTAAGGTA GAGGGTGAAC GTTACAGAAA AGCAGGCTGG GAAGCATATT TGAGAAGATG 
2821 CGGCCAGCAA AACTAACCTG CAGGAGGGCC GCATCATGTA ATTAGTTATG TCACGCTTAC 
2881 ATTCACGCCC TCCCCCCACA TCCGCTCTAA CCGAAAAGGA AGGAGTTAGA CAACCTGAAG 
2941 TCTAGGTCCC TATTTATTTT TTTATAGTTA TGTTAGTATT AAGAACGTTA TTTATATTTC 
3001 AAATTTTTCT TTTTTTTCTG TACAGACGCG TGTACGCATG TAACATTATA CTGAAAACCT 
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3061 TGCTTGAGAA GGTTTTGGGA CGCTCGAAGG CTTTAATTTG CGGCCAAGCT TGGCGTAATC 
3121 ATGGTCATAG CTGTTTCCTG TGTGAAATTG TTATCCGCTC ACAATTCCAC ACAACATACG 
3181 AGCCGGAAGC ATAAAGTGTA AAGCCTGGGG TGCCTAATGA GTGAGCTAAC TCACATTAAT 
3241 TGCGTTGCGC TCACTGCCCG CTTTCCAGTC GGGAAACCTG TCGTGCCAGC TGCATTAATG 
3301 AATCGGCCAA CGCGCGGGGA GAGGCGGTTT GCGTATTGGG CGCTCTTCCG CTTCCTCGCT 
3361 CACTGACTCG CTGCGCTCGG TCGTTCGGCT GCGGCGAGCG GTATCAGCTC ACTCAAAGGC 
3421 GGTAATACGG TTATCCACAG AATCAGGGGA TAACGCAGGA AAGAACATGT GAGCAAAAGG 
3481 CCAGCAAAAG GCCAGGAACC GTAAAAAGGC CGCGTTGCTG GCGTTTTTCC ATAGGCTCCG 
3541 CCCCCCTGAC GAGCATCACA AAAATCGACG CTCAAGTCAG AGGTGGCGAA ACCCGACAGG 
3601 ACTATAAAGA TACCAGGCGT TTCCCCCTGG AAGCTCCCTC GTGCGCTCTC CTGTTCCGAC 
3661 CCTGCCGCTT ACCGGATACC TGTCCGCCTT TCTCCCTTCG GGAAGCGTGG CGCTTTCTCA 
3721 TAGCTCACGC TGTAGGTATC TCAGTTCGGT GTAGGTCGTT CGCTCCAAGC TGGGCTGTGT 
3781 GCACGAACCC CCCGTTCAGC CCGACCGCTG CGCCTTATCC GGTAACTATC GTCTTGAGTC 
3841 CAACCCGGTA AGACACGACT TATCGCCACT GGCAGCAGCC ACTGGTAACA GGATTAGCAG 
3901 AGCGAGGTAT GTAGGCGGTG CTACAGAGTT CTTGAAGTGG TGGCCTAACT ACGGCTACAC 
3961 TAGAAGGACA GTATTTGGTA TCTGCGCTCT GCTGAAGCCA GTTACCTTCG GAAAAAGAGT 
4021 TGGTAGCTCT TGATCCGGCA AACAAACCAC CGCTGGTAGC GGTGGTTTTT TTGTTTGCAA 
4081 GCAGCAGATT ACGCGCAGAA AAAAAGGATC TCAAGAAGAT CCTTTGATCT TTTCTACGGG 
4141 GTCTGACGCT CAGTGGAACG AAAACTCACG TTAAGGGATT TTGGTCATGA GATTATCAAA 
4201 AAGGATCTTC ACCTAGATCC TTTTAAATTA AAAATGAAGT TTTAAATCAA TCTAAAGTAT 
4261 ATATGAGTAA ACTTGGTCTG ACAGTTACCA ATGCTTAATC AGTGAGGCAC CTATCTCAGC 
4321 GATCTGTCTA TTTCGTTCAT CCATAGTTGC CTGACTCCCC GTCGTGTAGA TAACTACGAT 
4381 ACGGGAGGGC TTACCATCTG GCCCCAGTGC TGCAATGATA CCGCGAGACC CACGCTCACC 
4441 GGCTCCAGAT TTATCAGCAA TAAACCAGCC AGCCGGAAGG GCCGAGCGCA GAAGTGGTCC 
4501 TGCAACTTTA TCCGCCTCCA TCCAGTCTAT TAATTGTTGC CGGGAAGCTA GAGTAAGTAG 
4561 TTCGCCAGTT AATAGTTTGC GCAACGTTGT TGCCATTGCT ACAGGCATCG TGGTGTCACG 
4621 CTCGTCGTTT GGTATGGCTT CATTCAGCTC CGGTTCCCAA CGATCAAGGC GAGTTACATG 
4681 ATCCCCCATG TTGTGCAAAA AAGCGGTTAG CTCCTTCGGT CCTCCGATCG TTGTCAGAAG 
4741 TAAGTTGGCC GCAGTGTTAT CACTCATGGT TATGGCAGCA CTGCATAATT CTCTTACTGT 
4801 CATGCCATCC GTAAGATGCT TTTCTGTGAC TGGTGAGTAC TCAACCAAGT CATTCTGAGA 
4861 ATAGTGTATG CGGCGACCGA GTTGCTCTTG CCCGGCGTCA ATACGGGATA ATACCGCGCC 
4921 ACATAGCAGA ACTTTAAAAG TGCTCATCAT TGGAAAACGT TCTTCGGGGC GAAAACTCTC 
4981 AAGGATCTTA CCGCTGTTGA GATCCAGTTC GATGTAACCC ACTCGTGCAC CCAACTGATC 
5041 TTCAGCATCT TTTACTTTCA CCAGCGTTTC TGGGTGAGCA AAAACAGGAA GGCAAAATGC 
5101 CGCAAAAAAG GGAATAAGGG CGACACGGAA ATGTTGAATA CTCATACTCT TCCTTTTTCA 
5161 ATATTATTGA AGCATTTATC AGGGTTATTG TCTCATGAGC GGATACATAT TTGAATGTAT 
5221 TTAGAAAAAT AAACAAATAG GGGTTCCGCG CACATTTCCC CGAAAAGTGC CACCTGACGT 
5281 CTAAGAAACC ATTATTATCA TGACATTAAC CTATAAAAAT AGGCGTATCA CGAGGCCCTT 
5341 TCGTCTTCAA GAATTAATTC GGTCGAAAAA AGAAAAGGAG AGGGCCAAGA GGGAGGGCAT 
5401 TGGTGACTAT TGAGCACGTG AGTATACGTG ATTAAGCACA CAAAGGCAGC TTGGAGTATG 
5461 TCTGTTATTA ATTTCACAGG TAGTTCTGGT CCATTGGTGA AAGTTTGCGG CTTGCAGAGC 
5521 ACAGAGGCCG CAGAATGTGC ACTAGATTCC GATGCTGACT TGCTGGGTAT TATATGTGTG 
5581 CCCAATAGAA AGAGAACAAT TGACCCGGTT ATTGCAAGGA AAATTTCAAG TCTTGTAAAA 
5641 GCATATAAAA ATAGTTCAGG CACTCCGAAA TACTTGGTTG GCGTGTTTCG TAATCAACCT 
5701 AAGGAGGATG TTTTGGCTCT GGTCAATGAT TACGGCATTG ATATCGTCCA ACTGCATGGA 
5761 GATGAGTCGT GGCAAGAATA CCAAGAGTTC CTCGGTTTGC CAGTTATTAA AAGACTCGTA 
5821 TTTCCAAAAG ACTGCAACAT ACTACTCAGT GCAGCTTCAC AGAAACCTCA TTCGTTTATT 
5881 CCCTTGTTTG ATTCAGAAGC AGGTGGGACA GGTGAACTTT TGGATTGGAA CTCGATTTCT 
5941 GACTGGGTTG GAAGGCAAGA GAGCCCCGAG AGCTTACATT TTATGTTAGC TGGTGGACTG 
6001 ACGCCAGAAA ATGTTGGTGA TGCGCTTAGA TTAAATGGCG TTATTGGTGT TGATGTAAGC 
6061 GGAGGTGTGG AGACAAATGG TGTAAAAGAC TCTAACAAAA TAGCAAATTT CGTCAAAAAT 
6121 GCTAAGAAAT AGGTTATTAC TGAGTAGTAT TTATTTAAGT ATTGTTTGTG CACTTGCCTG 
6181 CAAGCCTTTT GAAAAGCAAG CATAAAAGAT CTAAACATAA AATCTGTAAA ATAACAAGAT 
6241 GTAAAGATAA TGCTAAATCA TTTGGCTTTT TGATTGATTG TACAGGAAAA TATACATCGC 
6301 AGGGGGTTGA CTTTTACCAT TTCACCGCAA TGGAATCAAA CTTGTTGAAG AGAATGTTCA 
6361 CAGGCGCATA CGCTACAATG ACCCGATTCT TGCTAGCCTT TTCTCGGTCT TGCAAACAAC 
6421 CGCCGGCAGC TTAGTATATA AATACACATG TACATACCTC TCTCCGTATC CTCGTAATCA 
6481 TTTTCTTGTA TTTATCGTCT TTTCGCTGTA AAAACTTTAT CACACTTATC TCAAATACAC 
6541 TTATTAACCG CTTTTACTAT TATCTTCTAC GCTGACAGTA ATATCAAACA GTGACACATA 
6601 TTAAACACAG TGGTTTCTTT GCATAAACAC CATCAGCCTC AAGTCGTCAA GTAAAGATTT 
6661 CGTGTTCATG CAGATAGATA ACAATCTATA TGTTGATAAT TAGCGTTGCC TCATCAATGC 
6721 GAGATCCGTT TAACCGGACC CTAGTGCACT TACCCCACGT TCGGTCCACT GTGTGCCGAA 
6781 CATGCTCCTT CACTATTTTA ACATGTGGAA TTAATTCTCA TGTTTGACAG CTTATCATCG 
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6841 AACTCTAAGA GGTGATACTT ATTTACTGTA AAACTGTGAC GATAAAACCG GAAGGAAGAA 
6901 TAAGAAAACT CGAACTGATC TATAATGCCT ATTTTCTGTA AAGAGTTTAA GCTATGAAAG 
6961 CCTCGGCATT TTGGCCGCTC CTAGGTAGTG CTTTTTTTCC AAGGACAAAA CAGTTTCTTT 
7021 TTCTTGAGCA GGTTTTATGT TTCGGTAATC ATAAACAATA AATAAATTAT TTCATTTATG 
7081 TTTAAAAATA AAAAATAAAA AAGTATTTTA AATTTTTAAA AAAGTTGATT ATAAGCATGT 
7141 GACCTTTTGC AAGCAATTAA ATTTTGCAAT TTGTGATTTT AGGCAAAAGT TACAATTTCT 
7201 GGCTCGTGTA ATATATGTAT GCTAAAGTGA ACTTTTACAA AGTCGATATG GACTTAGTCA 
7261 AAAGAAATTT TCTTAAAAAT ATATAGCACT AGCCAATTTA GCACTTCTTT ATGAGATATA 
7321 TTATAGACTT TATTAAGCCA GATTTGTGTA TTATATGTAT TTACCCGGCG AATCATGGAC 
7381 ATACATTCTG AAATAGGTAA TATTCTCTAT GGTGAGACAG CATAGATAAC CTAGGATACA 
7441 AGTTAAAAGC TAGTACTGTT TTGCAGTAAT TTTTTTCTTT TTTATAAGAA TGTTACCACC 
7501 TAAATAAGTT ATAAAGTCAA TAGTTAAGTT TGATATTTGA TTGTAAAATA CCGTAATATA 
7561 TTTGCATGAT CAAAAGGCTC AATGTTGACT AGCCAGCATG TCAACCACTA TATTGATCAC 
7621 CGATATATGG ACTTCCACAC CAACTAGTAA TATGACAATA AATTCAAGAT ATTCTTCATG 
7681 AGAATGGCCC AGCGATATAT GCGGTGTGAA ATACCGCACA GATGCGTAAG GAGAAAATAC 
7741 CGCATCAGGC GCCATTCGCC ATTCAGGCTG CGCAACTGTT GGGAAGGGCG ATCGGTGCGG 
7801 GCCTCTTCGC TATTACGCCA GCTGGCGAAA GGGGGATGTG CTGCAAGGCG ATTAAGTTGG 
7861 GTAACGCCAG GGTTTTCCCA GTCACGACGT TGTAAAACGA CGGCCAGT 
// 
pLW2698_pCM252_URA3_TetO7_8LexAop-pGAL1 8024 bp 
 
FEATURES   Location/Qualifiers 
CDS    complement(28..1035) 
/label=TetR'-Activator 
promoter   complement(1036..1441) 
/label=8LexAop-pGAL1 
promoter   1453..1664 
/label="ADH1 transcriptional terminator" 
binding_site  1665..1983 
/label="7 TetO binding site" 
TATA_box   1984..2140 
/label="CYC1 TATA region" 
CDS    2149..2952 
/label=URA3 
terminator   2960..3221 
/label="CYC1 transcriptional terminator" 
Misc._feature  3222..8024 
/label="YCplac22 centromeric vector with the TRP1 marker" 
 
1 GAATTCTTAT TACGATCCTC GCGCCCCcta CCCACCGTAC TCGTCAATTC CAAGGGCATC 
61 GGTAAACATC TGCTCAAACT CGAAGTCGGC CATATCCAGA GCGCCGTAGG GGGCGGAGTC 
121 GTGGGGGGTA AATCCCGGAC CCGGGGAATC CCCGTCCCCC AACATGTCCA GATCGAAATC 
181 GTCTAGCGCG TCGGCATGCG CCATCGCCAC GTCCTCGCCG TCTAAGTGGA GCTCGTCCCC 
241 CAGGCTGACA TCGGTCGGGG GGGCCGTCGA CAGTCTGCGC GTGTGTCCCG CGGGGAGAAA 
301 GGACAGGCGC GGAGCCGCCA GCCCCGCCTC TTCGGGGGCG TCGTCGTCCG GGAGATCGAG 
361 CAGGCCCTCG ATGGTAGACC CGTAATTGTT TTTCGTACGC GCGCGGCTGT ACGCGGACCC 
421 ACTTTCACAT TTAAGTTGTT TTTCTAATCC GCATATGATC AATTCAAGGC CGAATAAGAA 
481 GGCTGGCTCT GCACCTTGGT GATCAAATAA TTCGATAGCT TGTCGTAATA ATGGCGGCAT 
541 ACTATCAGTA GTAGGTGTTT CCCTTTCTTC TTTAGCGACT TGATGCTCTT GATCTTCCAA 
601 TACGCAACCT AAAGTAAAAT GCCCCACAGC GCTGAGTGCA TATAAcGCgT TCTCTAGTGA 
661 AAAACCTTGT TGGCATAAAA AGGCTAATTG ATTTTCGAGA GTTTCATACT GTTTTTCTGT 
721 AGGCCGTGTA tCTgAATGTA CTTTTGCTCC ATtGCGATGA CTTAGTAAAG CACATCTAAA 
781 ACTTTTAGCG TTATTgCGTA AAAAATCTTG CCAGCTTTCC CCTTtTAAAG GGCAAAAGTG 
841 AGTATGGTGC CTATCTAACA TCTCAATGGC TAAGGCGTCG AGCAAAGCCC GCTTATTTTT 
901 TACATGCCAA TACAgTGTAG GCTGCTCTAC ACCaAGCTTC TGGGCGAGTT TACGGGTTGT 
961 TAAACCTTCG ATTCCGACCT CATTAAGCAG CTCTAATGCG CTGTTAATCA CTTTACTTTT 
1021 ATCTAATCTA GAcatTATAG TTTTTTCTCC TTGACGTTAA AGTATAGAGG TATATTAACA 
1081 ATTTTTTGTT GATACTTTTA TTACATTTGA ATAAGAAGTA ATACAAACCG AAAATGTTGA 
1141 AAGTATTAGT TAAAGTGGTT ATGCAGTTTT TGCATTTATA TATCTGTTAA TAGATCAAAA 
1201 ATCATCGCTT CGCTGATTAA TTACCCCAGA AATAAGGCTA AAAAACTAAT CGCATTATCA 
1261 TCCCcTCGAC GTACTGTACA TATAACCACT GGTTTTATAT ACAGCAGTAC TGTACATATA 
1321 ACCACTGGTT TTATATACAG CAGTCGACGT ACTGTACATA TAACCACTGG TTTTATATAC 
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1381 AGCAGTACTG gACATATAAC CACTGGTTTT ATATACAGCA GTCGAGGTAA GATTAGATAT 
1441 GCTCGAGTAA TTCGCGCCAC TTCTAAATAA GCGAATTTCT TATGATTTAT GATTTTTATT 
1501 ATTAAATAAG TTATAAAAAA AATAAGTGTA TACAAATTTT AAAGTGACTC TTAGGTTTTA 
1561 AAACGAAAAT TCTTGTTCTT GAGTAACTCT TTCCTGTAGG TCAGGTTGCT TTCTCAGGTA 
1621 TAGCATGAGG TCGCTCTTAT TGACCACACC TCTACCGGCA GATCAATTCC TCGATCGAGT 
1681 TTACCACTCC CTATCAGTGA TAGAGAAAAG TGAAAGTCGA GTTTACCACT CCCTATCAGT 
1741 GATAGAGAAA AGTGAAAGTC GAGTTTACCA CTCCCTATCA GTGATAGAGA AAAGTGAAAG 
1801 TCGAGTTTAC CACTCCTCAG TGACTATAGA GAAAAGTGAA AGTCGAGTTT ACCACTCCCT 
1861 ATCAGTGATA GAGAAAAGTG AAAGTCGAGT TTACCACTCC CTATCAGTGA TAGAGAAAAG 
1921 TGAAAGTCGA GTTTACCACT CCCTATCAGT GATAGAGAAA AGTGAAAGTC GAGCTCGGTA 
1981 CCCTATGGCA TGCATGTGCT CTGTATGTAT ATAAAACTCT TGTTTTCTTC TTTTCTCTAA 
2041 ATATTCTTTC CTTATACATT AGGTCCTTTG TAGCATAAAT TACTATACTT CTATAGACAC 
2101 GCAAACACAA ATACACACAC TAAATTACCG GATCAATTCG GGGGATCCAT GTCGAAAGCT 
2161 ACATATAAGG AACGTGCTGC TACTCATCCT AGTCCTGTTG CTGCCAAGCT ATTTAATATC 
2221 ATGCACGAAA AGCAAACAAA CTTGTGTGCT TCATTGGATG TTCGTACCAC CAAGGAATTA 
2281 CTGGAGTTAG TTGAAGCATT AGGTCCCAAA ATTTGTTTAC TAAAAACACA TGTGGATATC 
2341 TTGACTGATT TTTCCATGGA GGGCACAGTT AAGCCGCTAA AGGCATTATC CGCCAAGTAC 
2401 AATTTTTTAC TCTTCGAAGA CAGAAAATTT GCTGACATTG GTAATACAGT CAAATTGCAG 
2461 TACTCTGCGG GTGTATACAG AATAGCAGAA TGGGCAGACA TTACGAATGC ACACGGTGTG 
2521 GTGGGCCCAG GTATTGTTAG CGGTTTGAAG CAGGCGGCaG AAGAAGTAAC AAAGGAACCT 
2581 AGAGGCCTTT TGATGTTAGC AGAATTGTCA TGCAAGGGCT CCCTAtCTAC TGGAGAATAT 
2641 ACTAAGGGTA CTGTTGACAT TGCGAAGAGC GACAAAGATT TTGTTATCGG CTTTATTGCT 
2701 CAAAGAGACA TGGGTGGAAG AGATGAAGGT TACGATTGGT TGATTATGAC ACCCGGTGTG 
2761 GGTTTAGATG ACAAGGGAGA CGCATTGGGT CAACAGTATA GAACCGTGGA TGATGTGGTC 
2821 TCTACAGGAT CTGACATTAT TATTGTTGGA AGAGGACTAT TTGCAAAGGG AAGGGATGCT 
2881 AAGGTAGAGG GTGAACGTTA CAGAAAAGCA GGCTGGGAAG CATATTTGAG AAGATGCGGC 
2941 CAGCAAAACT AACCTGCAGG AGGGCCGCAT CATGTAATTA GTTATGTCAC GCTTACATTC 
3001 ACGCCCTCCC CCCACATCCG CTCTAACCGA AAAGGAAGGA GTTAGACAAC CTGAAGTCTA 
3061 GGTCCCTATT TATTTTTTTA TAGTTATGTT AGTATTAAGA ACGTTATTTA TATTTCAAAT 
3121 TTTTCTTTTT TTTCTGTACA GACGCGTGTA CGCATGTAAC ATTATACTGA AAACCTTGCT 
3181 TGAGAAGGTT TTGGGACGCT CGAAGGCTTT AATTTGCGGC CAAGCTTGGC GTAATCATGG 
3241 TCATAGCTGT TTCCTGTGTG AAATTGTTAT CCGCTCACAA TTCCACACAA CATACGAGCC 
3301 GGAAGCATAA AGTGTAAAGC CTGGGGTGCC TAATGAGTGA GCTAACTCAC ATTAATTGCG 
3361 TTGCGCTCAC TGCCCGCTTT CCAGTCGGGA AACCTGTCGT GCCAGCTGCA TTAATGAATC 
3421 GGCCAACGCG CGGGGAGAGG CGGTTTGCGT ATTGGGCGCT CTTCCGCTTC CTCGCTCACT 
3481 GACTCGCTGC GCTCGGTCGT TCGGCTGCGG CGAGCGGTAT CAGCTCACTC AAAGGCGGTA 
3541 ATACGGTTAT CCACAGAATC AGGGGATAAC GCAGGAAAGA ACATGTGAGC AAAAGGCCAG 
3601 CAAAAGGCCA GGAACCGTAA AAAGGCCGCG TTGCTGGCGT TTTTCCATAG GCTCCGCCCC 
3661 CCTGACGAGC ATCACAAAAA TCGACGCTCA AGTCAGAGGT GGCGAAACCC GACAGGACTA 
3721 TAAAGATACC AGGCGTTTCC CCCTGGAAGC TCCCTCGTGC GCTCTCCTGT TCCGACCCTG 
3781 CCGCTTACCG GATACCTGTC CGCCTTTCTC CCTTCGGGAA GCGTGGCGCT TTCTCATAGC 
3841 TCACGCTGTA GGTATCTCAG TTCGGTGTAG GTCGTTCGCT CCAAGCTGGG CTGTGTGCAC 
3901 GAACCCCCCG TTCAGCCCGA CCGCTGCGCC TTATCCGGTA ACTATCGTCT TGAGTCCAAC 
3961 CCGGTAAGAC ACGACTTATC GCCACTGGCA GCAGCCACTG GTAACAGGAT TAGCAGAGCG 
4021 AGGTATGTAG GCGGTGCTAC AGAGTTCTTG AAGTGGTGGC CTAACTACGG CTACACTAGA 
4081 AGGACAGTAT TTGGTATCTG CGCTCTGCTG AAGCCAGTTA CCTTCGGAAA AAGAGTTGGT 
4141 AGCTCTTGAT CCGGCAAACA AACCACCGCT GGTAGCGGTG GTTTTTTTGT TTGCAAGCAG 
4201 CAGATTACGC GCAGAAAAAA AGGATCTCAA GAAGATCCTT TGATCTTTTC TACGGGGTCT 
4261 GACGCTCAGT GGAACGAAAA CTCACGTTAA GGGATTTTGG TCATGAGATT ATCAAAAAGG 
4321 ATCTTCACCT AGATCCTTTT AAATTAAAAA TGAAGTTTTA AATCAATCTA AAGTATATAT 
4381 GAGTAAACTT GGTCTGACAG TTACCAATGC TTAATCAGTG AGGCACCTAT CTCAGCGATC 
4441 TGTCTATTTC GTTCATCCAT AGTTGCCTGA CTCCCCGTCG TGTAGATAAC TACGATACGG 
4501 GAGGGCTTAC CATCTGGCCC CAGTGCTGCA ATGATACCGC GAGACCCACG CTCACCGGCT 
4561 CCAGATTTAT CAGCAATAAA CCAGCCAGCC GGAAGGGCCG AGCGCAGAAG TGGTCCTGCA 
4621 ACTTTATCCG CCTCCATCCA GTCTATTAAT TGTTGCCGGG AAGCTAGAGT AAGTAGTTCG 
4681 CCAGTTAATA GTTTGCGCAA CGTTGTTGCC ATTGCTACAG GCATCGTGGT GTCACGCTCG 
4741 TCGTTTGGTA TGGCTTCATT CAGCTCCGGT TCCCAACGAT CAAGGCGAGT TACATGATCC 
4801 CCCATGTTGT GCAAAAAAGC GGTTAGCTCC TTCGGTCCTC CGATCGTTGT CAGAAGTAAG 
4861 TTGGCCGCAG TGTTATCACT CATGGTTATG GCAGCACTGC ATAATTCTCT TACTGTCATG 
4921 CCATCCGTAA GATGCTTTTC TGTGACTGGT GAGTACTCAA CCAAGTCATT CTGAGAATAG 
4981 TGTATGCGGC GACCGAGTTG CTCTTGCCCG GCGTCAATAC GGGATAATAC CGCGCCACAT 
5041 AGCAGAACTT TAAAAGTGCT CATCATTGGA AAACGTTCTT CGGGGCGAAA ACTCTCAAGG 
5101 ATCTTACCGC TGTTGAGATC CAGTTCGATG TAACCCACTC GTGCACCCAA CTGATCTTCA 
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5161 GCATCTTTTA CTTTCACCAG CGTTTCTGGG TGAGCAAAAA CAGGAAGGCA AAATGCCGCA 
5221 AAAAAGGGAA TAAGGGCGAC ACGGAAATGT TGAATACTCA TACTCTTCCT TTTTCAATAT 
5281 TATTGAAGCA TTTATCAGGG TTATTGTCTC ATGAGCGGAT ACATATTTGA ATGTATTTAG 
5341 AAAAATAAAC AAATAGGGGT TCCGCGCACA TTTCCCCGAA AAGTGCCACC TGACGTCTAA 
5401 GAAACCATTA TTATCATGAC ATTAACCTAT AAAAATAGGC GTATCACGAG GCCCTTTCGT 
5461 CTTCAAGAAT TAATTCGGTC GAAAAAAGAA AAGGAGAGGG CCAAGAGGGA GGGCATTGGT 
5521 GACTATTGAG CACGTGAGTA TACGTGATTA AGCACACAAA GGCAGCTTGG AGTATGTCTG 
5581 TTATTAATTT CACAGGTAGT TCTGGTCCAT TGGTGAAAGT TTGCGGCTTG CAGAGCACAG 
5641 AGGCCGCAGA ATGTGCACTA GATTCCGATG CTGACTTGCT GGGTATTATA TGTGTGCCCA 
5701 ATAGAAAGAG AACAATTGAC CCGGTTATTG CAAGGAAAAT TTCAAGTCTT GTAAAAGCAT 
5761 ATAAAAATAG TTCAGGCACT CCGAAATACT TGGTTGGCGT GTTTCGTAAT CAACCTAAGG 
5821 AGGATGTTTT GGCTCTGGTC AATGATTACG GCATTGATAT CGTCCAACTG CATGGAGATG 
5881 AGTCGTGGCA AGAATACCAA GAGTTCCTCG GTTTGCCAGT TATTAAAAGA CTCGTATTTC 
5941 CAAAAGACTG CAACATACTA CTCAGTGCAG CTTCACAGAA ACCTCATTCG TTTATTCCCT 
6001 TGTTTGATTC AGAAGCAGGT GGGACAGGTG AACTTTTGGA TTGGAACTCG ATTTCTGACT 
6061 GGGTTGGAAG GCAAGAGAGC CCCGAGAGCT TACATTTTAT GTTAGCTGGT GGACTGACGC 
6121 CAGAAAATGT TGGTGATGCG CTTAGATTAA ATGGCGTTAT TGGTGTTGAT GTAAGCGGAG 
6181 GTGTGGAGAC AAATGGTGTA AAAGACTCTA ACAAAATAGC AAATTTCGTC AAAAATGCTA 
6241 AGAAATAGGT TATTACTGAG TAGTATTTAT TTAAGTATTG TTTGTGCACT TGCCTGCAAG 
6301 CCTTTTGAAA AGCAAGCATA AAAGATCTAA ACATAAAATC TGTAAAATAA CAAGATGTAA 
6361 AGATAATGCT AAATCATTTG GCTTTTTGAT TGATTGTACA GGAAAATATA CATCGCAGGG 
6421 GGTTGACTTT TACCATTTCA CCGCAATGGA ATCAAACTTG TTGAAGAGAA TGTTCACAGG 
6481 CGCATACGCT ACAATGACCC GATTCTTGCT AGCCTTTTCT CGGTCTTGCA AACAACCGCC 
6541 GGCAGCTTAG TATATAAATA CACATGTACA TACCTCTCTC CGTATCCTCG TAATCATTTT 
6601 CTTGTATTTA TCGTCTTTTC GCTGTAAAAA CTTTATCACA CTTATCTCAA ATACACTTAT 
6661 TAACCGCTTT TACTATTATC TTCTACGCTG ACAGTAATAT CAAACAGTGA CACATATTAA 
6721 ACACAGTGGT TTCTTTGCAT AAACACCATC AGCCTCAAGT CGTCAAGTAA AGATTTCGTG 
6781 TTCATGCAGA TAGATAACAA TCTATATGTT GATAATTAGC GTTGCCTCAT CAATGCGAGA 
6841 TCCGTTTAAC CGGACCCTAG TGCACTTACC CCACGTTCGG TCCACTGTGT GCCGAACATG 
6901 CTCCTTCACT ATTTTAACAT GTGGAATTAA TTCTCATGTT TGACAGCTTA TCATCGAACT 
6961 CTAAGAGGTG ATACTTATTT ACTGTAAAAC TGTGACGATA AAACCGGAAG GAAGAATAAG 
7021 AAAACTCGAA CTGATCTATA ATGCCTATTT TCTGTAAAGA GTTTAAGCTA TGAAAGCCTC 
7081 GGCATTTTGG CCGCTCCTAG GTAGTGCTTT TTTTCCAAGG ACAAAACAGT TTCTTTTTCT 
7141 TGAGCAGGTT TTATGTTTCG GTAATCATAA ACAATAAATA AATTATTTCA TTTATGTTTA 
7201 AAAATAAAAA ATAAAAAAGT ATTTTAAATT TTTAAAAAAG TTGATTATAA GCATGTGACC 
7261 TTTTGCAAGC AATTAAATTT TGCAATTTGT GATTTTAGGC AAAAGTTACA ATTTCTGGCT 
7321 CGTGTAATAT ATGTATGCTA AAGTGAACTT TTACAAAGTC GATATGGACT TAGTCAAAAG 
7381 AAATTTTCTT AAAAATATAT AGCACTAGCC AATTTAGCAC TTCTTTATGA GATATATTAT 
7441 AGACTTTATT AAGCCAGATT TGTGTATTAT ATGTATTTAC CCGGCGAATC ATGGACATAC 
7501 ATTCTGAAAT AGGTAATATT CTCTATGGTG AGACAGCATA GATAACCTAG GATACAAGTT 
7561 AAAAGCTAGT ACTGTTTTGC AGTAATTTTT TTCTTTTTTA TAAGAATGTT ACCACCTAAA 
7621 TAAGTTATAA AGTCAATAGT TAAGTTTGAT ATTTGATTGT AAAATACCGT AATATATTTG 
7681 CATGATCAAA AGGCTCAATG TTGACTAGCC AGCATGTCAA CCACTATATT GATCACCGAT 
7741 ATATGGACTT CCACACCAAC TAGTAATATG ACAATAAATT CAAGATATTC TTCATGAGAA 
7801 TGGCCCAGCG ATATATGCGG TGTGAAATAC CGCACAGATG CGTAAGGAGA AAATACCGCA 
7861 TCAGGCGCCA TTCGCCATTC AGGCTGCGCA ACTGTTGGGA AGGGCGATCG GTGCGGGCCT 
7921 CTTCGCTATT ACGCCAGCTG GCGAAAGGGG GATGTGCTGC AAGGCGATTA AGTTGGGTAA 
7981 CGCCAGGGTT TTCCCAGTCA CGACGTTGTA AAACGACGGC CAGT 
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